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Abstract
The human gut microbiome is a complex and dynamic ecosystem, featuring a multitude of microbes all interacting with their hosts in an elaborate manner. Even
though this exchange is often mediated through microbial metabolic and functional
outputs, such as the production of certain metabolites, environmental exposures and
host lifestyle are highly influential in shaping the presence of microbial species irrespective of their individual roles. As such, a comprehensive understanding of the
microbiome requires researchers to examine the relationship between taxonomic abundance and function simultaneously. Assessing microbial contributions to important
ecosystem services can enable identification of robust functions supported by a variety of species, or to identify important keystone taxa that are associated with a
disease-causing biochemical pathway. The primary objective of this thesis is to assess
different approaches for investigating the taxa-function relationship and evaluate its
value in providing unique biological insights. First, we leveraged densely collected
multi-omics data from the New Hampshire Birth Cohort Study to identify genusmetabolite pairs that are core to infant gut microbiomes. Second, we developed a
novel statistical method that enable integrating taxa-function relationships in epidemiological studies. Third, we assessed microbial phenotypic traits as a potential
source for defnining interpretable and human-centric microbiome functions.
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Chapter 1

Introduction
Section 1.1

The human gut microbiome and population
health
1.1.1. Overview of the human gut microbiome
The human microbiome is the collection of microorganisims (which includes bacteria,
protozoa, archaea, fungi, viruses, and their genes) that participates in a symbiotic
co-existence with their hosts [289]. It is difficult to study human microbiomes outside
the host due to difficulties in being able to culture the majority of organisms [298].
However, advances in sequencing technologies have allowed researchers to glimpse the
inner workings of these complex communities via their genomes [345]. Researchers
found that different body sites harbor unique environmental determinants that give
rise to distinct groups of microbes [59]. For example, in the oral microbiome, oral
surfaces have different surface receptors [102], promoting only microbes with specific
adhesins that are complementary [1]. This results in differences such as Streptococcus
mitis bv.2 species being represented in the tongue dorsum but not even detected in
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the related lateral tongue surface [1]. Even though the degree of diversity across body
sites extend across the entire tree of life, most studies so-far have focused on profiling
bacteria, which exists in high-abundance and is relatively easy to profile [41].
The gut environment specifically promotes a consortium of microbes that varies
across the digestive track [185, 70]. Most microbiome research has been focused on
the colon via fecal samples [278], where it has been estimated to contain the highest
microbial density recorded in any habitat [267]. The gut microbiome is initially
acquired at birth via maternal transfer [266, 15, 333]. The community matures over
time, increasing in diversity and reaching an adult-like state in around 2-3 years of
age, where it is characterized mainly by members of the Firmicutes, Actinobacteria,
and Bacteroidetes phyla, with Bacteroides, Faecalibacterium, and Bifidobacterium as
the most abundant genera [142, 200]. Many of the species identified to be in the gut
cannot be found in other habitats, suggesting a strong co-evolutionary relationship
with human hosts [164].
Various environmental factors can shape the composition of the gut microbiome.
In early life, the mode of delivery and breastfeeding status are significant modifiers of
composition. Infants who were born via vaginal delivery have increased abundances
of Bacteroides, Pectobacterium, and Bifidobacterium genera, while those born via
Cesarian section have decreased diversity and higher propensity to be colonized by
Staphylococcus and members of the Clostridum cluster [183, 141, 274]. Breastfeeding
is associated with lower levels of Escherichia coli, Tyzzerella nexilis, and Roseburia
intestinalis while on the other hand promoting the coloization of various Bifidobacterium species such as B. breve and B. dentium which harborsspecific genes that help
in digesting complex oligosaccharides [274, 291]. Among adults, diet is of particular
interest. Studies have shown that the Western diet, high in saturated and trans fats
while low in mono and polyunsaturated fats, is associated with decreased abundance
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in Bifidobacterium, Eubacterium, and Lactobacillus genera [325]. Other extrinsic and
intrinsic factors such as smoking status [27] and alcohol consumption [74] also contribute to microbiome modulation (reviewed in [263]). This demonstrates that the
microbiome is likely to be highly variable in composition as it is sensitive to changes
in host physiology.

1.1.2. Outcomes associated with changes in gut microbiome composition
Observed shifts in gut microbiome composition are often associated with adverse
health outcomes. As such, there is a great interest in epidemiological applications,
where the microbiome can be identified as either a marker or as a causal agent in
human disease [90]. Observational studies have linked changes in the gut microflora to
various metabolic and infectious diseases. This is because host inflammation responses
can be linked to the microbiome’s role in mediating immune function (reviewed in
[302]). Short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, are
metabolic products of microbiota digestion from dietary fiber and resistant starches.
These compounds bind to G-protein-coupled receptor 43 expressed in immune cells, an
effect that allows for immune responses to resolve post-infection, thereby preventing
persistent inflammation. As such, the gut microbiome is found to be associated with
inflammation-related diseases such as colorectal cancer [49, 336] and inflammatory
bowel disease [101, 93, 174]. There are many other conditions (reviewed in [52]) that
can be linked to changes in the gut microbiome, such as Clostridium difficile infection
[306] and obesity [288, 9].
Additionally, the gut microbiome is also linked to other conditions that are not
localized in the intestinal tract. The gut-brain axis refers to how residential gut microbes are involved in regulating host cognition, mood, and behavior [207]. There
are established links, for example, between the gut microbiome and neurological conditions such as autisum spectrum disorder (ASD), where individuals with ASD have
3
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different gut microbial signatures (an increase in several mucosa-associated Clostridiales) compared to neurotypical controls [179]. Another instance of the gut microbiome’s overarching impact on human physiology is the gut-lung axis [83], where the
crosstalk between gut and lung communities is linked to chronic and acute respiratory
conditions. For example, a study from the Canadian Healthy Infant Longitudinal Development cohort identified decreases in Lachnospira, Veillonella, Faecalibacterium,
and Rothia genera among children at risk of asthma attacks [11].

1.1.3. Challenges in determining potential microbial biomarkers
Despite the wealth of microbiome association studies, there still exist considerable
challenges in identifying consistent microbial markers that have meaningful associations with health outcomes [76]. In a meta-analysis of 10 studies for inflammatory
bowel disease and obesity [300], no individual microbe was consistently associated
with subject case status. Even though false discoveries are expected since populationlevel studies are indeed only exploratory and hypothesis generating, the practice of
interpreting differentially abundant taxa lists using post-hoc literature searches makes
results unreliable and biased. As a result, validating these markers proves to be arduous as it is impossible to disentangle which hypotheses are more contextually probable
to follow-up in expensive in vitro or in vivo laboratory experiments.
Statistical and computational difficulties remain one of the major hurdles towards
this replication issue [165, 169]. A mainstay of research in the field is the usage of
high-throughput sequencing technologies to profile microbial communities taxonomically and genomically. Various steps within the sample processing protocol such as
storage, DNA extraction, and library preparation, can contribute to differences in
results between studies [55]. Contamination is also a big issue [65], especially in environments where there is low total microbial load [81], thereby producing erroneous
results. Additionally, bioinformatic analyses and use of different databases may also
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cause divergences in observations [206]. For example, when 16S rRNA gene amplicon sequencing is used for taxonomic profiling, choosing to cluster amplicon sequence
variants (ASVs) to operational taxonomic units (OTUs) using a sequence similarity
threshold can yield radically different observed community profiles [50, 206].
In addition to issues pertaining to converting raw sequence data to named microbes, statistical analyses used to identify relevant candidates also suffer from inconsistencies. Microbiome taxonomic data, like other sequencing data sets, is compositional [104, 249] and constrained by the total number of reads (or library size). This
constraint induces spurious negative correlations between variables, whereby changes
in true absolute counts might not be accurately reflected at the observed relative
scale [172, 212]. Microbiome data is sparse, containing a mixture of both structural
zeroes (true absence of a taxon), and technical zeroes (abundance below the limit of
detection) [136, 271]. This makes it difficult to distinguish between low-abundance
and absent taxa, especially when studies differ considerably in sequencing quality and
depth. Finally, microbiome data is also high-dimensional, where a typical data set
contains from hundreds of species to thousands of sequence variants resulting in a
high multiple testing burden. All of the challenges above contribute to methods that
have to make difficult trade-offs between power, type I error control, and effect size
estimations. As a consequence, researchers are faced with a complex landscape of
available methods, which have been shown to produce different results on the same
data sets [219].
In addition to technical challenges, the gut microbiome itself is also dynamic with
a great degree of intra-individual variability. Even though the adult gut microbiome
composition is stable over longer time scales [59], studies have also shown that shifts in
composition occur on a day-to-day basis, impacted by host diet and lifestyle [63, 64].
However, the magnitude of shifts are small when compared to between host variability.
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In the original human microbiome project (HMP) paper, researchers estimated that
for signature genera that are supposed to be habitat-specific, their presence in samples
collected from respective environments can be as low as 17% (highest 84%) [59]. In
another study of gut microbiomes from a Chinese cohort of healthy individuals (N
= 120), around 90 (±16) species-level taxa (assayed using full length 16S rRNA
gene sequencing) were shared between individuals from the total of 1,235 identified
species [332]. This effect is consistent even when looking at the strain level [175].
For context, humans share around 99.5% of their genomes [125]. The degree of
microbiome personalization is significant enough to warrant initial exploration of
forensic applications [89].

Section 1.2

Approaching microbiome research from a
mechanistic perspective
1.2.1. The functional microbiome
The end goal of medical and epidemiological research on the gut microbiome is to
ascertain why selected microbes exist in a given environment, and how they can
affect human physiology to cause or mediate disease. The questions of “why” and
“how” usually underline discussions surrounding microbial function [144], the answers
to which can allow for the design of therapeutics and interventions [75]. As such,
researchers are interested in moving beyond looking at the microbiome from a purely
taxonomic perspective to a functional one [116].
One of the most important and well-known roles of the gut microbiome involves
the fermentation of foods into metabolites that can be absorbed by its host. Studies
have shown that the microbiome is involved in the digestion of all three macronutrient
sources from the human diet: carbohydrates, lipids, and proteins (reviewed in [228]).
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For carbohydrates, even though the human gut can hydrolyze and absorb certain
sugars such as glucose, fructose, and lactose in the proximal gastrointestinal (GI)
tract, the complexity of bonds that exist between monosaccharide units in dietary
starches (especially plant polysaccharides) means that the majority of carbohydrates
pass through to the distal GI where it is digested by very well-equipped microbes
[319]. The species Bacteroides thetaiotaomicron alone has 260 glycoside hydrolases
in its genome [329], well beyond that of native human enzymes. The by-product
of carbohydrate fermentation are SCFAs (most notably acetate, proprionate, and
butyrate) [182], which are compounds that not only have inherent nutritional value
but also play a role in maintaining the gut epithelial barrier. Even though proteins
and fats are not as central to microbiome function as carbohydrates, certain important
compounds have been shown to be linked to gut communities (reviewed in [208]). In
a study by Backhed et al., germ-free mice were fed significantly more chow compared
to wild-type controls yet had 42% less body fat [14]. Surprisingly, when a single
species from the microbiome of wild-type mice was transplanted (also Bacteroides
thetaiotaomicron), these formerly germ-free mice were able to partially recover their
capacity to produce body fat, thereby suggesting a relationship between gut microbes
and the process of adiposity. This provides further evidence for a link between the
gut microbiome and obesity [288].
The microbiome is also implicated with immune programming. Even though the
specific signalling pathways are still under active research, this process is mediated
through commensal secreted metabolites or surface-associated antigens that interact
directly with host immune cells (reviewed in [21]). For example, murine studies have
shown that the innate immune receptor Toll-like receptor 5 (TLR5) selects for certain
microbes during the neonatal period by serving as a sensor for bacterial flagellin [96].
During early life, in order to accommodate the initial colonization process, host im-
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mune response is limited and certain types of cell activity is suppressed. Microbes can
directly induce this by secreting molecules such as sphingolipids that inhibit the induction of invariant natural killer T cells (iNKT) [8]. Even though this process results
in an increased propensity of being infected, it also suppresses the host’s inflammatory
response, preventing excessive behaviors that might cause harmful outcomes such as
necrotizing enterocolitis [221]. This crosstalk continues throughout life, where the
microbiome participates in a co-operative relationship that helps maintain intestinal
homeostatsis (reviewed in [341]).
Overall, the gut microbiome participates in extensive biochemical pathways that
help maintain homeostasis and promote human health. The list of potential targets
grows as more studies demonstrate new and exciting host-microbe intractions. It is
clear that profiling microbial function can help get at the questions of “why” certain
microbes exist, as well as “how” they can lead to positive or negative health outcomes.

1.2.2. Approaches to characterize function in epidemiological studies
Advances in high-throughput molecular technologies have allowed researchers to comprehensively profile different functional components of the microbiome [90]. Although
powerful, each meta‘omic method faces different challenges in accomplishing their intended goals, such as complex sampling preparation strategies or limited resolution
and annotation. Here, we give a short description of major microbiome profiling
technologies currently in use and the types of biological insight they can provide.

Metagenomics. Metagenomics refers to untargeted DNA sequencing of the entire
gene content of a sample via “shotgun” shearing of fragments [248]. In terms of
taxonomic profiling, metagenomic approaches can provide species to strain level resolution [286], as well as being able to detect non-bacterial organisms such as archaea
and viruses. In terms of function, researchers can estimate the abundance of certain
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gene families in the entire community, which can be used downstream to infer entire
pathways and even predict structural variants [140]. Finally, assembly-based approaches can categorize sequence fragments into putative genomes, thereby enabling
the discovery of novel strains and genes [239]. However, since this is a DNA-based approach, gene family copy numbers only represent functional potential rather than true
outputs. This is further complicated by the fact that it is challenging to discern which
bacteria are “alive” since DNA is a stable molecule [248]. As such, inferences about
microbiome function drawn from metaegenomic data sets are limited, and difficult to
trace back to specific microbes. Finally, databases are woefully biased towards easily
identifiable strains, whereby most genes are defined as unmapped, making annotating
specific functions difficult.

Metatranscriptomics and Metaproteomics. Metatranscriptomics and metaproteopmics refer to profiling the entire transcript (i.e. RNA) and protein content of a
sample [91]. Both techniques measure downstream products of gene abundances,
therefore they are better representations of the total amount of functional information that is “active” within a community. Metatranscriptomics involve nucleic acid
sequencing similar to metagenomics (in fact, with proper tagging, one can simultaneously sequence both the transcriptional and genomic content of a sample), while
metaproteomics requires separation and quantification using a combination of liquid
chromatography (LC) and mass spectrometry (MS). Both metatranscriptomics and
metaproteomics can be mapped back to sequences obtained from original metagenomics results via sequence translation. This allows for powerful multi-omics approaches that can identify how a function reservoir is activated and expressed downstream. For example, in a paired metagenomic-metatranscriptomic analysis of healthy
gut microbiomes, researchers found that even though there is a reservoir of genes
coding for biosynthesis of amino acids, low transcriptional activity suggests that this
9
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function is under-expressed [92]. This is consistent with the fact that these procedures
are energetically unfavorable [228]. Despite such benefits, there are various challenges
in the technical aspect of these profiling approaches. For metatranscriptomics, not
only are mRNAs highly unstable, they are dwarfed in abundance by rRNA in the total
RNA pool, requiring specialized techniques to enrich for them while also removing
human contaminants. For metaproteomics, the process of protein purification and
extraction is demanding due to the complexity of the environment, requiring more
biomass as well as special sample preparations to reach the degree of depth obtained
by nucleic acid sequencing technologies [160, 261, 293].

Metabolomics. Metabolomics refers to the direct quantification of metabolites and
other small molecules. It is different from metatranscriptomics and metaproteomics
in the fact that there is no convenient map to sequence information [91], making
direct integration with taxonomic or gene abundances from metagenomic sequencing
more challenging. However, metabolomics reflects the layer of microbiome function
that is closest to the host-microbiome interface, as measured metabolites interact directly with host receptors or participate in collaborative metabolic pathways [277].
Integrative multi-omics data sets featuring metabolomics have shown important links
between microbes, their metabolic outputs, and human disease. For example, a study
identified that changes in the microbiome have been implicated in the production of
trimethylamine N-oxide (TMAO), a compound associated with cardiovascular disease, from l-carnitine (commonly found in red meat) [303]. One large benefit of
metabolomics is that its sample preparation requirements are not as demanding as
that of metaproteomics [93, 293]. However, each molecule has different properties
and chemical structures, which means that some compounds are easier to measure
than others, creating biases in which type of features gets measured [277]. Finally,
metabolomic profiles are highly variable and sensitive to perturbations such as food
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consumption prior to measurement [118]. As such, it is suggested that metabolite
flux might be a more meaningful measure of microbiome function rather than crosssectional measures of concentration.

1.2.3. Obstacles in a function-based approach
A common misconception is that microbiome functional profiles are relatively more
stable across individuals compared to their taxonomic counterparts [59]. This means
that analyses focusing on community-wide functional ‘omics analyses might produce
more consistent and validatable results. However, the degree of comparative stability
is difficult to ascertain due to differences in the scale of comparison across taxonomy
and function [156]. In fact, when gene families are considered instead of pathways, the
degree of stability decreased significantly [124]. Additionally, empirical studies have
also shown that using pathway abundances are not significantly better at classifying
patients disease status [330].
Two major challenges exist for function-driven microbiome analyses (reviewed in
[116]). First, the large number of available molecular technologies mean that there is
considerable choice in what constitutes as “function” in a certain context. In other
words, depending on the research question, researchers have to make a decision on the
analytical unit of microbial function, be it gene family abundance, pathway presenceabsence, or concentrations of groups of metabolites. For example, in an analysis
of strain-specific functional adaptation of the infant gut microbiome from the DIABIMMUNE cohort [291], the authors were interested in microbial capacity to digest
human milk oligosaccharides (HMO) as a core ecosystem function. However, HMO
metabolism is not encoded as a single pathway in frequently used databases such as
the Kyoto Encyclopedia of Genes and Genomes (KEGG) or Gene Ontology (GO),
but rather as a group of 30 genes identified via literature review. As such, defining
functions based on the research question of interest can provide meaningful interpre11

1.3 An integrative approach to incorporate both structure and
function
tations on the services that microbes confer. Second, there is a considerable amount
of “microbial dark matter” that hampers the characterization of functional dynamics
[131]. For example, in a study involving metatranscriptomic profiling, around 9%
of differentially abundant transcripts had unknown function [115]. Results can be
misleading if these limitations are not acknowledged or improved upon.

Section 1.3

An integrative approach to incorporate both
structure and function
1.3.1. Importance of taxa-function relationships
A holistic understanding of microbiome-related processes requires a conception of the
relationship between taxonomic compositions and their functional profiles, termed
the taxa-function relationship [156, 116]. Unfortunately, limited numbers of studies
have explored taxonomic drivers of functional shifts beyond anecdotal searches in the
literature [188], where it is more common to study them independently. This gap is
problematic because even though drivers of the microbiome’s impact on host health
are its functional outputs, modulation can only occur at the taxonomic level. Niche
differentiation driven by abiotic factors, such as the availability of nutrients, shape
community assembly [237]. As such, any attempt to design restorative interventions or
understand environmental perturbations requires the ability to pinpoint exact groups
of taxon relevant to the functional processes of interest [318].
The taxa-function relationship is also integral to the complex ecological processes that exist within the microbiome. The plasticity of certain functions to external perturbations can be attributed to redundancies in the number of contributing
strains [299, 215]. This idea of “robustness” [84] can be used as a proxy to diagnose
community-wide or function-specific dysbiosis [295]. This also helps explain the un12
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derlying mechanisms as to why healthy microbiomes are found to be generally more
“diverse”, fitting with the prevailing ecological theory linking biodiversity and ecosystem functioning in microbial systems [284]. On the other hand, if a core function is
only contributed by a single taxon, targeted therapies can be designed to improve
growth conditions or to provide the necessary probiotic supplements.
Finally, taxa-function relationships can also enhance quality of existing populationlevel studies. Providing the relevant context that can increase interpretability, while
also helping researchers distinguish possible false positives when considering targets
for validation.

1.3.2. Challenges and opportunities
Many studies have attempted to systematically tackle taxon-function integration in
microbiome studies [188, 295, 84, 226]. However, they face challenges regarding assumptions, limitations in resolution, and biases in reference databases. For example,
FishTaco [188], a tool to estimate species contributions to functional shifts, assumes
that the functional content of contributing microbes is consistent at the species level,
ignoring strain-level variation. Other ecological processes such as inter-taxa interactions and horizontal gene transfer can also radically change the taxa-function landscape, whereby removals or additions of certain contributing species might affect other
seemingly unrelated members. Additionally, there are difficulties in defining relevant
functions. Even though pathway annotations from reference databases such as KEGG
are informative, it is still difficult to interpret long lists of pathways identified as differentially abundant.
However, despite such drawbacks, there are numerous opportunities. Utilizing
different multi-omic approaches can provide additional insight into “active” functions
whose products are persistent in the gut environment [130]. This is particularly
important considering that microbes might harbor genes but can choose not to express
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them depending on environmental or ecological conditions [199]. Defining functions
in terms of ecosystem roles such as traits [308] can allow for more interpretable results
that are relevant to the condition of interest. The goal would be to look for context
specific functions such as in the aforementioned study by Vatanen et al. [291] where
multiple related gene clusters are simultaneously evaluated.
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Chapter 2

Associations between the gut
microbiome and metabolome in
early life
This work was published on August 28th, 2021 as a Research Article at BMC Microbiology. The final article can be found here:
Nguyen, Q.P., Karagas, M.R., Madan, J.C., Dade, E., Palys, T.J., Morrison, G.H.,
Pathmasiri, W.W., McRitche, S., Sumner, S.J., Frost, H.R., Hoen, A.G. Associations
between the gut microbiome and metabolome in early life. BMC Microbiol 21, 238
(2021). https://doi.org/10.1186/s12866-021-02282-3

Section 2.1

Abstract
Background: The infant intestinal microbiome plays an important role in metabolism
and immune development with impacts on lifelong health. The linkage between the
taxonomic composition of the microbiome and its metabolic phenotype is undefined
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and complicated by redundancies in the taxon-function relationship within microbial communities. To inform a more mechanistic understanding of the relationship
between the microbiome and health, we performed an integrative statistical and machine learning-based analysis of microbe taxonomic structure and metabolic function
in order to characterize the taxa-function relationship in early life.
Results: Stool samples collected from infants enrolled in the New Hampshire Birth
Cohort Study (NHBCS) at approximately 6-weeks (N = 158) and 12-months (N =
282) of age were profiled using targeted and untargeted nuclear magnetic resonance
(NMR) spectroscopy as well as DNA sequencing of the V4-V5 hypervariable region
from the bacterial 16S rRNA gene. There was significant inter-omic concordance
based on Procrustes analysis (6 weeks: p = 0.056; 12 months: p = 0.001), however
this association was no longer significant when accounting for phylogenetic relationships using generalized UniFrac distance metric (6 weeks: p = 0.376; 12 months: p
= 0.069). Sparse canonical correlation analysis showed significant correlation, as well
as identifying sets of microbe/metabolites driving microbiome-metabolome relatedness. Performance of machine learning models varied across different metabolites,
with support vector machines (radial basis function kernel) being the consistently
top ranked model. However, predictive R2 values demonstrated poor predictive performance across all models assessed (avg: -5.06% – 6 weeks; -3.7% – 12 months).
Conversely, the Spearman correlation metric was higher (avg: 0.344 – 6 weeks; 0.265
– 12 months). This demonstrated that taxonomic relative abundance was not predictive of metabolite concentrations.
Conclusions: Our results suggest a degree of overall association between taxonomic
profiles and metabolite concentrations. However, lack of predictive capacity for stool
metabolic signatures reflects, in part, the possible role of functional redundancy in
defining the taxa-function relationship in early life as well as the bidirectional nature
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of the microbiome-metabolome association. Our results provide evidence in favor
of a multi-omic approach for microbiome studies, especially those focused on health
outcomes.

Section 2.2

Background
The human gut microbiome is a complex and diverse system of microorganisms that
co-inhabit the intestinal lumen and play a crucial role in modulating human health
and disease [270, 229]. The development of the microbiota in early life is a sensitive
process akin to primary ecological succession [145], and therefore both reliant on, and
vulnerable to, external perturbations. Studies have linked microbiome alterations to
long-term health consequences, including risk of obesity [273], type I diabetes [147],
and inflammatory bowel disease [10]. As such, there is a need to understand how the
microbiome participates in the multifactorial pathways leading to long-term disease
outcomes. One key to this open question lies in the currently undefined relationship
between the taxonomic structure of the microbiome and its metabolic phenotype.
Previous studies addressing this question have mainly focused on DNA-based profiling
of microbial functional potential, which, due to complicated regulatory mechanisms
at the cellular level beyond the genome, is not equivalent to the microbiota’s realized
functional landscape [116].
There exists a bidirectional association between the metabolome and the microbiome in the gut [287, 86]. These low molecular weight molecules can either be nutrients that shape the composition of the microbiome [228] or important byproducts of
host-microbe nutrient co-metabolism that help regulate host metabolic homeostasis
[114, 168, 224]. For example, members of the Clostridium clusters can produce and
increase serum levels of branched chain amino acids, which are markers for insulin re-
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sistance and diabetes [233, 220]. However, studies suggest that the fecal metabolome
specifically can be used as a readout of gut microbe metabolic functions. Zierer et
al. [343] showed in a large cohort of adult females (n = 786) from the TwinsUK
study that around 60% of the fecal metabolome is associated with microbial composition, where on average, 67% of variance in the metabolome can be explained by the
microbiome.
Recent studies have integrated the metabolome in microbiome analyses of health
outcomes, most notably Lloyd et al. [174] from the integrative Human Microbiome
Project. However, these studies have mostly focused on adult populations with specific metabolic disease etiologies such as inflammatory bowel disease. Only a limited
number of studies [301, 13, 275, 335, 36, 143], have simultaneously profiled the gut
microbiome and metabolome from infant stool samples. These studies have preliminarily established that metabolomic profiles shift as taxonomic abundances change
between subject case/control status [301, 275, 335, 117]. Specifically, Ayeni et al.
(n = 48) [13] and Kisuse et al. (n = 35) [143] demonstrated that inter-sample distances calculated using metabolite abundances are correlated with those calculated
from taxonomic profiles using Mantel tests across African and Asian cohorts. However, studies to date have either focused on preterm infants [301, 275, 335] or had
small sample sizes (less than 50) [13, 36, 143]. We identified a major gap in defining
microbiome-metabolome relatedness among infants from a population-based cohort
capturing both early in infancy and near the first birthday, with regards to determining the strength of association and to identify key contributors to the overall
concordance.
Here, we present our study investigating associations between microbe abundances
assayed with 16S rRNA sequencing and metabolomic profiles measured with 1 H NMR
spectroscopy in a cohort of infants representing a rural general population from the
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New Hampshire Birth Cohort Study (NHBCS). This is a unique epidemiological cohort with multi-omic profiling of infant stool samples at multiple time points accompanied with rich sociodemographic, dietary and health outcomes data [183]. Our study
utilizes predictive modeling, multivariate correlation methods and distance-based approaches to characterize the dynamic relationship between the gut microbiome and
the gut metabolome in early life.

Section 2.3

Results
The overall workflow and subject selection process are described in Fig 2.1. Primary
analyses were performed on paired microbiome-metabolome data sets on samples
collected at approximately 6 weeks (N = 158 samples) and 12 months (N = 282
samples) of age (65 subjects have paired samples collected at both time points).
In order to take advantage of the most samples from this study, each time point
was analyzed separately with sensitivity analyses performed on sample pairs. As
such, the sample size N will thereafter represent the number of samples found in
each time point rather than the number of unique infants. After processing and
filtering, we evaluated a final taxonomic dataset of 48 genera in 6 weeks samples and
72 genera in 12 months samples. Metabolomic profiles were represented as 208 unique
untargeted spectral bins and a concentration-fitting method [309] was used to acquire
specific relative concentrations of 36 targeted metabolites. These metabolites were
chosen based on a literature search (Supplementary Note 4) for compounds known
to be associated with commensal gut microbes. Results presented here will primarily
feature the targeted dataset, with accompanying figures and tables for the untargeted
data set in the supplemental section. Fig 2.1 shows the overall workflow including
the sample selection process. In summary, we performed three analyses: First, an
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overall concordance analysis using ordinations with ecological distances; second, a
parametric multivariate correlation approach with a variable selection component to
quantify the overall correlation and determine important factors that contribute to
the overall microbiome-metabolite association; third, a predictive analysis approach
to see if taxonomic abundance alone can accurately predict the concentrations of
specific metabolites.

Figure 2.1: Overview of the analysis. Panel A describes the subject selection workflow and panel B describes the analytic pipeline.

2.3.1. Study population
Study subject characteristics are summarized in Table 2.1 separately for both subjects providing samples at 6-week of age (N = 158) and 12-months of age (N = 282).
Characteristic of our population, most infants are White (97.5% among subjects contributing a 6-week sample; 95.4% among subjects contributing a 12-month sample),
delivered vaginally (6 weeks samples: 72.2%; 12 months samples: 70.9%) and did not
have any systemic antibiotic exposure during initial hospitalization following birth
(6 weeks samples: 95.6%; 12 months samples 97.2%). The average birth weight was
also similar across subjects irrespective of the sample time point, 3370 g (± 480)
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for infants contributing 6-week samples and 3430 g (± 528) for infants contributing
12-month samples. Similarly, the average gestational age was 39.1 weeks (± 1.59)
(6-week samples) and 39 weeks (± 1.7) (12-month samples). At the time of 6-week
sample collection, 62% of infants had been exclusively breastfed while by the time of
12-month sample collection, 59.2% of infants received breast milk supplemented with
formula, however a large minority (35.1%) remained exclusively breastfed. There were
more male than female infants in the cohort (53.8% male among infants contributing
a 6-week sample; 56.4% male among infants contributing a 12-month sample). Maternal smoking during pregnancy was rare (6-week samples: 7%; 12-month samples:
5%).

2.3.2. Inter-omic sample distance comparison suggests overall concordance
between data sets
Global concordance between the microbiome and the metabolome was observed across
both time points and metabolomic data sets (Fig 2.2A, Fig B.1A) when analyzed
using a symmetric Procrustes test with samples ordinated by Euclidean distances
Materials and Methods. It is noted that the p-value at 6 weeks for the targeted data
set (p = 0.057) was only trending close to significant at the 0.05 level.
Since the Procrustes test was performed on principal coordinate (PCoA) ordinations of sample distances, the result is sensitive to the choice of dissimilarity metric. In
addition to standard Euclidean distances, the generalized UniFrac (gUniFrac) metric
was also leveraged to account for phylogeny in calculating differences between samples. With gUniFrac, the association was not significant at either time points for
the targeted data set only (Fig 2.2B), while the untargeted data set still maintained
strong concordance (6 weeks samples – p = 0.001; 12 months samples – p = 0.006;
Fig B.1B).
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Table 2.1: Selected characteristics of subjects contributing samples at 6 weeks (N =
158) and at 12 months of age (N = 282)
6 weeks
(N = 158)

12 months
(N = 282)

Birthweight (grams)
Mean (Standard Deviation)
Median [Minimum, Maximum]
Missing

3370 (480)
3430 (528)
3430 [1910, 4710] 3450 [1320, 4660]
2 (1.3%)
4 (1.4%)

Sex
Male
Female

85 (53.8%)
73 (46.2%)

159 (56.4%)
123 (43.6%)

Feeding mode until time of sample collection
Unknown
Exclusively breastfed
Exclusively formula fed
Mixed

6 (3.8%)
98 (62%)
13 (8.2%)
41 (25.9%)

7 (2.5%)
99 (35.1%)
9 (3.2%)
167 (59.2%)

Delivery Mode
Vaginal
Cesarean

114 (72.2%)
44 (27.8%)

200 (70.9%)
82 (29.1%)

Gestational Age (Weeks)
Mean (SD)
Median [Minimum, Maximum]

39.1 (1.59)
39.1 [33.4, 43.0]

39 (1.70)
39.1 [29.1, 42.0]

Post-delivery infant systemic antibiotic exposure
No
Yes

151 (95.6%)
7 (4.4%)

274 (97.2%)
8 (2.8%)

Maternal smoking during pregnancy
No
Yes
Missing

143 (90.5%)
11 (7.0%)
4 (2.5%)

262 (92.9%)
14 (5.0%)
6 (2.1%)

Infant Race
Other
White

4 (2.5%)
154 (97.5%)

13 (4.6%)
269 (95.4%)
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Figure 2.2: Inter-omics Procrustes biplots comparing PCoA ordinations of targeted metabolite profiles and taxonomic relative abundances for 6 weeks (left panels)
(N = 158) and 12 months (right panels) (N = 262). Top panels present analyses
based on ordinations from Euclidean distances of genus level abundances after centered log ratio transformation and Euclidean distances of log-transformed metabolite
profiles. Bottom panel presents analyses based on gUniFrac distance of amplicon sequence variant (ASV) relative abundances and Euclidean distances of log-transformed
metabolite profiles. There were significant associations between the microbiome and
the metabolome (both targeted and untargeted) when utilizing Euclidean distances,
however this association goes away when the gUniFrac distance was employed for the
targeted metabolites only.
2.3.3. Sparse canonical correlation analyses reveal the core set of microbemetabolite groups driving inter-omic relatedness
Given broad concordance between the gut microbiome and metabolome from sample
distance analyses, we employed sparse canonical correlation analysis (sCCA) and
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pairwise Spearman rank correlation to ascertain the strength of association as well
as to identify core microbes and metabolites driving this relationship (Materials and
Methods).
The majority of taxa (65% of total genera at 6-weeks and 80% at 12-months) and
metabolites (100% of total metabolites at 6-weeks and 80% at 12-months) were part
of significant (FDR threshold 0.05) Spearman pairwise comparisons (Supplementary
Note 1). This demonstrated a high level of congruence, where most microbes are
involved in metabolic processes captured in the stool metabolome. This was also
reflected in the significant multivariate correlation (permutation p < 0.001). However,
at 6 weeks (correlation: 0.606 [ 0.61 – 0.73 ]), the degree of concordance was slightly
higher than at 12 months (correlation: 0.52 [0.431 - 0.646]) but this difference was
not significant due to overlapping confidence intervals. The canonical correlation was
slightly higher in the untargeted data set (6 weeks: 0.636 [0.621 – 0.733]; 12 months:
0.49 [0.475 – 0.702]), however the difference between time points was similar (Fig B.2,
Supplementary Note 2).
Using sCCA, we identified a core set of microbes and metabolites that are major
contributors to the multivariate correlation (Fig 2.3 right panels; Supplementary Note
2). Selected microbes (in both the targeted and untargeted data set) belonged to the
Firmicutes, Actinobacteria and Proteobacteria phyla, as those are the most commonly
found phyla in the infant gut [183, 15]. However, previously established dominant
genera such as Bifidobacterium, Bacteroides and Lactobacillus were not consistently
selected across both time points. In the targeted data set Bifidobacterium was selected
only at 6 weeks and Lactobacillus was only selected at 12 months. Most notably, more
microbes were selected at 12 months compared to 6 weeks in the targeted data set,
however in the untargeted data set this pattern was reversed (Fig B.2, right panels). In
terms of selected metabolites, the majority of the selected metabolites in the targeted
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data set were amino acids (Supplementary Note 1), with some short chain fatty acids
(SCFAs) selected at the 6-week time point.

2.3.4. Microbial community structure is weakly predictive of stool metabolite relative concentrations
In order to determine how well the fecal metabolome acts as a functional representation of the gut microbiome, we fitted metabolite-specific prediction models based
on taxonomic profiles. Chosen models include random forest (RF), elastic net (EN),
support vector machines with radial basis kernel (SVM-RBF) and sparse partial least
squares (SPLS), all of which had previously been shown to work well with microbiomeassociated learning tasks [342]. Evaluation was based on predicted R2 and Spearman
correlation coefficient (SCC) as measured using 100 repeats of 5-fold nested cross
validation (Materials and Methods).
Predictive performance was more dependent on the metabolite being predicted
than by choice of model (Fig 2.4, Supplementary Note 3, Supplementary Note 1).
Looking at predictive R2 (Fig 2.4A), the average posterior mean performance across
all models and metabolites was negative for both time points (-5.6% at 6 weeks; -3.07%
at 12 months), which indicated that for most prediction tasks the fitted model was less
predictive than a naive, intercept only model. At 6 weeks 22.2% of metabolites had
models that perform significantly better than the null (lower bound of 95% credible
interval larger than 0) while at 12 months 38.9% of metabolites fit the classification.
However, even among such metabolites, the maximum R2 is only 11.8% at 6 weeks
and 8.7% at 12 months. Conversely, SCC values were higher in comparison (crossmetabolite avg.: 0.339 at 6 weeks and 0.249 at 12 months) (Fig 2.4B, Supplementary
Note 3). At 6 weeks, 83% of metabolites were significantly more performant than
the null, while at 12 months all metabolites were selected. Using a more stringent
cutoff as used by Mallick et al. [187], the majority of metabolites at 6 weeks (69.4%
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of total metabolites) still remained as well predicted while conversely at 12 months
only 38.9% (of total metabolites) were predictable.
Results from the untargeted analysis showed higher performance values for both
evaluation metrics (Supplementary Note 3). Specifically, 56.7% of metabolites bins
at 6 weeks and 42.7% of bins at 12 months had R2 values significantly higher than
0. However, under SCC, while 57% of metabolite bins at 6 weeks had SCC values
significantly larger than 0.3 cutoff, only 28.8% of metabolite bins at 12 months fit
this criterion. Despite better performance, the overall average values were still low,
suggesting that across the entire metabolome few metabolites were highly predictable.
Despite weak predictive performance values, we were still interested in determining
a model that stands out as the most appropriate for our prediction task. Aggregating performance across metabolites stratified by model for both evaluation metrics
(Fig 2.5, top panel), it can be observed that the average performances were similar (Supplementary Note 3), for which no semi-targeted analyses performed better
on average than the naive model under R2 . This is further illustrated when model
performance was aggregated by rank using Borda scores (Fig 2.5, bottom panel). A
higher score indicated that a model was selected as the top choice more times than
others, where an even score distribution across models corroborated the suggestion
that no model was best across all prediction tasks. That said, SVM-RBF seemed to
be the highest scoring model, particularly for the 6-week time point. The untargeted
analysis also found similar results (Fig B.3).

2.3.5. Sensitivity analyses
We performed both Procrustes and correlation analyses on a data set restricted to
the 65 subjects with paired samples collected at both time points (6 weeks and 12
months). Each time point was analyzed separately as in our main analysis. In the
targeted data set, significant Procrustes concordance was observed at 12 months (p26
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value = 0.003) but not at 6 weeks (p-value = 0.106). This association was no longer
significant when considering taxonomic ordination using the gUniFrac distance metric
(6 weeks). Surprisingly, in the untargeted data set, no association was observed across
both time points and choice of distance metric (Fig B.5, Fig B.6). In the canonical
correlation analyses, significance was only observed in the targeted data set at 6
weeks only (6 weeks: permutation p-value = 0.044; 12 months: permutation p-value
= 0.388). Even though most correlations were not significantly different from the
permuted null, the canonical correlation coefficient is higher at 6 weeks compared
to 12 months in both the targeted (6 weeks: 0.676 [0.661 – 0.765]; 12 months: 0.52
[0.484 – 0.663]), and untargeted (6 weeks: 0.703 [0.685 – 0.788]; 12 months: 0.444
[0.52 – 0.705]) data sets (Fig B.7, Fig B.8).
Furthermore, to ascertain the uncertainty of model choice, we evaluated all selected modelling approaches with simulated data sets based on bootstrapped resampling of taxonomic relative abundances (Fig B.4). For the first simulation scenario,
models were assessed against generated metabolite concentrations under different
degrees of model saturation (number of taxa associated with the outcome) and association strength (signal to noise ratio). As expected, model performance asymptotically reached perfect prediction with increasing signal strength and model saturation,
which demonstrated that prediction models were able to capture predictive associations should they arise even in sparse microbiome data sets. Most notably, simulation
performance differed more by signal-to-noise ratio than model saturation, which indicated that the strength of association plays a larger role in the observed weak
predictive performance than the number of taxa involved. Surprisingly, we obtained
very similar results to our real data values under our lowest simulation setting (model
saturation = 5%; signal-to-noise ratio 0.5). As such, it can be suggested that the lack
of predictability is due to weak coupling rather than model choice.
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Section 2.4

Discussion
In this study, we provide a descriptive and hypothesis generating analysis of the
relationship between fecal microbial taxonomic abundances and metabolite concentrations with multi-omic profiling via paired targeted sequencing of the 16S rRNA
gene and 1 H NMR metabolomics at multiple time points. Ecological, statistical and
machine learning approaches were applied to provide a multi-faceted view of this association. To our knowledge, this study is one of the few comprehensive investigations
addressing the microbiome/metabolome interface in a large general population cohort
of infants.

2.4.1. The microbiome is significantly correlated but weakly predictive of
the metabolome
Overall global concordance was found from three independent methods (Procrustes
analysis, sCCA and univariate Spearman correlation), consistent with previous studies on both infant [13, 143] and adult populations [174, 193]. This overall effect was
found at both time points, suggesting there coupling exists throughout infancy despite
high levels of both inter- and intra-individual variability in taxonomic compositions
[15].
Although our analyses demonstrated significant multivariate and univariate correlation between the microbiome and the metabolome, most metabolites were not
predictable when evaluated across multiple machine learning models. Even among
the small number of metabolites that are significantly predictable compared to the
null, the maximum performance values were still low for both the untargeted and
targeted analyses. When compared to a recent study performing metabolite predictions from taxonomic abundances using an adult cohort [187], both the number of
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well-predicted metabolites and the average performance values were much lower, even
when using similar evaluation criterion and cut offs. It is unlikely that model choice
was driving the lack of predictability, since all chosen methods had been shown to be
suited for microbiome-associated prediction tasks [342, 232] as well as covering both
non-linear and linear associations. This is further evidenced in our sensitivity analyses, where non-parametric simulations demonstrated that low predictability across
both evaluation metrics was driven by low signal-to-noise ratio rather than model
choice or number of taxa driving the association.
These results can be attributed to the limitations of our study design. We utilized
partial 16S rRNA sequencing instead of whole genome shotgun sequencing. This
limits our taxonomic resolution to the Genus level for most of the analysis [132].
Since bacterial functions relevant to human metabolism are likely to be strain specific
[338, 175], we hypothesized that aggregating to Genus level might dilute the direct
effects, where different strains within the same Genus might have opposite impacts on
the abundance of a certain metabolite. This would result in a lack of predictability as
the same feature would contain elements that both increase and decrease the values
of the outcome of interest.
However, we can potentially attribute overall performance to other ecological processes. A likely candidate is functional redundancy, an aspect ubiquitous in microbial
communities [176], plays an important role in this weak coupling. Functional redundancy is the ecological phenomena that multiple species representing a spectra of
taxonomic groups can perform similar roles [176, 295], and is usually a marker for
ecosystem resilience [7]. Under this paradigm, the loss of a certain metabolite producing taxa would not impact the abundance of that metabolite as different taxa can
complement the functional role, complicating taxa to metabolite predictions. This is
evidenced when inter-omic associations is no longer significant in Procrustes analyses
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when phylogenetic relatedness was adjusted using the gUniFrac distance metric. Since
gUniFrac adjusts for phylogeny by weighting the differences in proportions of each
taxa across two samples by the branch length from constructed evolutionary trees
[48], the absence of an association suggests that samples with similar metabolic profiles might be numerically comparable (cluster together under Euclidean distances)
but with evolutionarily divergent taxonomic compositions. This is further supported
by our supplementary PICRUSt2 analyses, where we found for most pathways no
single genera dominate functional contribution (Fig B.10). Functional redundancy is
also consistent with previous research in human associated microbiomes [178].

2.4.2. Taxa and metabolites selected to be core to the microbiome-metabolome
correlation reveal the importance of amino acid metabolism
Taxa and metabolites with non-zero loading coefficients in sCCA analyses were identified as factors driving this overall correlation. The sCCA procedure utilized a
L1-penalized matrix decomposition of the cross-product matrix akin to a LASSO
regression problem [316], which means that variables were selected based on their
importance to the overall covariance between taxa and metabolite abundances.
At six weeks, two short chain fatty acids (SCFAs), butyrate and propionate, were
selected as core to the microbiome-metabolome interface. SCFAs (which includes
compounds such as isobutyrate, and acetate) are important metabolites obtained
primarily from colonic microbial fermentation of carbohydrates that escape digestion
in the small intestines [210]. Butyrate is an energy source for colonocytes [161] as
well as participating in the maintenance of the gut epithelial barrier through mucin
production [236]. Similarly, propionate is part of the gluconeogenesis pathway in
liver hepatocyte cells, which is core to lipid and energy metabolism in liver [68].
Most importantly, SCFAs participate in immune programming in early life, where
the reduction in SCFA producing bacteria is associated with inflammatory bowel
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disease [61, 265].
SCFA production in early life is linked to the Bifidobacterium and Bacteroides
catabolism of human milk oligosaccharides (HMO) [128, 158, 189], which explains
the selection of the Bifidobacterium genera at 6 weeks where infants are exclusively
on a milk-based diet. This is further supported in our supplementary PICRUSt2
analysis, where predicted pathways whose abundance significantly correlate with butyrate concentrations were those associated with breakdown of sugars into butanoate
(Fig B.9). The genera breakdown of those functions features prominently Bacteroides,
Bifidobacterium, Lachnoclostridium, Flavonifractor, and Clostridium sensu stricto 1
genera (Fig B.10). This demonstrates that at 6 weeks, infant microbiome-metabolome
interaction is primarily concerned with breakdown complex sugars into SCFAs, cementing it’s functional role in microbiome development [274].
Surprisingly, the selected Bifidobacterium genus is negatively correlated with butyrate abundance. We hypothesized that this might be due the complex cross-feeding
relationship that exist between Bifidobacterium and butyrate-producing taxa [258].
On one hand, some Bifidobacterium species can be completely commensal, producing
secondary metabolites such as acetate that assist in the growth of butyrate producing
species. On the other hand, other Bifidobacterium strains such as B. longum LMG
11047 and B. adolescentis can compete for the same substrates as butyrate producing
species [203]. The selection of the negative association between Bifidobacterium and
butyrate suggests that butyrate-suppressing Bifidobacterium strains might be more
important in our infant samples.
However, the most selected metabolites in sCCA analyses are amino acids (7 out
of 10 metabolites selected at 6 weeks were amino acids). Prior studies have shown
that the microbiota participate in regulating host amino acid homeostasis by acting
as both producers and utilizers [220]. The most common amino acid fermenters in
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the human gut include those from the Clostridia class [62]. Our results further support this as most selected microbes with positive correlation with amino acids are
of the Eisenbergniella, Flavonifractor, Ruminococcaceae UCG-004, Oscillibacter and
Ruminiclostridium genera under Clostridia. This is further seen in our supplemental
PICRUSt2 analyses, where predicted abundance of isoleucine and methionine biosynthesis pathways are significantly correlated with observed concentrations (Fig B.9).
Aside from being fermenters, microbes can also either directly utilize amino acids
and incorporate them into protein synthesis, or catabolize them as an energy source,
producing secondary metabolites. Even though the process of amino acid catabolism
for energy alone is not energetically efficient [228], it produces secondary metabolites
such as aforementioned SCFAs, which are important molecules in the metabolic interactions between the microbiota and the host. However, amongst selected microbes
whose abundance are negatively correlated with amino acid concentrations (hence,
suggestive of catabolism), we do not observe corresponding positive correlation with
selected SCFAs. We hypothesized that this might be due to the fact that bacterial concentrations are higher in distal parts of the intestine [86, 220] where nutrient
availability is low. This lack of available carbohydrates might incentivize microbes
to conserve energy by directly incorporating free amino acids rather than metabolizing them. On the other hand, prior studies suggested that microbial amino acid
catabolism is compartment specific and occurs in more proximal regions [62, 182].
However, our study design is limited to cross-sectional metabolomic profiling, which
limits the possibility of detecting SCFAs that are rapidly produced and absorbed.

2.4.3. The microbiome is more tightly coupled with the metabolome in
early infancy
Results suggest some level of significant difference in microbiome-metabolome coupling across development. Canonical correlation, while not significantly different,
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were lower at 12 months than at 6 weeks, suggesting a time-varying effect. When
looking at predictability, we observed a higher number of well predicted metabolites
at 6 weeks compared to 12 months. Among those selected as well predicted metabolites, the average performance values (both R2 and SCC) where higher. This is also
replicated in the global untargeted data set. Furthermore, in our supplementary PICRUSt2 analyses, there exists a higher number of significantly correlated predicted
pathway abundance to observed metabolite concentrations (Fig B.11), indicating increased metabolic coupling between the microbiome and the metabolome at 6 weeks
compared to at 12 months.
There are various factors that can contribute to the difference in microbiomemetabolome coupling between infants at 6 weeks and 12 months. First, there exists
substantive differences in dietary patterns for those included in our analysis. The
majority of infants at 6 weeks (62%) were exclusively breastfed, while that number is markedly less (35%) at 12 months, at which time infants are also consuming
complimentary solid family foods. This transition in diet to solid foods have been
shown to induce a change in the gut microbiome composition and diversity due to
increased amounts of fiber and protein [205, 157], which might favor certain microbes
over others. Such changes in diet, particularly the cessation of breastmilk intake,
also contributed towards the development of infant gut microbiomes towards a more
“adult like” state [15, 205]. We hypothesized that earlier in life when infants are
only consuming a limited type of food (predominantly breast milk or formula), the
microbiome participates more actively in host-microbiome co-metabolic activity as
infants are more reliant on microbes to breakdown complex nutrients (reviewed in
[202]). Conversely, at one year of age where the microbiome has matured, this relationship is not as strongly coupled as a larger share of the metabolome comes from
host-produced metabolites.
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However, as analyses were conducted within each timepoint independently with
little subject overlap, further investigations are required to make more conclusive
statements about the potential time-varying effect of microbiome-metabolome coupling. Particularly, aside from differences in diet, factors such as differences in antibiotic exposure [57] and maternal covariates [180] might result in differences between
time points. In future studies we hope to examine this factor using samples across
multiple time points for the same infants.

2.4.4. Limitations
This study has various limitations. First, we utilized partial 16S rRNA gene sequencing instead of shotgun whole genome sequencing, which limits our taxonomic
resolution to the genus level for most of the analysis [338]. We hypothesized this
lack of resolution contribute to overall lack of predictability, as well as limiting the
interpretability of variables selected by the sCCA process as species and strain level
differences can result in completely separate metabolic contributions [175]. For example, we cannot disentangle the different Bifidobacterium strains that might compete
with butyrate producing taxa and generating the negative correlation between measured SCFAs and Bifidobacterium abundance.
Second, our cohort includes only infants from the NHBCS, a population-based
cohort reflecting mostly rural and White demographics of northern New England in
the United States. While this increases confidence in the internal validity of our study,
this homogeneity in race and geography limits the generalizability of our results to
other populations.
Third, our study is a cross-sectional survey if microbiome-metabolome relationships at two different time points. This means that we cannot capture associations
relating to metabolites that are highly produced and consumed. This means that the
metabolites selected might not be representative of the intricate relationship between
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the microbiome and the metabolome. This interpretation is further limited by the
lack of annotation for our untargeted metabolite bins, which cannot be compensated
by the small number of metabolites selected for the targeted analyses.
Finally, each time point was analyzed independently with only 65 subjects with
samples in both time points. As such, this limits the ability to explore the differences
in coupling across the first year of life.

Section 2.5

Conclusion
In conclusion, we conducted one of the first large-scale multi-omics analysis of the
microbiome-metabolome relationship using samples from a large birth cohort study
at 2 time points (6 weeks and 12 months). Although we found global concordance
between the microbiome and the metabolome, the inter-omic concordance is weak,
where bacterial abundances at the genus level cannot accurately predict metabolite
concentrations. We hypothesized that this might be due to functionally relevant
diversity at the strain level, as well as the impact of functional redundancy on the
contribution of each microbe to metabolite abundances. Additionally, we were able
to identify metabolites and microbes driving the overall correlation. Results pointed
to support the importance of SCFA metabolism particularly at 6 weeks, as well as the
role of amino acid metabolism, either as a source of SCFA and energy in the absence
of carbohydrates, or as a general mechanism for microbes to save energy as they
incorporate amino acids around their environment. Finally, our analysis suggests
preliminary evidence that the degree of microbiome-metabolome coupling changes
across time, being much more integrated at six weeks compared to one year.
We conclude that although the metabolome is a functional output of the microbiome, there exists massive challenges in being able to trace specific microbial
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contributions to host-microbe metabolism due to the complexity of factors such as
functional redundancy and strain level variability. As such, we recommend studies to
profile both the microbiome and the metabolome, as aspects of microbial metabolic
contributions cannot be found solely through one omic data set. This is particularly
important in settings where it is important to have a mechanistic understanding of
the role of microbes such as developing of microbiome therapies [163].

Section 2.6

Materials and Methods
2.6.1. Study population
Subjects for this study were from the New Hampshire Birth Cohort Study (NHBCS)
who provided infant stool samples at 6-weeks and 12-months after birth. These two
timepoints are chosen as each correspond to routine maternal postpartum visit, allowing sample collection with minimal participant burden. Furthermore, at both time
points, infant feeding patterns are comparatively more well established. As described
in previous studies [183, 180], NHBCS is a prospective study of mother-infant dyads
in New Hampshire, USA. Participants eligible are pregnant women between the ages
of 18 and 45 years old, currently receiving routine prenatal care at one of the study
clinics, consuming water out of a private well with no intention to move prior to
delivery. The Center for the Protection of Human Subjects at Dartmouth provided
institutional review board approval. All methods were carried out in accordance with
guidelines. Written informed consent was obtained for participation from all subjects for themselves and their children. Comprehensive sociodemographic, exposure
and outcome data such as infant feeding method, delivery mode, maternal smoking
status, etc. were collected for all participants through surveys, medical records and
telephone interviews conducted during pregnancy, about 6 weeks postpartum, and
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updated every 4 months up until first year of age and every 6 months thereafter.

2.6.2. Collection of infant stool samples
Infant stool samples were collected at 6-weeks and 12-months. Stool samples were
provided in diapers and stored by subjects in their home freezer (−20◦ C) until they
were able to return it to the study site. Stool was thawed at 4◦ C so that it could
be aliquoted into cryotubes. Stools collected for 16S rRNA gene sequencing were
aliquoted (range 350-850 mg) into 3ml RNAlater and homogenized before storing
at −80◦ C. Stools collected for metabolomic analysis were aliquoted (1-2 grams) into
15ml centrifuge tubes before storing at −80◦ C.

2.6.3. Taxonomic profiling using 16S rRNA targeted gene sequencing
RNAlater stool samples were thawed and DNA was extracted using the Zymo Fecal
DNA extraction kit (Cat #D6010, Zymo Research, Irvine, CA), according to the
manufacturer’s instructions. For each sample extraction, 400µl RNAlater stool slurry
(50–100 mg of stool) was used to isolate DNA. Extractions were performed in batches
of multiple samples and included a composite RNAlater stool positive control and a
RNAlater negative control. Lysis was performed using 750µl Lysis Buffer in ZR
BashingBead™ Lysis Tubes (0.5 mm beads), mixed and then shaken on a Disruptor
Genie for 6 min. Eluted DNA was quantified on a Qubit™ fluorometer using the
Qubit™ dsDNA BR Assay. Average coefficient of variation of DNA yields (µg/µl) for
composite RNAlater stool positive controls was 28%. No DNA was ever detectable in
negative control elutions. Concentrations of DNA samples used for 16S rRNA gene
sequencing range from 1 ng/µl to 25 ng/µl.
The V4-V5 hypervariable region of bacterial 16S rRNA gene was sequenced at
Marine Biological Laboratory in Woods Hole, MA, using standard Illumina MiSeq
amplicon approach (paired end sequenced between 518F and 926R) [222, 121]. As
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described previously [183, 180], 16S rDNA V4-V5 amplicons were generated from
purified genomic DNA samples using fusion primers. The use of forward primers
containing one of eight five-nucleotide barcodes between the Illumina-specific bridge
and sequencing primer regions and the 16S-specific region and a single reverse primer
containing 1 of 12 Illumina indices enables 96 samples per lane multiplexing. Amplifications were done in triplicate with one negative control for internal quality control
at MBL. We used qPCR (Kapa Biosystems) to quantify the amplicon pool, and one
Illumina MiSeq 500 cycle paired end run to sequence each pool of 96 libraries. We demultiplex and divided datasets using Illumina MiSeq reporter and a custom Python
script. Demultiplexed reads derived from Illumina sequencing were denoised and
quality filtered using DADA2 (v. 1.12.1) [40] in R (v. 3.6.1) [251]. Illumina adapter
sequences were removed prior using cutadapt (v. 1.18). We utilized DADA2’s filterAndTrim function to remove reads either containing a quality score of 2 or lower
(minQ = 2) or with expected errors [77] of 2 (maxEE = c(2,2)) or higher. Post filtering, we obtained an average of 119,800 reads per sample for 6-week samples and
120,480 reads per samples for 12-month samples. On average, we 74.7% of reads were
kept for 6-week samples and 76.3% of reads were kept for 12-month samples. We then
use the RDP classifier implemented natively in the DADA2 R package with SILVA
database (v. 128) to profile the taxonomy of identified amplicon sequence variants
(ASVs).
2.6.4. Metabolomics profiling using untargeted and targeted 1 H NMR
1

H NMR metabolomics was performed in collaboration with the NIH Eastern Re-

gional Comprehensive Metabolomics Resource Core (RCMRC) at UNC Chapel Hill.
De-identified stool aliquots were shipped on dry ice and immediately stored at −80◦ C
for metabolomics analysis. Samples were thawed and ∼150mg of stool samples were
transferred to MagNA Lyser tubes after recording the weight. Samples were then ho38
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mogenized with 50% acetonitrile in water by using the Omni Bead Disruptor (Omni
International, GA, USA). Homogenized samples were centrifuged at 16000 rcf and the
supernatant was separated into another tube. An aliquot (1000 µL, 100 mg equivalent of fecal mass) was transferred into an Eppendorf tube and lyophilized overnight.
The dried extract was reconstituted in 700 µL of NMR master mix (containing 0.2M
phosphate buffer, 0.5 mM DSS-d6 (internal standard), and 0.2% sodium azide (preventing bacterial growth)), vortexed on a multi tube vortexer at speed 5 for 2 min
and centrifuged at 16000 rcf for 5 min. A 600 µl aliquot of the supernatant was transferred into pre-labeled 5mm NMR tubes. Additionally, study pooled quality control
(QC) samples (created from randomly selected study samples) and batch pooled QC
samples were generated from supernatants of study samples and aliquots of supernatants were dried and reconstituted similar to study samples described above and
used for QC purposes.
1

H NMR spectra of feces extracts were acquired on a Bruker 700 MHz NMR

spectrometer using a 5 mm cryogenically cooled ATMA inverse probe and ambient
temperature of 25◦ C. A 1D NOESY presaturation pulse sequence (noesygppr1d [18,
69], [recycle delay, RD]-90◦ -t1-90◦ -tm-90◦ -acquire free induction decay (FID)]) was
used for data acquisition. For each sample, 64 transients were collected into 64k data
points using a spectral width of 12.02 ppm, 2 s relaxation delay, 10 ms mixing time,
and an acquisition time of 3.899 s per FID. The water resonance was suppressed using
resonance irradiation during the relaxation delay and mixing time. NMR spectra were
processed using TopSpin 3.5 software (Bruker-Biospin, Germany). Spectra were zero
filled, and Fourier transformed after exponential multiplication with line broadening
factor of 0.5. Quality control measures included review of each NMR spectrum for line
shape and width, phase and baseline of spectra, and tight clustering of QC samples
in Principal Component Analysis [37]. NMR bin data (0.49-9.0 ppm) were generated
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(untargeted data) excluding water (4.73-4.85 ppm) using intelligent bucket integration
of 0.04 ppm bucket width with 50% looseness using ACD Spectrus Processor (ACD
Labs Inc, Toronto, Canada).The integrals of each bin were normalized to the total
spectral intensity of each spectrum and transferred to analysis software. This resulted
in a collection of spectral bins with bin-specific relative abundances, which will be
called the untargeted data. In addition, relative concentration of library-matched
metabolites (selected from the literature implicated to be important in host-microbe
relationships - Supplementary Note 4) was determined by using Chenomx NMR Suite
8.4 Professional software [309].This data set will be called the targeted data set.

2.6.5. Software and tools
All analyses were performed using the R programming language (v. 3.6.3) [251] and
associated packages. All data wrangling steps were performed using phyloseq [196],
plyr and tidyverse packages [310], as well as the compositions package [290] for logratio transformations. All figures were generated using the ggplot2 [311], cowplot
[313], viridis [98] and pheatmap [146] packages. Additionally, the tidymodels [152]
suite of packages was utilized to assist in all modelling tasks. Specific packages used
for modelling will be enumerated below. All scripts as well as intermediary analysis
objects are available on GitHub with all dependencies and their versions (https:
//github.com/qpmnguyen/infant_metabolome_microbiome).
2.6.6. Data transformation and normalization
For microbiome data, we retained all ASVs present in at least 10% of samples [187] and
added one pseudocount to all cells [153]. We then subsequently aggregated all ASVs to
the genus taxonomic level [342] and converted data to relative proportions using total
read counts by sample to account for differential sequencing depth. We further filtered
out taxa with mean relative proportion < 0.005% [30]. This filtration step resulted
40

2.6 Materials and Methods
in 46 genera for 6-week samples and 72 genera for 12-month samples. To address the
compositional problem induced by a sum to one constraint, we apply the centered
log ratio transformation (CLR), which is often used to remove such constraints in
microbiome data sets [4]. The CLR transformation is favored compared to other
statistically equivalent log-ratio transformations due to its scale invariant property
and ease of interpretation [104].
For metabolomic data sets, we employed different transformations to approximate
homoscedasticity depending on the data type (targeted vs untargeted). For targeted
metabolites, we performed a log(x + 1) transformation while for untargeted metabolites we utilized the arcsine square root transformation which has been previously
used for transforming composition metabolomics data sets [187].

2.6.7. Distance matrix analyses
Principal coordinates analysis (PCoA) was performed using the pcoa function from
the ape package in R [230] with sample distance matrices. The PCoA procedure seeks
to represent high dimensional multivariate data sets in lower dimensions through
eigen decomposition of the doubly centered distance matrix. PCoA allows the usage
of non-Euclidean distances between samples such as ecological indices, which makes it
a preferable method for sample ordination compared to principal component analysis
(PCA).
We constructed Euclidean distance matrices for both metabolic and taxonomic
profiles post data transformation described in the previous section. Additionally, gUniFrac distances (alpha = 0.5) [48] were considered for taxonomic data using the implementation provided in the package MiSPU [323]. gUniFrac requires a phylogenetic
tree, of which an approximate maximum likelihood phylogenetic tree was constructed
with representative ASV sequences using FastTree (v 2.1) [244]. Multiple sequence
alignment was performed using the AlignSeqs function from the DECIPHER pack41
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age in R [320] and trees were midpoint rooted using phytools [255]. Since multiple
sequence alignment is not conserved under filtering and aggregation of ASVs, gUniFrac distance calculations were performed with pre-filtered ASV-level abundances
normalized to relative abundances.
The first two axes of constructed ordinations were then compared using a symmetric Procrustes procedure implemented in the protest function in the vegan package
[227]. Procrustes superimposes two ordinations by translating and rotating the coordinates, which preserves the general structure of the data. This method performs a
superimposition fit between two data sets minimizing the sum-of-squared differences
(m2 ), which describes the degree of concordance between the two configurations normalized to unit variance. Significance is obtained by testing against the permuted
null using a permutation test. This method was shown to have more power while also
limiting type I error compared to the traditional Mantel test in ecological analysis
[238]. Significance was determined using a permutation test on the sum of squared
differences with 999 permutations [37].

2.6.8. Sparse canonical correlation and Spearman correlation analyses
Sparse canonical correlation analysis (sCCA) was performed to identify strongly associated metabolite-microbe groups. sCCA seeks to find linear combinations of variables
from each dataset that maximizes the correlation with each other while simultaneously thresholding variable specific weights to induce sparsity and performing variable
selection. The correlation coefficient in the first canonical variate quantifies the overall
degree of multivariate associations. As such, sCCA is a popular method in integrating multi-omics datasets with the ability to select more biologically relevant sets of
features compared to traditional ecological methods such as co-inertia analysis [42].
In this study, we use the sCCA implementation in the package PMA in R [316] which
uses a novel penalized matrix decomposition procedure to achieve sparsity [317]. We
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tune hyperparameters using a permutation approach in the CCA.permute function
(nperms = 50) prior to fitting the final model. We obtained the correlation coefficients as a measure of overall correlation between the two data sets and calculated
a bootstrapped 95% confidence interval (nboot = 5000). Additionally, we tested for
significance using a permutation test (nperm = 1000) for α at the 0.05 level. In order
to keep the structure of the data set across different permutations, we use the function randomizeMatrix from the package picante in R [138] using the richness null
model, which randomizes community abundances within samples to maintain sample
species richness.
Pairwise Spearman correlations were also performed using the cor function in R.
Hypothesis testing was done using cor.test, with multiple hypothesis testing correction
using the Benjamini-Hochberg procedure [24] using p.adjust. An FDR value of 0.05
is used as cutoff for significance pairwise correlations. Visualization was done using
pheatmap package in R.
2.6.9. Predictive modelling and evaluation
We choose candidate models based on previous research utilizing supervised learning
with microbiome associated prediction tasks [342, 232, 187]. Specifically, we chose
random forest (RF) [33], support vector machine with radial basis function kernel
(SVM-RBF) [32], elastic net (EN) [344] and sparse partial least squares (SPLS) [54],
which have all been shown to perform with high-dimensional predictors. These models also support linear and non-linear associations between the microbiome and the
outcome of interest. Model fitting, parameter tuning, and evaluation were done using
caret package in R [314]. Parallel processing was performed using the doParallel
[60] and parallel packages.
We evaluate prediction performance by performing 100 repeats of 10-fold nested
cross validation, whereby within each training fold is a separate 5-fold cross-validation
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procedure done to perform hyperparameter selection when appropriate with parameter grids modelled after Pasolli et al. [232]. For RF, we set the number of trees
to be 500, and the number of features used in each decision tree to be the square
root of the number of the original features. For SVM-RBF, we tuned across a grid
for the regularization parameter C (values 2(−5) , 2(−3) , . . . , 215 ) and the kernel width
parameter γ (values 2(−15) , 2(−13) , . . . , 23 ). For EN, we tuned over a grid of the regularization parameter λ and the L1 to L2 penalty ratio α, where for each α value
(spaced by 0.1) between 0 (equivalent to a LASSO model) and 1 (equivalent to a
ridge regression model), we evaluate 100 lambda values chosen by the glmnet procedure. For SPLS, we kept the concavity parameter κ constant at 0.5 while tuning
the number of components K (values 1, 2, . . . , 10) and the thresholding parameter η
(values 0.1, 0.2, . . . , 0.9).
We utilize standard regression evaluation metrics include predictive R2 and Spearman correlation coefficient (SCC). These statistics were chosen due to their ability to
capture two different aspects of the regression task. Predictive R2 captures the predicted residual sum of squares (PRESS) normalized by the total sum of squares, which
can be thought of as PRESS values for a naive, intercept only model. On the other
hand, SCC quantifies the monotonic association between true and predicted values,
providing perspective as to whether the predicted values can capture the overall trend
of the outcome. Prior to evaluation, all metabolites were back transformed to their
original scale. In order to perform comparisons between models across time points
and metabolites as well as ascertaining the uncertainty of each evaluation metric, a
Bayesian approach as presented in [23]. Specifically, a generalized Bayesian hierarchical linear model (with identity link and gaussian standard error) in the following
form was fitted for each metabolite:
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Evaluation Statistic ∼ Model + (1|repeat) + (1|repeat : fold)
This model assumes that the distribution of the evaluation statistic as a linear function of model assignment, with random intercepts varying among repeats and for
folds within each repeat. Models were fitted using implementation in the R package tidyposterior [151] using default weakly informative priors as described in the
rstanarm package [35]. Using this model, a predictive posterior mean and 95% credible interval can be generated. The posterior mean is then used to rank the best
performing model for each metabolite according to the evaluation metric of interest.
Ranks are then aggregated using the Borda method [173] to generate Borda scores.
In detail, for each metabolite, 4 points are added to the top ranked model, 3 points
to the second ranked model and so on. The model with the highest total points for
each metric is the most performant model aggregated across all prediction tasks.

2.6.10. Simulation design
Simulations were performed to examine the behavior of models under known association/null settings in order to validate findings.
For the first simulation scenario, a linear association between genus-level taxonomic abundance and log transformed metabolite concentrations were simulated.
The predictor matrix were bootstrapped resamples of the community matrix post
data processing. β coefficient values were sampled from the standard normal distribution N (0, 1) values for each genus would have a probability p (0.05, 0.1, 0.5, 0.95) of
being 0 which determines the sparsity of the coefficients (or the level of model saturation). We generate metabolite outcome values Y following the model Y = β0 +Xβ +ϵ
where X is the n × p simulated taxonomic predictor matrix, β is the p × 1 previously
defined coefficient vector, ϵ ∼ N (µ = 0, σ = σϵ ) is the standard normal noise vector.
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√
Similar to Xiao et al. 2018 [327] and Shi et al. 2016 [269], we set all β0 = 6/ 10 and
σϵ = (σ(β0 + Xβ))/SNR where signal-to-noise ratio (SNR) are set at 0.5, 0.7, 3, 5 to
simulate both situations where noise is higher than signal and vice versa. For each
simulation setting, 100 data sets were generated. For the second simulation scenario,
null models were assessed through a permutation procedure using the picante package in R as described earlier. A total of 500 permutations was performed for each
model.
To evaluate the predictive capacity of models for each simulation scenario, each
data set was split into a train and test set (80% train; 20% test). Within each training
set, a 10-fold cross validation procedure was employed to tune any hyperparameters.
Similar evaluation metrics were assessed as described in the model fitting section.

2.6.11. Metagenomic prediction with PICRUSt2
We conducted a PICRUSt2 (version 2.3.0 b) [73] analysis to investigate the potential
relationship between the functional metagenome (obtained via in sillico predictions)
and measurements of associated metabolites. We performed this analysis for metabolites obtained in the targeted data set. The PICRUSt2 pipeline was performed on
pre-filtered ASV sequences and abundance tables using default settings. Snakemake
was used to construct the computational pipeline [204].
After obtaining predicted MetaCyc pathway abundances [45], for each metabolite, we selected a subset of the pathways where the metabolite is a known product
(accessed via MetaCyc SmartTables; 6-week samples: https://metacyc.org/group?
id=biocyc13-50254-3822215614, 12-month samples: https://metacyc.org/group?
id=biocyc13-50254-3822215614) and performed Spearman correlation analysis with
the measured metabolite abundances. For each significant correlation (significance
level defined as q-values below 0.05 following the Benjamini-Hochberg procedure [24]),
we profiled the relative contributions of the top five Genera. Relative contribution is
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calculated as total abundance of a pathway assigned to that Genus across all samples
divided by the total abundance of the pathway across all samples. Additionally, pairwise Spearman correlation between all identified pathway abundances and targeted
metabolite concentrations was also performed. Significance is defined similarly as
FDR adjusted q-values below 0.05.

Section 2.7

Availability of data and materials
The 16S rRNA gene sequencing datasets used in this study are stored in the National Center for Biotechnology Information (NCBI) Sequence Read Archive: http:
//www.ncbi.nlm.nih.gov/sra under accession number PRJNA296814. The raw
and processed metabolomics data is available at the NIH Common Fund’s National
Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https:
//www.metabolomicsworkbench.org where it has been assigned Project ID PR001146.
The data can be accessed directly via its project DOI: https://doi.org/10.21228/
M8K69N. All intermediary analysis objects and scripts are available on GitHub.

Section 2.8

Acknowledgements
We thank the participants of the New Hampshire Birth Cohort Study and to the study
staff, without whom this research would not be possible. We would also like to thank
all members of the Microbiome research group at Dartmouth College and our collaborators at the University of North Carolina and the Marine Biological Laboratory for
all advice and additional assistance in preparing this manuscript.

47

2.8 Acknowledgements

Figure 2.3: Pairwise Spearman correlation of concentration-fitted metabolites and
genus-level taxonomic abundances for 6-weeks (panel A, N = 158) and 12-months
(panel B, N = 282) infants. Left panel displays the overall correlation pattern,
where non-significant correlations are not colored (false discovery rate (FDR) controlled q-value < 0.05). Right panel displays the same heatmap restricted to taxa
and metabolites selected by the sparse CCA procedure. Additionally, correlation
coefficient of the first sCCA variate pair, bootstrapped 95% confidence interval and
permutation p-value are also reported. Significant microbiome-metabolome correlation was observed at both time points, however no significant difference was found
between the time points.
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Figure 2.4: Forest plots of each prediction performance metric (R2 - Panel A,
Spearman correlation - Panel B) for each time point (6 weeks (N = 158), 12 months
(N = 282)) across all 36 metabolites and 4 machine learning models. 95% credible
interval and predictive posterior means were generated using Bayesian modelling of
the evaluation statistic (Materials and Methods) after 100 repeats of 5-fold nested
cross validation. Red vertical lines indicate a value of 0 for the evaluation metric
(equivalent to null model). Metabolites were classified as predictable if the null value
did not lie within the estimated 95% credible interval. For most metabolites, predictive performance was not significantly better than null models.
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Figure 2.5: Comparative analysis predictive model performance across all metabolites in the targeted dataset for both 6-weeks (N = 158) and 12-months (N = 282)
time points. Top panel shows superimposed boxplots and violin plots of the distribution of predictive posterior mean for each evaluation metric across all 36 metabolites. Bottom panels show aggregated model rankings for all metabolites using R2
(left) and Spearman correlation (right) using Borda scores (Materials and Methods).
Higher scores indicate that a model was consistently selected as a better performing.
Relatively similar Borda scores and cross-metabolite average predictive performances
indicate that no model was clearly the most performant. However, support vector
machines (with radial basis function kernel) was highest scoring model.
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CBEA: Competitive balances for
taxonomic enrichment analysis
This chapter was accepted for publication on May 5th, 2022 as a Research Article at
PLOS Computational Biology and is currently in press. The latest pre-print of the
article can be found here:
Nguyen, Q.P., Hoen, A.G., Frost, H.R. CBEA: Competitive balances for taxonomic
enrichment analysis. bioRxiv. https://doi.org/10.1101/2021.09.07.459294

Section 3.1

Abstract
Background: Research in human-associated microbiomes often involves the analysis
of taxonomic count tables generated via high-throughput sequencing. It is difficult to
apply statistical tools as the data is high-dimensional, sparse, and compositional. An
approachable way to alleviate high-dimensionality and sparsity is to aggregate variables into pre-defined sets. Set-based analysis is ubiquitous in the genomics literature
and has demonstrable impact on improving interpretability and power of downstream
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analysis. Unfortunately, there is a lack of sophisticated set-based analysis methods
specific to microbiome taxonomic data, where current practice often employs abundance summation as a technique for aggregation. This approach prevents comparison
across sets of different sizes, does not preserve inter-sample distances, and amplifies
protocol bias. Here, we attempt to fill this gap with a new single-sample taxon enrichment method that uses a novel log-ratio formulation based on the competitive
null hypothesis commonly used in the enrichment analysis literature.
Methods: Our approach, titled competitive balances for taxonomic enrichment analysis (CBEA), generates sample-specific enrichment scores as the scaled log-ratio of the
subcomposition defined by taxa within a set and the subcomposition defined by its
complement. We provide sample-level significance testing by estimating an empirical
null distribution of our test statistic with valid p-values.
Results: Herein, we demonstrate, using both real data applications and simulations,
that CBEA controls for type I error, even under high sparsity and high inter-taxa
correlation scenarios. Additionally, CBEA provides informative scores that can be
inputs to downstream analyses such as prediction tasks.

Section 3.2

Background
The microbiome is the collection of microorganisms (bacteria, protozoa, archaea,
fungi, and viruses) which co-exist with their host. Previous research has shown that
changes in the composition of the human gut microbiome are associated with important health outcomes such as inflammatory bowel disease [245], type II diabetes [268],
and obesity [9]. To understand the central role of the microbiome in human health,
researchers have relied on high-throughput sequencing methods, either by targeting a
specific representative gene (i.e. amplicon sequencing) or by profiling all the genomic
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content of the sample (i.e. whole-genome shotgun sequencing) [52]. Raw sequencing
data is then processed through a variety of bioinformatic pipelines [40, 286], yielding various data products, one of which are taxonomic tables which can be used to
study associations between members of the microbiome and an exposure or outcome
of interest.
However, there are unique challenges in the analysis of these taxonomic count
tables [166, 165]. The data is sparse, high-dimensional, and likely compositional
[104, 166, 165]. Even though these problems are challenging, a very approachable
solution is to use set-based analysis methods, also termed gene set testing in the
genomics literature [139, 105]. Aggregated variables can be less sparse, and testing
on a smaller number of features can reduce the multiple-testing burden. As such,
gene set testing methods have been shown to increase power and reproducibility of
genomic analyses. Furthermore, through the usage of functionally informative sets
defined a priori based on historical experiments (for example MSigDB [276], and
Gene Ontology [12]), gene set analysis also allows for more biologically informative
interpretations.
A diverse set of methods have already been developed in this field. Traditional
methods utilize the hypergeometric distribution to test for the overrepresentation of
a gene set using a candidate list of genes screened based on a marginal model [105].
Unfortunately, these approaches are sensitive to the differential expression test as well
as the chosen threshold when trying to select genes for the candidate list. Aggregate
score methods, which are generally preferred [126], instead assign a score for each
gene set based on gene-specific statistics such as z-scores or fold change. Of these
approaches, methods such as GSEA [276] perform a test for each gene set at the
population level, summarizing information across all samples. Conversely, methods
such as GSVA [111] and VAM [95], generate enrichment scores at the sample level and
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are more akin to a transformation. In addition to being able to screen for enriched
sets per sample, this strategy also allows for the flexible incorporation of different
downstream analyses, such as fitting prediction models, or performing dimension
reduction.
In microbiome research, even when no explicit enrichment analysis is performed,
researchers often aggregate taxa to higher Linnean classification levels such as genus,
family, or phylum. However, there is limited research done to extend existing setbased methods to microbiome relative abundance data. Some software suites, such as
MicrobiomeAnalyst, do offer tools to perform enrichment testing with curated taxon
sets [53]. However, the approach used in MicrobiomeAnalyst is a form of overrepresentation analysis at the population level and therefore similarly sensitive to the
differential abundance approach used and p-value threshold. One of the primary challenges for adapting gene set analysis to the microbiome context is the compositional
nature of the data. Sequencing technologies constrain the total number of reads,
and samples are expected to have the same number of reads instead of DNA content
[250, 249]. However, different samples still yield arbitrarily different total read counts
[104, 212], suggesting the use of normalization methods to allow for proper comparison of feature abundances across samples. However, microbiome data sets do not
follow certain assumptions that enable the cross-application of methods from similar
fields (such as RNA-seq) [249, 250]. For example, DESeq2’s estimateSizeFactors
[177] assumes that the majority of genes acts as housekeeping genes with constant
expression levels across samples. As such, practitioners often rely on total sum normalization to transform count data into relative proportions that sum to one [307].
Some studies have provided emprical performance evaluations supporting this normalization schema [194]. Since this approach imposes a sum constraint on the data,
post normalization microbiome data sets are compositional [104], which means that
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the abundance of any taxon can only be interpreted relative to another. Under this
scenario, log-ratio based approaches from the compositional data analysis (CoDA)
literature [6] are motivated to address this issue.
Unfortunately, the standard practice for aggregating variables using element-wise
summations (referred to as amalgamations in the CoDA literature), does not adequately address the compositional issue [195]. First, inter-sample Aitchison distances
computed on original parts are not preserved after amalgamation [79]. This means
that cluster analyses might show different results depending on the level of amalgamation and differs from the those computed from original variables. Second, amalgamations do not allow for comparison between sets of different sizes within the same
experimental condition since larger sets will have larger means and variances. Third,
considering that each taxa has specific measurement biases [195], an amalgamation
based approach would make the bias of the amalgamated variable dependent on the
relative abundance of the its constituents. In other words, if taxon 1 has abundance
A1 and bias B1 , while taxon 2 has abundance A2 and bias B2 , then the bias of the
aggregate variable (for example, a genera) is (A1 B1 + A2 B2 )/(A1 + A2 ) (see Appendix
1. from McLaren et al. [195]). This means that bias invariant approaches (such as
analyses of ratios) would no longer be invariant when applied to amalgamated variables as bias now varies across samples. The alternative would be to multiply the
proportions rather than to sum them [79].
Here, we present a taxon-set testing method for microbiome relative abundance
data that addresses the aforementioned issues. Our approach generates enrichment
scores at the sample level similar to GSVA [111] and VAM [95]. We leverage the
concept of the Q1 competitive hypothesis presented in Tian et al. [283] to formulate
the enrichment of a set as the compositional balance [257] of taxa within the set
and remainder taxa using multiplication as the method of aggregating proportions
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[79]. This well-defined null hypothesis allows us to perform significance testing with
interpretable results through estimating the empirical distribution of our statistic
under the null that can also account for variance inflation due to inter-taxa correlation
[324].
In the following sections, we present our approach titled competitive balances for
taxonomic enrichment analysis (CBEA). First, we present the step-by-step formulation of CBEA and discuss its statistical properties. Second, we detail our evaluation
strategy using both real data and parametric simulations, and the methods we are
comparing against. Third, we present results on enrichment testing using CBEA
for single samples as well as at the population level. Fourth, we show the performance of CBEA in downstream disease prediction. Finally, we discuss our results
and the limitations of our method. An R package implementation of CBEA can
be installed via Bioconductor. The development version can be found on GitHub
(www.github.com/qpmnguyen/CBEA).

Section 3.3

Materials and Methods
3.3.1. Competitive balances for taxonomic enrichment analysis (CBEA)
The CBEA method generates sample-specific enrichment scores for microbial sets
using products of proportions [80]. Details on the computational implementation of
CBEA can be found in the Supplementary Materials. The CBEA method takes two
inputs:
• X: n by p matrix of positive proportions for p taxa and n samples measured through either targeted sequencing (such as of the 16S rRNA gene) or
whole genome shotgun sequencing. Usually X is generated from standard taxonomic profiling pipelines such as DADA2 [40] for 16S rRNA sequencing, or
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MetaPhlAn2 [286] for whole genome shotgun sequencing. CBEA does not accept X matrices with zeroes since it invalidates the log-ratio transformation.
Users can generate a dense matrix X using a method of choice, however by
default mode CBEA will add a pseudocount of 10−5 if zeroes are detected in
the matrix.
• A: p by m indicator matrix annotating the membership of each taxon p to m
sets of interest. These sets can be Linnean taxonomic classifications annotated
using databases such as SILVA [247], or those based on more functionally driven
categories such as tropism or ecosystem roles (Ai,j = 1 indicates that microbe i
belongs to set j).
The CBEA method generates one output:
• E: n by m matrix indicating the enrichment score of m pre-defined sets identified in A across n samples.
The procedure is as follows:
(a) Compute the CBEA statistic: Let M be a n by m matrix of CBEA scores.
Let Mi,k be CBEA score for set k and sample i:
sP
Mi,k =

k

Aik (p −
p

P

k

Aik )


ln

g(Xi,j |Aj,k = 1)
g(Xi,j |Aj,k ̸= 1))


(3.1)

where g(.) is the geometric mean. This represents the ratio of the geometric
mean of the relative abundance of taxa assigned to set k and remainder taxa.
(b) Estimate the empirical null distribution Enrichment scores represent the
test statistic for the Q1 null hypothesis Ho that relative abundances in X of
members of set k are not enriched compared to those not in set k. Since the
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distribution of CBEA under the null vary depending on data characteristics
(Fig 3.1), an empirical null distribution will be estimated from data.
• Compute the CBEA statistic on permuted and un-permuted X.
Let Xperm be the column permuted relative abundance matrix, and Mperm
be the corresponding CBEA scores generated from Xperm . Similarly, we
have Munperm be CBEA scores generated from X.
• Estimate correlation-adjusted empirical distribution for each set.
For each set, a fit a parametric distribution to both Mperm and Munperm .
The location measure estimated from Mperm and the spread measure estimated from Munperm will be combined as the correlation-adjusted empirical
null distribution Pemp for each set. Two available options are the normal
distribution and the mixture normal distribution. For the normal distribution, parameters were estimated using the method of maximum likelihood
implemented in the fitdistr package [66]. For the mixture normal distribution, parameters were estimated using an expectation-maximization
algorithm implemented in the mixtools package [22].
(c) Calculate finalized CBEA scores with respect to the empirical null.
Enrichment scores Ei,k are calculated as the cumulative distribution function
(CDF) values or z-scores with respect to Pemp distribution. Raw p-values can
be calculated by subtracting E from 1.

3.3.2. Properties of CBEA
CBEA and balances between groups of parts. The CBEA statistic is based
on the multiplication-based aggregation approach used to calculate balances between
groups of parts [79]. These balances are computed using the isometric log ratio (ILR)
transformation [80] formula. For a given balance i splitting variables across sets R
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and S, we have the balance coordinate x∗i as:
x∗i

r
=

rs
log
r+s



g(Xj|j∈R )
g(Xj|j∈S )


(3.2)

where r and s are the cardinalities of sets R and S respectively, g(z) is the geometric
mean, and Xj are values of the original predictors with indexes defined by membership
in R and S.
CBEA belongs to a set of methods that seek to leverage compositional balances
for the analysis of microbiome data [304, 257, 213, 272]. Unlike methods such as
PhILR [272], CBEA does not present an orthonormal basis for the complete ILR
transformation (such as a a sequential binary partition) [80]. Therefore, it is not
a subclass of the ILR transformation and is adjacent to this approach. A similar
method to CBEA would be phylofactor [304]. However, instead of performing an
optimization procedure to identify interesting balances, CBEA constructs balances
a priori using pre-defined sets, and formulates the enrichment of a set as the scaled
log-ratio between the center of the subcomposition represented by microbes within
the set and the center of the subcomposition represented by remainder taxa. This
formulation aligns with the Q1 null hypothesis from the gene set testing literature
[283].

Estimating the null distribution. We can assume that the CBEA statistic, similar to other log-ratio based transforms, follows a normal distribution [80, 5]. However,
when applying CBEA for hypothesis testing at the sample level, it is expected that the
researcher would be testing a large number of hypotheses. Under the assumption that
the number of truly significant hypotheses is low, Efron [78] showed that estimating
the null distribution of the test statistic directly (termed the empirical null distribution) is much more preferable than using the theoretical null due to unobserved
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confounding effects inherently part of observational studies. As such, to perform significance testing using CBEA, we also estimated the null distribution from observed
raw CBEA variables.
This assumption is also supported by preliminary simulation studies (detailed
below). We simulated microbiome taxonomic count data under the global null across
different data features and compute raw CBEA scores and compute kurtosis and
skewness in Fig 3.1A. We found that the characteristics of the null change depending
on sparsity and inter-taxa correlation. Sparsity seems to drive the distribution to be
more positively skewed while inter-taxa correlation encourages platykurtic (negative
kurtosis). The effect is most dramatic under both high inter-taxa correlation and
sparsity. This heterogeneity further supports the decision to estimate an empirical
null distribution, as suggested by Efron [78].
Additionally, the degree of kurtosis and skewness also suggests that the normal
distribution itself might not be a good approximation of the null. To address this issue,
we also evaluated a two-component normal mixture distribution. The goodness of fit
of the mixture normal and the normal distribution using Kolmogorov-Smirnov (KS)
test statistic computed on fitted normal and mixture normal distribution when fitted
on CBEA scores in simulation scenarios under the global null is shown in Fig 3.1B.
We can see that the mixture normal distribution is a better fit (lower KS scores) than
the normal distribution across both sparsity and correlation settings.
We performed our empirical null estimation by fitting our distribution of choice
and computing relevant parameters on raw CBEA scores on taxa-permuted data
(equivalent to gene permutation in the gene expression literature). As such, the null
distribution is characterized by scores computed on sets of equal size with randomly
drawn taxa.
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Figure 3.1: Properties of the null distribution of CBEA under the global null simulations. Panel (B) presents kurtosis and skewness of CBEA scores while panel
(A) presents the goodness of fit (as Kolmogorov-Smirnov D statistic) for mixture
normal and normal distributions. Panel (C) is a density plot of the shape of the
null distribution. Results indicated the necessity of estimating an empirical null and
demonstrating that the mixture distribution was the better fit compared to the basic
normal.
Variance inflation due to inter-taxa correlation. When taxa within a set
are highly correlated, the variance of the sample mean of taxon-wise statistics is
inflated. Without loss of generalizability, for a set of taxa with taxon-specific statistics
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x1 , . . . , xp we have the variance of the mean x̄ to be:
1
V ar(x̄) = 2
m

!
X

(σi2 ) +

i=1

X

ρij σi σj

(3.3)

i<j

where σi is the standard deviation of taxon i and ρij is the correlation between i and
j. The second term of (3.3) is the correlation dependent variance component, which
goes to 0 if there is no correlation. The CBEA statistic follows a similar pattern.
Since the geometric mean of a set of variables is equivalent to the exponential of the
arithmetic mean of their logarithms, we can re-write CBEA score for a set k with size
K as follows:
s
Mi,k =


K(p − K)
log Xi,j|j∈K − log Xi,j|j ∈K
/
K + (p − K)

(3.4)

where p is the overall number of taxa, j is the index of a taxa and K is the set of
indices of taxa in set k. The CBEA statistic then looks similar to a t-statistic for
difference in means of log-transformed proportions. As such, the pooled variance of
CBEA is dependent on the variance inflation of both mean components log Xi,j|j∈K
and log Xi,j|j ∈K
/ . The result of this variance inflation is inflated type I error since
highly correlated sets are also detected as significantly enriched.
However, as Wu et al. [324] showed, performing column permutation to estimate
the null distribution of a competitive test statistic doesn’t allow for adequate capture
of this variance inflation factor since the permutation procedure disrupts the natural
correlation structure of the original variables. It is important to address this problem
since there is strong inter-taxa correlation within the microbiome [153]. Our strategy
for addressing this issue is to use the location (or mean) estimate from the column
permuted raw score matrix with the spread (or variance) estimate taken from the
original un-permuted scores. This still allows us to leverage the null distribution gen62
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erated via column permutation while using the proper variance estimate taken from
scores where the correlation structure has not been disrupted. As such, this procedure assumes that the variance of the test statistic under the alternate hypothesis is
the same as that of the null. Details of the computational implementation to this
estimation process can be found in the Supplementary Note 1.
However, set-based analysis is an exploratory approach that can help generate
functionally informative hypotheses, and as such users might not want strict type I
error control in favor of higher power. This is especially true for competitive hypotheses, where its stricter formulation compared to the self-contained approach implies
that the test naturally has lower power [105, 2]. Furthermore, sets that are highly
correlated compared to background can be biologically relevant. Therefore, CBEA
provides an option for users to specify whether correlation adjustment is desired.

Section 3.4

Evaluation
We based our evaluation strategy on gene set testing benchmarking standards set by
Geistlinger et al. [100] and utilized the same approaches whenever possible. All data
sets are obtained from either the curatedMetagenomicData [231] and HMP16SData
[262] R packages (2020-10-02 snapshot), or downloaded from the Qiita platform
[106]. All code and data sets used for evaluation of this method is publicly available and can be found on GitHub (www.github.com/qpmnguyen/CBEA_analysis).
Additional packages used to support this analysis includes: tidyverse [312], pROC
[259], phyloseq [197], mia [85], targets [155].
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3.4.1. Statistical significance
We evaluate the inference procedure of CBEA compared to alternate methods using
two approaches: randomly sampled taxa sets and sample label permutation. These
analyses were performed on the 16S rRNA gene sequencing of the oral microbiome
from the Human Microbiome Project [59, 245]. This data set contains 369 samples
split into two subsites: supragingival and subgingival. We processed this data set by
removing all samples with total read counts less than 1000 and OTUs whose presence
(at least 1 count) is in 10% of samples or less.

Sample-level inference. Due to CBEA’s self-contained null hypothesis, we can
perform inference at the sample level for the enrichment of a set. We evaluated this application by generating one random taxon-set of different sizes S ∈ {20, 50, 100, 150, 200}
across 500 iterations. Random sets can act as our estimate for type I error since this
matches the CBEA null hypothesis stated in Materials and Methods, where we expect
within each sample, sets of randomly drawn taxa should not be significantly enriched
compared to the remainder background taxa. For this evaluation, we estimated type
I error as the fraction of samples where our random set is detected as significant at
a p-value threshold of 0.05 with confidence bands computed from the standard error
across all iterations. Additionally, this analysis also tests whether CBEA is sensitive
to different set sizes.

Population-level inference. We can perform enrichment testing at the population
level by generating corresponding sample level CBEA scores and performing a twosample test such as Welch’s t-test. In order to evaluate CBEA under this context, we
generated CBEA scores of sets representing genus-level annotation in above gingival
data set [59, 245] and applied a t-test to test for enrichment (similar to GSVA [111])
across a randomly generated variable indicating case/control status (repeated 500
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times). Type I error is estimated as the fraction of sets per iteration found to be
significantly enriched with confidence bands computed from the standard error across
all iterations. In addition, we also performed a random set analysis assessment,
where we generated 100 sets of different set sizes S ∈ {20, 50, 100, 150, 200} and
evaluated the fraction of genera that were found to be differentially abundant across
the original labels (supragingival versus subgingival subsite). 95% confidence intervals
were computed using the Agresti-Couli approach [3].

3.4.2. Phenotype relevance
We want to evaluate whether sets found to be significantly enriched by CBEA are
relevant to the research question. To perform this assessment, we relied on the gingival data set mentioned above [59, 245]. This data set was chosen because its clear
biological interpretation can serve as the ground truth. Specifically, we expect aerobic microbes to be enriched in the supragingival subsite where the biofilm is exposed
to the open air, while conversely anaerobic microbes thrive in the subgingival site
[281]. Genus-level annotations for microbial metabolism from Beghini et al. [20]
were obtained from the GitHub repository associated with Calagaro et al. [38]. For
sample-level inference, we assessed power as the fraction of supragingival samples
where aerobic microbes are significantly enriched. For population-level inference,
power is the fraction of sets representing genus level taxonomic assignments that
were significant across subsite labels.
In addition to statistical power, we also assessed phenotype relevance through
evaluating whether highly ranked sets based on CBEA scores are more likely to be
enriched according to the ground truth. This is represented by the area under the
receiving operator curve (AUROC/AUC) scores computed on CBEA scores against
true labels (similar approach was used to evaluate VAM [95]). DeLong 95% confidence
intervals for AUROC [67] were obtained for each estimate.
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3.4.3. Disease Prediction
CBEA scores can also be used for downstream analyses such as disease prediction
tasks. We utilized two data sets for this evaluation:
(a) Whole genome sequencing of stool samples from inflammatory bowel disease
(IBD) patients in the MetaHIT consortium [225]. This data set contains 396
samples from a cohort of European adults, where 195 adults were classified as
having IBD (which includes patients diagnosed with either ulcerative colitis or
Crohn’s disease). We processed this data by removing all samples with less
than 1,000 total read counts as well as any OTU that was present (with nonzero proportions) in 10% of the samples or less. Prior to model fitting, we
back-transformed relative abundances into count data (to align the format with
our 16S rRNA gene sequencing data set) using the provided total number of
reads aligned to MetaPhlan marker genes (per sample).
(b) 16S rRNA gene sequencing of stool samples from IBD patients in the RISK
cohort [101]. This data set contains 16S rRNA gene sequencing samples from a
cohort of pediatric patients (ages < 17) from the RISK cohort enrolled in the
United States and Canada. Of the 671 samples obtained, 500 samples belong
to patients with IBD. We processed this data set by removing all samples with
less than 1,000 total read counts as well as any OTU that was present (at least
1 count) in 10% of the samples or less.
We evaluate disease prediction performance by fitting a random forest model [33]
using as inputs CBEA scores to classify samples of patients with IBD and healthy
controls. Random forest was chosen as a baseline learner due to its flexibility as an
out-of-the-box model that is easy to fit. In this instance we evaluated predictive performance of a default random forest model (without hyperparameter tuning) AUROC
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after 10-fold cross validation. Additionally, we utilized SMOTE to correct for class
imbalances [47]. Implementation was done using the tidymodels suite of packages
[152].

3.4.4. Comparison Methods
We benchmarked the statistical properties of CBEA against existing baseline approaches. For sample-level inference analyses, utilized the Wilcoxon rank-sum test,
which non-parametrically tests the difference in mean counts between taxa from a
pre-defined set and its remainder similar to CBEA. For assessments at the population level, we compared CBEA against performing a standard test for differential
abundance with set-level features generated via element-wise summations instead.
We chose DESeq2 [177] and corncob [191] because they represent both methods extrapolated from RNA-seq [197] and those developed specifically for microbiome data.
Since disease prediction models and rankings-based phenotype relevance analyses
seek to evaluate the informativeness of CBEA scores instead of relying on computing p-values, we compared performance against other single sample based approaches
from the gene set testing literature, specifically ssGSEA [17] and GSVA [111]. Additionally, for evaluating prediction, we also compared performance against a standard analysis plan where inputs are count-aggregated sets with the centered log-ratio
(CLR) transformation.

Section 3.5

Results
In this section, we present results for evaluating statistical significance, phenotype
relevance, and predictive performance. In addition to real data, we also evaluated
models based on parametric simulations, where results can be found in the Supple-
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mental Materials.

3.5.1. Statistical Significance
Inference at the sample level. CBEA provides significance testing at the sample
level through a self-contained competitive null hypothesis. Generating random sets
approximate the global null setting where within each sample, sets generated by
randomly sampling taxa should not be significantly more enriched than remainder
taxa.
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Figure 3.2: Random taxa set analyses for inference at the sample level of CBEA
under different parametric assumptions compared against a Wilcoxon rank-sum test.
Type I error (y-axis) was evaluated by generating random sets of different sizes (x axis) (500 replications per size) and computing the fraction of samples where the set
was found to be significantly enriched at α = 0.05. Error bars represent the mean type
I error ± sample standard error computed across 500 replications of the experiment.
Only the unadjusted CBEA with the mixture normal distribution and the Wilcoxon
rank sum test were able to control for type I error at 0.05. All approaches are invariant
to set sizes.

Fig 3.2 demonstrates type I error of sample-level inference evaluated using the
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random set approach. The Wilcoxon rank sum test and unadjusted CBEA under
mixture normal assumption demonstrated good type I error control at the appropriate
α level. This fits with our expectations since the mixture normal distribution has a
much better fit than the normal distribution especially at the tails of the empirical
distribution (Fig 3.1). However, other variants of CBEA demonstrated inflated type
I error, especially correlation adjusted variants compared to their unadjusted counter
parts. Encouragingly, all methods demonstrate consistent performance across all set
sizes, with a slight increase in type I error at the highest levels.
Interestingly, simulation results (Fig C.1) showed an opposite pattern. Adjusted
approaches were good at controlling for type I error, especially under the low intertaxa correlation values within the set (similar to generating random sets where the
natural correlation structure is disrupted). In these simulations, unadjusted approaches and the Wilcoxon rank sum test had significant type I error inflation with
increasing correlation. All approaches seem to be invariant to the level of data sparsity.

Inference at the population level. Similar to other single sample approaches to
gene set testing such as GSVA [111], we can perform inference at the population level
by utilizing a two-sample difference in means test. Here, we evaluate using CBEA
scores generated under different settings with Welch’s t-test in a supervised manner
to assess whether a set is enriched across case/control status.
Fig 3.3 shows results for this scenario using both random sample label and random
set evaluations. The random sample label approach (Fig 3.3A) provides a controlled
setting where we can estimate type I error rate controlled at α = 0.05. Across all
replications, CBEA methods were able to control for type I error at the nominal
threshold of 0.05, with CBEA raw scores being the most performant. Neither output
types, correlation adjustment, nor distributional assumption improved performance
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Figure 3.3: Random sample label (A) and random set (B) analyses for population
level inference. (A) Type I error (x -axis) was estimated as the overall fraction of
sets found to be enriched α = 0.05 using randomly generated sample labels (500
permutations). Error bars represent the mean type I error ± sample standard error.
(B) Proportion of significant sets (y-axis) using 100 randomly generated sets of different set sizes (x -axis). Confidence intervals computed using Agresti-Couli method
for binomial proportions. For sample label permutation (A), all CBEA approaches
were able to control for type I error but not for corncob and DESeq2. For random
set analyses (B), all approaches demonstrate similar rate of accepting significant sets
and were invariant to overall set size.
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values. Surprisingly, DESeq2 and corncob both exhibit significantly inflated type I
error.
We also assessed the impact of set-size on the inference procedure by testing
for enrichment using the original sample labels but with randomly sampled sets of
different sizes (Fig 3.3B). Overall we observed very similar values across CBEA as
well as corncob and DESeq2, suggesting that no individual method is systematically
identifying too many significant sets. Additionally, similar to analogous analyses at
the sample level, no approach was significantly sensitive to changes in set sizes.

3.5.2. Phenotype Relevance
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Figure 3.4: Statistical power (A) and score rankings (B) to assess phenotype relevance. (A) Power (x -axis) was estimated as the overall fraction of aerobic microbes
found to be enriched in supragingival samples at α = 0.05. 95% confidence intervals
were computed using the Agresti-Couli approach for binomial proportions. (B) Score
rankings were evaluated by comparing computed scores against true values using AUROC (x -axis). DeLong 95 % confidence intervals for AUROC were computed.
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Inference at the sample level. In Fig 3.4, we evaluate whether sets found to
be significant by CBEA are relevant to the phenotype of interest. We leveraged the
gingival data set as stated in Evaluation section where we know beforehand that
aerobic microbes are more likely to be enriched in supragingival subsite samples and
vice versa.
We estimated statistical power using this data set as the fraction of supragingival
samples where the set representing aerobic microbes were significantly enriched. We
observed that adjusted CBEA approaches demonstrate much lower power compared
to the Wilcoxon rank-sum test and unadjusted variants. This is surprising given the
fact that in statistical significance analyses, the adjusted CBEA approach provides
inflated type I error, especially if the normal distribution assumption was chosen,
which indicates a mismatch in estimating the null distribution since a high type I
error did not result in increased power.
We also evaluated phenotype relevance by assessing whether enriched sets according to ground truth are preferentially ranked higher using assigned continuous scores
(instead of performing a hypothesis test). This aspect is captured through computing
AUROC values comparing computed enrichment scores and true labels. Consistent
with the previous type I error evaluation, adjusting for correlation did not improve
performance, where obtained AUROC were around 0.5 and at the same level as the
benchmark Wilcoxon rank sum statistic. Unadjusted methods were much better at
ranking true enriched sets, however the mean AUROC values are lower than alternate
single sample enrichment methods (GSVA [111] and ssGSEA [17]) even though this
difference is not significant due to overlapping confidence intervals.
The above results were replicated in simulation studies where we observed that adjusted approaches were very conservative and demonstrated significantly lower power
(Fig C.3) with increasing correlation even at the highest evaluated effect sizes. When
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assessing score rankings, the performance of CBEA was closer to ssGSEA and GSVA
compared to real data evaluations, however all single sample approaches were much
better than using the W statistic from the Wilcoxon Rank Sum test.
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Figure 3.5: Statistical power to assess phenotype relevance of inference tasks at
the population level. Power (x -axis) was estimated as the overall fraction of sets
representing genera that are aerobic or anaerobic microbes found to be differentially
enriched across sample type (supragingival or subgingival). 95% confidence intervals
were computed using the Agresti-Couli approach for binomial proportions.
Inference at the population level. We also assessed statistical power for population level inference scenarios using a similar approach. Here, enrichment scores
for sets representing all identified genera were computed, and power was estimated
as the fraction of sets found to be differentially enriched across sample site labels
(supragingival or subgingival). We compared these results against performing a differential abundance test of genus level features generated via sum-based approaches.
Results are shown in Fig 3.5. Some CBEA variants, such as CDF outputs for the mixture normal distributional assumption, did not correctly detect as many significant
sets as DESeq2 or corncob despite very close performance values. Using raw CBEA
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scores was best approach, however it did not exceed values obtained from DESeq2
and corncob.

3.5.3. Disease Prediction
Since CBEA can generate informative scores that can discriminate between samples
with inflated counts for a set (Fig 3.4), we wanted to assess whether they can also
act as useful inputs to predictive models. In this section we assessed the predictive
performance of a standard baseline random forest model [33] with different single
sample enrichment scoring methods as inputs (CBEA, ssGSEA, and GSVA). Additionally, we also compared predictive performance of using these scores against the
a standard approach of using the centered log ratio transformation (CLR) on taxon
sets aggregated via abundance summations.
We fit our model to two data sets with a similar disease classification task of
discriminating patients who were diagnosed with IBD (includes both Crohn’s disease
and ulcerative colitis) using only microbiome taxonomic composition. The two data
sets represent different microbiome sequencing aprpaoches: the Gevers et al. [101]
data set uses 16S rRNA gene sequencing, while the Nielsen et al [225] data set uses
whole genome shotgun sequencing.
Fig 3.6 illustrates the performance of our model with AUROC as the evaluation
criteria. In the 16S rRNA data set, the best performing CBEA variant (CDF values computed from an unadjusted mixture normal distribution) outperforms both
GSVA and ssGSEA but not the standard CLR approach. Interestingly, in the whole
genome sequencing data set, CBEA outperforms CLR, but was similar in performance to GSVA. However, due to large confidence intervals, no method significantly
out-performed other evaluated approaches. As such, these results indicate that, for a
given pre-determined collection of sets, CBEA generated scores are can be informative and provide competitive performance when acting as inputs to disease predictive
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Figure 3.6: Predictive performance of a naive random forest model trained on
CBEA, ssGSEA, GSVA generated scores as well as the standard CLR approach on
predicting patients with inflammatory bowel disease versus controls using genus level
taxonomic profiles. Data sets used span both 16S rRNA gene sequencing (Gevers
et al. [101]) and whole-genome shotgun sequencing (Nielsen et al. [225]). CBEA
performs better than GSVA and ssGSEA but not as well as CLR, with the exception
of the whole genome sequencing data set.
models. Simulation studies (Fig C.5) showed similar results, however CBEA more
consistently underperformed compared to CLR across all scenarios. Interestingly, the
performance gap decreases with increasing sparsity levels and correlation.
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Section 3.6

Discussion
3.6.1. Inference with CBEA
CBEA is a microbiome-specific approach to generate sample specific enrichment scores
for taxonomic sets defined a priori. The formulation of CBEA as a comparison
between taxa within the set and its complement corresponds to the competitive null
hypothesis in the gene set testing literature [283]. Since this null hypothesis is selfcontained per sample, this allows users perform enrichment testing at the sample
level. Additionally, in combination with a difference in means test, CBEA can also
test for enrichment at the population level across case/control status similar to GSVA
[111].
For single-sample analyses, we demonstrated that the CBEA approach (unadjusted with mixture normal parametric assumption) was able to control for type I
error at the nominal level of 0.05 under the global null (Fig 3.2) while also demonstrating adequate power (Fig 3.4). This performance is consistent across different
set sizes as well as our prior distributional fit analyses (Fig 3.1), where the mixture
normal displayed superior fit to the null distribution. Unfortunately, other variants of
CBEA demonstrated neither good type I error control nor power. Interestingly, while
the adjusted methods showed poor performance in real data evaluations (Fig 3.2), in
simulation studies (Fig C.1, Fig C.3) these approaches were able to control for type I
error well with the trade-off of much lower power. For the population-level inference
task, CBEA also performed very well. Under the permutation global null, representing genera abundance using CBEA scores in combination with Welch’s t-test controls
for type I error at the correct α threshold while also keeping respectable power. Since
the population level enrichment test is equivalent to a differential abundance test
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using set-based features, we compared the CBEA approach against using elementwise summations with corncob [191] and DESeq2 [177] to test for set-level differential
abundance. We chose DESeq2 because it is an older approach from the bulk RNAseq literature that has strong support for usage in microbiome taxonomic data [197].
Alternately, corncob is a newer method developed specifically for microbiome taxonomic data sets, where taxonomic counts are modeled directly using a beta-binomial
distribution instead of relying on normalization via size factor estimation. We observed that using this approach resulted in an inflated type I error compared to all
variants of CBEA (Fig 3.2), yet did not improve power (Fig 3.4). Results for CBEA
approaches were replicated in simulation analyses, however for corncob and DESeq2
we observed an opposite effect: in simulation experiments, both methods show good
type I error control but low power (Fig C.2, Fig C.4).
We hypothesized that the discrepancy between simulation and real data evaluations could be due to differences in our assumptions regarding the data generating
process that informed our simulation schema. For the non-zero component of each
taxon, we sampled from the same negative binomial distribution where designated
enriched taxa were generated with inflated means (but the same dispersion). These
marginals were simulated to account for block exchangable correlation within the
enriched set only. This might have affected our results in two ways. First, our simulation scenario ensures that all designated non-enriched taxa are identical to each
other. This is not the case for real data, where our null scenario involves randomly
sampled sets that might by chance all have taxa with inflated means compared to
remainder taxa. This is represented in Fig C.7, where the distribution of type I
error across 500 replications is right skewed for underperforming CBEA variants, indicating that these approaches are much more sensitive compared to the Wilcoxon
rank sum test or unadjusted CBEA with mixture normal distribution. Second, as
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described in the Background section, we did not consider taxon-specific biases that
distort the observed relative abundance of taxa compared to true values [195]. In the
context of sum-based aggregations, the resulting bias of the aggregated taxon-set is
dependent on the relative abundances of the contributing taxa (Appendix I in [195]).
Conceptually, this means that measurement error for a taxon-set is different across
samples as relative abundance of contributing taxa changes, leading to issues when
attempting to perform inference. As such, we expect methods like corncob or DESeq2
when performed on such sum aggregates in the presence of taxon-specific biases to
have inflated type I error compared to our multiplication based approach. This also
explains why conversely in simulation studies, where taxon-specific biases are absent,
corncob and DESeq2 performed better.

3.6.2. Downstream analysis using predictive models
The sample-level enrichment scores generated by the CBEA method can be used in
downstream analyses such as disease prediction. We evaluated whether CBEA can
be used to generate set-based features for disease prediction models. We fit a basic
random forest model [33] to predict continuous and binary outcomes using CBEA generated scores as inputs. Similar to our inference analysis, we compared CBEA against
both ssGSEA and GSVA. Additionally, we also evaluated CBEA with the approach
where counts of a set were aggregated using sums and applied the centered log-ratio
transformation (CLR). This is because CLR is considered standard practice in using
microbiome variables as predictors for a model [104]. Results showed that CBEA
generate scores perform well across both real data and simulation scenarios. Since
predictive models consider the effect of variables jointly (and in the case of random
forest, consider interactions as well), good performance indicates that CBEA scores
can capture joint distribution of sets, enabling both uniset and multi-set type analyses. Comparatively, CBEA generated scores outperformed other enrichment score
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methods (GSVA and ssGSEA), suggesting that it is more tailored for microbiome
taxonomic data sets. This is consistent with our sample ranking analysis (Fig 3.4),
where CBEA scores are on average more informative when used to rank samples based
on their propensity to have inflated counts. However, CBEA did not outperform the
CLR approach across our simulation studies, and only marginally performed better in
the real data analysis with WGS data. Fortunately, in simulation studies, this performance gap between CLR and CBEA decreases with higher sparsity and correlation,
especially in low effect saturation scenarios.

3.6.3. Limitations and future directions
These above results demonstrate the applicability of CBEA under different data analysis scenarios. If researchers are interested in performing inference, they can decide
between an unsupervised sample level approach (i.e. screen samples for enrichment
of certain characteristics) or a supervised population level approach (i.e. identifying
characteristics that are differentially abundant across case/control status). For the
unsupervised approach, utilizing the unadjusted CBEA with the mixture normal distribution provides a good initial starting point. In the case where researchers only
want to screen samples with mean-inflated taxon sets (instead of additionally detecting taxon sets with increased correlation), they can apply the adjusted approach,
which can be effective at conserving type I error even for high correlation scenarios.
However, the trade off for this adjustment is power, which decreases with increasing correlation. For the supervised analysis, all CBEA variants control for type I
error and provide adequate statistical power. However, using raw CBEA scores with
difference-in-means test such as Welch’s t-test is preferable since is the least computationally expensive (no estimation process) while still outperforming the use of a
sum-based approach with a standard differential abundance test. Beyond inference,
CBEA scores are flexible and can be useful for downstream analysis. We demon79

3.6 Discussion
strated that for a given number of set-based features, CBEA can produce informative
scores that contribute to competitive performance of prediction models even in low
signal-to-noise ratios with high inter-taxa correlation and sparsity. This is especially
true for whole genome sequencing data sets, where CBEA outperfrorms the standard
approach of applying a CLR transformation. Researchers might find CBEA useful
under situations of high sparsity and inter-taxa correlation, or if the property of a singular covariance matrix (a byproduct of the CLR transformation [104]) is undesired.
Even though we only evaluated prediction models, researchers can benchmark their
own usage of CBEA for other downstream tasks such as sample ordination. However,
there are various limitations to our evaluation of CBEA. First, our simulation analysis
may not capture the appropriate data-generating distributions underlying microbiome
taxonomic data. There is strong evidence to suggest that our zero-inflated negative
binomial distribution is representative [39], however other distributions such as the
Dirichlet multinomial distribution [322] have been used in the evaluation of prior studies. More recent studies have suggested utilizing the hierarchical multinomial logistic
normal distribution to model microbiome data sets [214, 181]. As such, there is space
to evaluate and adapt CBEA to these different distributional assumptions that underlie the data generating process. Second, we were not able to evaluate the phenotype
relevance of enrichment results as in Geistlinger et al. [100] due to limited consistent
annotations for microbiome signatures in health and disease, especially those that
are experimentally verified (and not just from differential abundance studies). We
attempted to perform this evaluation by leveraging the gingival data set similar to
[39]. However, we acknowledge that this is not a perfect solution, since the oxygen
usage label of each microbe in the data set is only available at the genus level, and the
difference in counts for obligate aerobes and anaerobes across the supragingival and
subgingival sites might not be as clear cut. As such, results from power analyses using
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this data set is only relative between the comparison methods and cannot be treated
as absolute measures of power or phenotype relevance. Third, fitting the mixture
normal distribution to raw CBEA scores using the expectation-maximization algorithm is difficult, as the convergence rate is slow when there is high overlap between
the mixtures, resulting in small mixing coefficient for one of the components and
increased runtime (FigC.6) [218]. In our implementation, we attempted to account
for this by increasing the maximum number of iterations and relaxed the tolerance
threshold. Finally, we assumed that taxa within a set are all equally associated with
the outcome. This limits our ability to evaluate the performance of CBEA when only
a small number of taxa within the set is associated with the outcome, or if there are
variability in effect sizes or association direction of taxa within a set.
Our evaluation also showed various drawbacks of the CBEA method itself. First,
inference with CBEA at the sample level is limited, and can be affected by inter-taxa
correlation if users wish to only detect mean-inflated sets. Second, for downstream
analyses, CBEA might not always perform better than competing methods, especially when being used to generate inputs to predictive models. We hypothesized
that this might be due to the lack of fit for the underlying null distribution in high
correlation settings, especially the identifiability problem associated the estimation
procedure associated with adjusting the mixture normal distribution. As such, we
hope to refine the null distribution estimating procedure by either choosing a better
distributional form, or to further constrain the optimization procedure of the mixture
normal distribution by fixing the third and fourth moments.
In addition, CBEA itself did not consider other aspects of microbiome data. First,
across all analyses, we relied on adding a pseudocount to ensure log operations are
valid. Users can directly address this by incorporating model-based zero correction
methods prior to modelling such as in [192] or [135]. However, in our simulation stud-
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ies, sparsity seems to not have a significant impact on the overall performance of our
approach. Second, CBEA also treated all taxa within the set as equally contributing to the set. Incorporation of taxa-specific weights (similar to PhILR [272]) could
reduce the influence of outliers, such as rare or highly invariant taxa. Finally, even
though for a given set of a priori annotations CBEA can generate useful summary
scores, such values are limited in their utility if the annotations themselves are not
meaningful. As such, curating and validating sets (similar to MSigDB [276]) based
on physiological or genomic characteristics of microbes [308] or their association with
human disease (in beta BugSigDB https://bugsigdb.org/Main_Page) can allow for
incorporating functional insights into microbiome-outcome analyses.

Section 3.7

Conclusion
Gene set testing, or pathway analysis, is an important tool in the analysis of highdimensional genomics data sets; however, limited work has been done developing set
based methods specifically for microbiome relative abundance data. We introduced
a new microbiome-specific method to generate set-based enrichment scores at the
sample level. We demonstrated that our method can control for type I error for
significance testing at the sample level, while generated scores are also valid inputs
in downstream analyses, including disease prediction and differential abundance.

Section 3.8

Availability of data and materials
All data sets are available publically via Qiita, HMP16SData, and curatedMetagenomicData
with raw sequence data available on NCBI in their respective project repositories. All
analysis scripts and generated figures are available on GitHub (https://www.github.
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Chapter 4

Evaluating trait databases for
taxon set enrichment analysis
This chapter was submitted as a pre-print on bioRxiv and can be found here:
Nguyen, Q.P., Hoen, A.G., Frost, H.R. Evaluating trait-based sets for taxonomic
enrichment analysis applied to human microbiome data sets. bioRxiv. https://doi.
org/10.1101/2022.05.16.492155

Section 4.1

Abstract
Background Set-based pathway analysis is a powerful tool that allows researchers
to summarize complex genomic variables in the form of biologically interpretable sets.
Since the microbiome is characterized by a high degree of inter-individual variability
in taxonomic compositions, applying enrichment methods using functionally driven
taxon sets can increase both the reproducibility and interpretability of microbiome
association studies. However, there is still an open question of which knowledge base
to utilize for set construction. Here, we evaluate microbial trait databases, which
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aggregate experimentally determined microbial phenotypes, as a potential avenue for
meaningful construction of taxon sets.
Methods Using publicly available microbiome sequencing data sets (both 16S rRNA
gene metabarcoding and whole-genome metagenomics), we assessed these trait-based
sets on two criteria: first, do they cover the diversity of microbes obtained from a
typical data set, and second, do they confer additional predictive power on disease
prediction tasks when assessed against measured pathway abundances and PICRUSt2
prediction.
Results Trait annotations are well annotated to a small number but most abundant taxa within the community, concordant with the concept of the core-peripheral
microbiome. This pattern is consistent across all categories of traits and body-sites
for whole genome sequencing data, but much more heterogenous and inconsistent in
16S rRNA metabarcoding data due to difficulties in assigning species-level traits to
genus. However, trait-set features are well predictive of disease outcomes compared
against predicted and measured pathway abundances. Most importantly trait-set features are more interpreable and reveal interesting insights on the relationship between
microbiome, its function, and health outcomes.

Section 4.2

Introduction
Advancements in high-throughout sequencing technologies have allowed researchers
to characterize the identity and functional potential of a large proportion of microorganisms in human-associated microbiomes. This has enabled efficient study of
the link between health outcomes and the microbiota without reliance on currently
limited culture-based approaches [154]. As such, there has been an increase in microbiome profiling studies, primarily aiming towards identifying specific microbes that
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are differentially abundant between groups of individuals defined by an exposure or
disease state vs a control population [340]. However, such analyses face unique computational and statistical challenges [166], which includes addressing the burden of
multiple testing and providing meaningful biological interpretations.
The challenge of understanding results of microbiome analyses in a broader context
of biological systems mirrors that of other high-throughput data sets. One approach
that has proven to be fruitful in human genomic studies is gene set testing (or pathway
analysis) which focuses on analyzing the coordinated expression of groups of genes
(termed gene sets or pathways) [186]. From a statistical perspective, set-based statistics are are more reproducible and have greater power compared to their gene-level
counterparts [105]. The true benefit of set-based approaches, however, is the ability
to incorporate a priori knowledge of specific cellular processes [170]. Microbiome
differential abundance analyses can also benefit from set-based approaches instead
of a microbe-centric approach. In addition to statistical benefits such as reduced dimensionality and sparsity [223, 148], set-based approaches are also more reflective of
the underlying biology. Like genes, microbes act in concert with co-abundant partners to drive biochemical processes that interact with the host, thereby impacting
health outcomes [326]. For example, when comparing patients with inflammatory
bowel disease against healthy subjects, microbes thought to be disease-causing for inflammatory bowel disease were also strongly co-occurring [101], suggesting that they
might jointly contribute to the microbiome-disease causal pathway instead of acting as
independent factors. This is also represented in the development of therapies, where
products often contain multiple strains of bacteria [25, 75]. Furthermore, organizing
microbes into functionally-driven groups (also termed “guilds” [326]) is also congruent
with the perspective that human microbiomes are complex ecosystems whose properties emerge from localized interactions between microbial communities representing
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individuals that exploit and contribute to their environment in similar ways [87].
Unfortunately, there is currently limited research in curating and evaluating appropriate microbe annotations similar to the transcriptomic literature. Repositories like the Molecular Signatures Database (MSigDB) [170] aggregate information
about gene function across multiple sources, incorporating both laboratory results
and computational inferences. Even though similar databases such as Disbiome [129]
and MSEA [148] exist, they are usually human-centric and define microbial groups
based on their potential to be pathological rather than through common biochemical
roles. As such, these databases are limited in generating meaningful hypotheses linking taxonomic changes to ecosystem function especially in novel disease conditions.
Trait-based analysis [308, 26, 184], with its long history in traditional macroecological studies [87, 149], is a promising approach to address this gap. Traits directly
represent microbial physiological characteristics and metabolic phenotypes (for example, sulfur reduction, nitrate utilization, or gram positivity) and therefore can serve
as annotations for potential ecosystem function. For 16S rRNA gene sequencing
data sets, where one can only obtain taxonomic abundances, performing enrichment
analysis on trait-based sets can elucidate the taxa-function relationship and identify microbial processes that are differentially active between healthy and diseased
patients. For whole genome metagenomic data sets, traits still offer unique perspectives. First, traits are often sourced from the long history of laboratory experiments
such as journal articles and Bergey’s Manual of Systematic Archaea and Bacteria
[285] which is different from homology-based sequence queries typically performed to
profile gene family abundances. Second, traits are complex phenotypes that represent
multiple molecular pathways, which means that they are more comparable to higherorder pathway annotations in hierarchical databases such as Kyoto Encyclopedia of
Genes and Genomes (KEGG) [134] and MetaCyc [45]. As such, utilizing traits as
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the source to group microbes into functional and phenotypical categories can assist in
interpreting microbiome profiling studies, and generating mechanistically meaningful
hypotheses that link ecosystem function and its taxa.
Even though trait-based approaches have been utilized in various studies [308,
26, 107, 149], to our knowledge there is currently no effort to formalize trait-based
databases in terms of microbial sets and evaluate their utility in a typical enrichment
analysis of 16s rRNA metabarcoding or metagenomic data. Here, we constructed
taxon sets from pre-existing trait databases at both the species and genus level.
Then, we computed the coverage of these traits across different human-associated
environments and sequencing approaches. Finally, we evaluated whether trait-based
set features confer predictive capacity for diseased individuals compared to measured
(from whole genome sequencing data) and predicted (from PICRUSt2 [73]) pathway
abundances. Finally, we identified the most important features for prediction and
assessed whether they matched existing literature on the microbiome-disease relationship of interest.

Section 4.3

Material and methods
All analyses were performed in the R programming language (version 4.1.2) [251]
and the Python programming language (version 3.10.4). All graphics were generated
using ggplot2 [311], ggsci [328], patchwork [234]. Tabular data manipulation was
performed using pandas for python, and tidyverse [310] suite of packages for R.
Additional packages utilized include: BiocSet [209], taxizedb [46], phyloseq [196],
TreeSummarizedExperiment [119]. For enrichment analyses, we leveraged the CBEA
[223] method (version 1.0.1) developed previously by our lab. All analyses were performed using the snakemake workflow [204]. All reproducible code and intermediate
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analysis products can be found on GitHub (https://www.github.com/qpmnguyen/
microbe_set_trait).
4.3.1. Generating taxonomic sets from trait databases
We utilized pre-compiled trait databases from previous publications: Madin et al.
2020 [184] and Weissman et al. 2021 [308]. The former was chosen due to the fact
that it is the most comprehensive compilation of microbial (bacteria and archaea)
physiological traits based on existing sources to date. The latter is a newer database
that hand curates traits specifically for human microbiomes based on Bergey’s manual. Both of these databases source their trait assignments primarily from biochemical and microbiological laboratory experiments over genomic-based annotation. We
focused our analyses on categorical traits, namely metabolism, gram stain, enzymatic pathways, sporulation, motility, cellular shape, and substrate utilization. We
are particularly interested in traits belonging to the class of enzymatic pathways
and substrate utilization as they represent functions that most directly impact the
microbe-host relationship [295].
We combined both databases into a joint knowledge base and constructed sets
for each available categorical trait. Additionally for the Madin et al. database, we
updated data entries sourced from Genomes Online Database (GOLD) [216] due to
the fact that compared to other compiled sources, GOLD is continuously updated
via community submissions. We grouped all traits belonging to the same National
Center for Biotechnology Information (NCBI) species-level identifier. When there
are conflicts in assigning traits, we prioritized Weissman et al. over Madin et al.
and GOLD due to its hand curated nature. If there are ambiguities in taxonomic
assignment in the Weissman et al. source, we considered that trait to be missing.
The exceptions to the above logic are enzymatic pathways and substrate utilization
categories where trait values across sources for the same species are concatenated
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instead of reconciled. For example, if a species A has entries from multiple databases
suggesting the presence of “nitrogen degredation” and “ammonia degredation”, then
instead of attempting to chose the best annotation based on source we assumed that
species A has the capacity to metabolize both nitrogen and ammonia.
All traits are defined at the species level via NCBI identifiers, however, due to
restrictions for 16S rRNA gene sequencing data sets to resolve beyond the genus level
[132], we also assigned traits to each genus based on a two-step process for each major
trait category:
• A hypergeometric test is used to ascertain whether the genus is underrepresented in the database based on the total number of species assigned to that
genus in NCBI Taxonomy [264] compared to our trait database. If a genus
is underrepresented in our database (i.e. the proportion of species number of
genera in the database is significantly less than what one would expect if one
were to randomly draw species from the NCBI database), then the trait is not
assigned to that genus since we do not have enough information. Specifically,
we assessed P (X ≤ x) at α = 0.05 where X ∼ Hypergeometric(k, N, K), with
x as the total number of species assigned to that genus in the database with an
assigned value for the trait category of interest, k as the total number of species
in the database with an assigned value for the trait category, N as the total
number of species in NCBI Taxonomy, and K as the total number of species
assigned to the genus in NCBI Taxonomy.
• For all genera that are well represented in the database, we then assessed the
proportion of species under that genus that have the trait. If over 95% of species
of a given genus have the trait, then the trait is assigned to the genus.
We then defined trait-based sets using the aforementioned assignments. Each trait
value with a category, e.g. “obligate anaerobic” from the category “metabolism”, is
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defined as a set with elements representing the species (or genus) annotated to that
trait value. In the analysis stage, each identified taxon within a data set is matched
to a trait based on their NCBI identifier. For 16S rRNA gene metabarcoding data
sets, we matched all amplicon sequence variants (ASV) with traits belonging to the
genus level NCBI identifier matched to the ASV sequence. All processed databases
and resulting taxonomic sets can be found on GitHub in the analysis repository.

4.3.2. Evaluation data sets
We evaluated trait-based sets on publicly available 16S rRNA gene metabarcoding
and whole-genome metagenomic data sets. For study-specific metabarcoding data
sets, we obtained data directly from associated European Nucleotide Archive (ENA)
repositories and re-processed raw sequence files into ASV tables using the dada2
QIIME 2 (version 2022.2) plugin [40, 31]. Taxonomic classification was performed
using a pre-trained weighted naive bayes model [29, 133] using the SILVA NR 99
database version 138 [247] available via QIIME 2. For all our metagenomic data
sets, we downloaded taxonomic and pathway abundance tables directly from the
curatedMetagenomicData R package [231] (2021-10-19 snapshot), which processed
the data via the bioBakery [19] metagenomic data processing pipeline by the package
authors. Data from the Human Microbiome Project (HMP) was obtained using the
HMP16SData [262] (for metabarcoding data) and curatedMetagenomicData [231] (for
metagenomic data) R packages.
To assess trait annotation coverage, we utilized data from both Phase I and II of
the HMP [59] as it contains surveys for multiple human-associated environments from
healthy subjects. For predictive and concordance analyses, we focused on colorectal
cancer (CRC) and inflammatory bowel disease (IBD) as study conditions. Both CRC
and IBD are well represented across both metabarcoding and metagenomic data sets,
allowing comparisons across sequencing methodology. Furthermore, these conditions
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are also under active study within the microbiome literature, which improves the
ability to interpret the biological significance of the results. For CRC, we utilized
data from Zeller et al. [337], Feng et al. [88], Gupta et al. [108], Hannigan et al.
[110], Thomas et al. [279], Vogtmann et al. [296], Wirbel et al. [315], Yachida et
al. [331], and Yu et al. [336]. For IBD, we utilized data from the integrative HMP
[245], Gevers et al. [101], Hall et al. [109], Ijaz et al. [123], Li et al. [167], Nielsen
et al. [225], and Vich Vila et al. [294]. A detailed description of each data set and
data-processing procedures is available in the Supplementary Materials.

4.3.3. Coverage analysis
In this analysis, we sought to identify how well trait databases cover the taxonomic
diversity of different human-associated environments. We leveraged healthy samples
from multiple body sites from Phase I and II of the HMP [59]. We quantified coverage
as a per-sample measure considering both taxa absence/presence and its abundance.
• For each sample, we computed the proportion of taxa that is present (non-zero
counts) assigned to at least one trait (a sample-level trait-specific richness).
• For each sample, we computed the proportion of reads assigned to taxa that is
present and annotated to at least one trait (a sample-level trait-specific evenness).
In addition to coverage stratified by trait categories and body sites, we also generated category-specific and site-specific coverage values by averaging across all sites
or categories, respectively.

4.3.4. Prediction analysis
We also aimed to evaluate whether trait-based features can add information for
microbiome-based disease prediction compared to other data inputs. Here, we gen92
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erated sample-level enrichment scores for each trait using CBEA and utilized them
as inputs to a standard random forest model [33]. Model fitting was done using
scikit-learn [235] where all parameters were set to default values with the exception of the total number of trees per ensemble (500) and the total number of features
considered per split (equal to the square root of the total number of features). We
compared model performance using trait enrichment scores against measured and PICRUSt2 predicted pathway abundances (for metagenomic and metabarcoding data
sets, respectively).
Model performance was measured using the area under the receiver operating
characteristic curve (AUROC) and Brier scores [34]. These metrics and associated
confidence intervals were obtained by fitting and evaluating the model via a 10-fold
cross-validation procedure. To obtain calibrated predictive probabilities for Brier
scores, we applied Platt’s method (using CalibratedClassifierCV) with 5-fold cross
validation nested within the training fold and used the ensemble model to generate
test set probabilities [242].
In order to identify which features are important to the disease prediction process,
for each input type we re-split the entire data set into train/test splits (80% training
data). We then refitted our calibrated random forest model on the training set as
described above. Since our final model is an ensemble of calibrated random forest
classifiers, we obtained feature importance values as the average across all calibrated
cross validation folds (N = 10). Feature importance per random forest model is defined based on the implementation in scikit-learn as the decrease in Gini impurity
when the feature is split averaged across all decision trees in a forest.
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Section 4.4

Results
4.4.1. Database coverage
We computed the coverage for each trait category across each body site in the HMP
data set. Fig 4.1 illustrates results for species-level trait assignment for samples
profiled via whole genome metagenomics. In panel A, coverage is evaluated as the
total number of taxa present per sample annotated to a trait (a measure of crosstrait richness), while in panel B coverage is the total number of reads assigned to
taxa annotated to a trait (a measure of cross-trait evenness). Richness provides
a general overview on how many members of a community is assigned to a trait,
while evenness accounts for their relative abundances by up-weighting species that
have high abundance across all samples. Overall, for any body site, at most 25% of
taxa are assigned to a trait, but when considering the proportion of reads, coverage
increased to more than 80%. This shows that traits are usually well annotated to the
most abundant taxa. This pattern holds for samples profiled with 16S rRNA gene
sequencing (Fig D.1), even though the proportions were much lower due to difficulties
in aggregating species level traits to genus. For many body sites and trait category
combinations, traits could not be assigned to any taxa.
We also observed heterogeneity in the annotation coverage across different body
sites and trait categories. For richness, nasal cavity and vaginal body sites were the
lowest in coverage, with less than 5% of taxa annotated with at least one trait across
all trait categories while conversely, oral cavity sites consistently had the highest
coverage under this metric. This pattern was reversed when considering coverage as
the proportion of assigned reads per sample, but overall values were consistently high.
Averaging coverage across body sites (Fig 4.2) also supports this observation, showing
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Figure 4.1: Trait annotation coverage across different body sites for the HMP data
set profiled using whole genome shotgun sequencing. Panel (A) illustrates the proportion of present taxa per sample annotated to at least one trait. Panel (B) illustrates
the proportion of reads assigned to taxa annotated to at least one trait which accounts
for taxa relative abundances. Each plot facet represents different trait categories that
were evaluated. Error bar represents the standard error of the evaluation statistic of
interest across the total number of samples evaluated per body site.
overall that the proportion of reads covered are similar across all body sites despite
differences in the proportion of present taxa covered by trait annotations. Similar
results were observed for sites profiled with 16S rRNA gene sequencing (Fig D.1),
where oral sub-sites have the highest coverage across both richness and evenness
metrics but, on average, all sites were similar in coverage statistics. Surprisingly,
stool samples were low in coverage across multiple categories despite being one of the
well studied systems.
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Figure 4.2: Trait annotation coverage statistics for HMP data across samples profiled with both 16S rRNA gene metabarcoding and whole genome metagenomics.
Panel (A) illustrates coverage statistics for each body site averaged across evaluated
samples and trait categories. Panel (B) illustrates statistics for each trait category
averaged across evaluated samples and body sites.
We also stratified our coverage analyses by trait categories (Fig 4.1, Fig 4.2,
Fig D.1). For samples profiled with whole genome sequencing, all trait categories
are evenly covered, with about 15% - 20% of taxa were annotated to a trait of any
category. However, these taxa comprise around 75% to 100% of the total reads per
sample suggesting that the overall read level coverage is very high. However, in
samples profiled with 16S rRNA gene sequencing, the overall coverage value across
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categories is low. Sporulation, substrate utilization and motility are the most covered
category while pathways and metabolism has no coverage at all.

4.4.2. Predictive analysis
To determine the utility of trait-based sets, we generated enrichment scores for covered traits using CBEA [223] for evaluated data sets and compared the predictive
performance of using trait-set enrichment scores as inputs compared to alternative
functional-based predictors. We evaluated two disease conditions, CRC and IBD,
with data sets drawn from both 16S rRNA gene metabarcoding and whole genome
metagenomic profiling techniques. We fitted a calibrated random forest model to each
input type and computed predictive performance as AUROC (discriminatory power)
and Brier scores (probability estimates) using 10-fold cross-validation.
For the CRC prediction task, traits covered 2.7% of taxa and 27.3% of reads for
the 16S rRNA gene metabarcoding data set, while for the whole genome sequencing
data set, traits covered 9.1% of taxa and 87.2% of reads. For the IBD prediction task,
traits covered 1.61% of taxa and 26.7% of reads for 16S rRNA gene metabarcoding
data set, while for the whole genome sequencing data set, traits covered 6.6% of taxa
and 91.2% of reads.
Fig 4.3 illustrates results of our model evaluations. Overall, enrichment scores for
trait-sets are as good as other alternate function-based predictors at discriminating
between case and control patients across both CRC and IBD conditions. Aside from
pure discrimination power, models fitted on CBEA trait-set scores are also equivalent
in approximating predicted probabilities. This is surprising especially for the 16S
rRNA gene metabarcoding data sets, where the trait coverage is low. Even though
the differences in performance is not significant, there are instances where trait-set
scores perform slightly better than their pathway abundance counterparts. Since
trait-features are also more descriptive, utilizing them can increase interpretation
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while also not sacrificing performance.
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Figure 4.3: Predictive performance of a calibrated random forest model across different disease conditions, profiling technique, and performance metrics. Scores were
obtained via 10-fold nested cross validation where within each training fold there is a
10-fold cross validation procedure to calibrate predicted probabilities. For each condition and data type, CBEA trait-set scores were compared against MetaCyc pathway
abundances from relevant sources (measured abundances for whole genome sequencing data sets and PICRUSt2 predicted abundances for 16S rRNA gene metabarcoding
data sets)
In addition to predicted performance, we also identified the top 10 features that are
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most important for model fitting. Since our model involves a 10-fold cross-validation
procedure within the training set to calibrate predicted probabilities, top features
are identified using the mean feature importance value across the 10 folds. Fig 4.4
illustrates results for whole genome metagenomic data sets while Fig D.2 illustrates
results for the 16S rRNA gene metabarcoding data sets. Even though these are the
top 10 features, the observed mean feature importance statistics are low, suggesting
that no individual features were definitively the most important in discriminating
between patient classes.

Section 4.5

Discussion
4.5.1. Traits are annotated with high coverage at the species-level
We computed the coverage of trait annotation on a typical dataset to understand
the extent in which community function is captured, thereby serving as a proxy for
expected confidence for an enrichment analysis performed using trait-based taxon sets.
Low coverage in this case indicates that the database does not adequately capture
the diversity of microbes found in the target data. This is because there might not
be enough taxa present in the data set to serve as evidence for the trait. Alternately,
this could also mean that the analysis is missing a majority of underlying community
traits, many of which might be core to the health outcome association of interest but
simply missing in the analysis. We computed coverage based on two metrics: first,
a richness-like metric which computes coverage as the proportion of taxa present per
sample annotated to a trait (for a given category and data set); second, an evennesslike metric that accounts for relative abundances of each annotated taxa by computing
coverage as the proportion of reads per sample annotated to a trait.
When evaluated on the HMP data set (Fig 4.1), we can see that the overall
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Figure 4.4: Top 10 important features based on random forest model fitted different
inputs from data sets profiled with whole genome metagenomics. Features were selected from mean decrease in Gini impurity averaged across 500 decision trees and 10fold cross-validation (nested with the training set) as implemented in scikit-learn.
AUROC scored on a held-out test set is also presented for each input type and disease
condition.
richness coverage is low (less than 25% of identified species) across all sites and data
sets, particularly for nasal cavity and vaginal sub-sites. However, when considering
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evenness of coverage, almost all of reads were annotated to a trait. This is consistent
with the observation that relative abundances of human-associated microbiomes are
highly skewed [59], where a small number of species usually dominate the community.
As such, even though traits might only cover a small number of taxa, they might
represent the majority of community abundance. For example, Ravel et al. [253]
observed that Lactobacillus species dominate the vaginal microbiome and, in some
phylotypes, almost all reads are assigned to a single species. This shows that our
trait-database has high degree of coverage across the most abundant taxon within
a community, which supports utilizing these sets to perform exploratory analyses.
However, low richness coverage also indicates that our database might not capture
traits associated with rare taxa, which can play an important role in regulating host
health [292].
Unfortunately, coverage is significantly lower for samples profiled using 16S rRNA
gene metabarcoding (Fig D.1). For some trait categories, such as pathways, no traits
were assigned to any taxa (Fig 4.2). We hypothesized that this is due to two issues.
First, metabarcoding data sets can only resolve taxonomies at the genus level [132],
while traits are usually defined at the species and strain levels. Aggregating consensus
traits to the genus is difficult due to the high degree of strain and species level diversity
within the microbiome [44]. Second, taxonomic assignments for metabarcoding data
sets are often based amplification of a specific hyper-variable region for a marker
gene (most often the 16S rRNA gene). This means that taxonomic assignment can
be sensitive to the choice of region, and can be inaccurate. Furthermore, the choice
of taxonomic database (e.g. Ribosomal Database Project [58], SILVA [247]) can also
play a part in reducing the ability for trait annotation coverage. Differences between
taxonomic paths [16] can result in certain taxa not being able to be matched to traits,
whose annotations are based on NCBI identifiers.
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4.5.2. Trait-set features are predictive of disease outcomes
We assessed the predictive performance of models fit on trait-set enrichment scores
compared to other function-based inputs. For whole genome sequencing data sets,
measured pathway abundances were utilized as a comparison point while for 16S
rRNA gene sequencing data sets, predicted pathway abundances via PICRUSt2 were
utilized instead. Fig 4.2 shows that across all conditions and profiling techniques,
trait-set features are competitive in producing well performing models and were able
to discriminate between cases and controls. Surprisingly, performance was also comparable in the 16S rRNA gene sequencing data set despite overall low coverage across
both richness and evenness metrics. This demonstrates that trait-set abundances
can still provide an informative approximation to functional potential similar to PICRUSt2 that can be used for exploratory and hypothesis generating purposes.
To determine which features are important for overall model performance, we extracted the top 10 features based on the mean decrease in Gini impurity. However,
the overall feature importance values are not high, suggesting that no individual feature was dominant in classifying patient status. This is further supported by the fact
that some nonsense features show up in the top 10 list for models fit using pathway
abundances such as PWY-7235 and LYSINE-DEG-PWY, which are mammalian and
eukaryotic pathways, respectively. However, the models still show respectable discriminatory power when evaluated on the test set (AUROC ∼ 0.7). Since random forest
models can capture interactions between predictors [112], we hypothesized that the
interaction between features contribute to test set performance rather than marginal
effects. As such, we did not observe a high degree of feature importance scores since
these measures are not designed to capture interaction effects [321].
However, despite such limitations, we were still able to recover existing knowledge
about the condition of interest. For example, “sulfide reduction;pathways” was shown
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to be an important feature in discriminating subjects with CRC vs control subjects in
Fig 4.4. This is supported by previous research showing that an increase in abundance
of sulfate reducing bacteria is associated with the condition [331]. Mechanistically,
this process, when using methionine or cysteine as substrates [49], generates H2 S as
a product, which can stimulate CRC by inhibiting butyrate oxidation (which helps
prevent the breakdown of the gut barrier) as well as promoting the generation of
reactive oxygen species [190]. Another trait feature is “urea degredation;pathways”,
which suggests the importance of bacterial-driven urea hydrolysis process, which is
one of the main sources of ammonia in the human gut [28]. Sustained exposure of
colonocytes to free ammonia may contribute to the development of CRC [56], which
is supported by animal experiments showing histological damage in the distal colon
after long-term ammonium exposure [171].

4.5.3. Limitations and future directions
Even though our results demonstrate that utilizing trait-based sets can provide meaningful insight to microbiome data sets, there are several major challenges to widespread
adoption. Although trait databases do not suffer from the same types of biases that
exist in genomic reference databases [330], the reliance on curated experimental data
means that traits are usually only annotated for species that are well studied and
culturable. While using predictive models can help in assigning traits to a broader
category of taxa [305], such automated approaches can result in misclassification of
traits and increased noise in downstream analyses. Additionally, high-quality trait
annotations require a time-consuming, manual curation process [308]. A source that
is based on user submission such as GOLD [216] can cover a larger number of taxa
and traits, but unfortunately can have erroneous and duplicated assignments due to
the lack of a standardized nomenclature. There is currently a gap in producing a
high-quality and diverse trait databases that are maintained and continuously up103
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dated.
In addition to issues with trait database quality, there are also problems matching
the identity of taxa in a given trait database with identifiers found in references for
sequence-based taxonomic profiling such as SILVA [247]. For whole genome metagenomic data sets, standard tools (such as MetaPhlan [19]) can provide NCBI identifiers
at the species or strain levels. However, it is currently unclear how to aggregate or disaggregate traits if the taxonomic resolution of the observed data set is higher or lower
than that of the trait database in use. This is even more difficult with metabarcoding
datasets, where low taxonomic resolution makes trait-to-taxa assignments sparse and
less confident.
Finally, there are also hurdles in being able to properly validate traits that are
found to be significantly enriched due to a lack of ground truth data sets. While
some traits can be matched to pathways directly, others involve complex coordination
of multiple genetic pathways. As such, further investigation into ways to identify
biological concordance between obtained results and external measurements can help
improve confidence in utilizing traits for microbiome analyses.

Section 4.6

Conclusion
Set-based enrichment analysis is a useful approach for analyzing microbiome data
sets since it not only reflects underlying biology but can also provide more unique
perspectives of function that is linked to ecosystem services. Microbial trait databases
are a promising resource to construct taxon-sets as traits represent physiological phenotypes. We demonstrated that trait-based sets have high coverage across body sites,
especially for samples profiled using whole genome metagenomics. Furthermore, enrichment scores computed on such sets are also competitive in predicting case/control
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status compared to pathway abundances. As such, trait features found to be important in model fitting can be used to define interesting mechanistic hypotheses.

Section 4.7

Availability of data and materials
All data sets are available publically via Qiita, HMP16SData, and curatedMetagenomicData
with raw sequence data available on NCBI in their respective project repositories. All
analysis scripts and generated figures are available on GitHub (https://www.github.
com/qpmnguyen/microbe_set_trait).
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Chapter 5

Conclusion
Taxa-function relationships are difficult to characterize due to the different scales in
which they operate [156]. For the taxonomic layer, one can look at species, strain,
or even cell states [198]. For the functional layer, it can be gene family abundance,
transcript expression, or metabolite concentrations. Each degree of granularity increases the complexity of both the data collection process as well as its interpretation. However, no approach is “wrong” as each taxa-function combination can reveal
unique biological knowledge. For example, even in the face of strain-level variation,
an analysis of genus level taxa and metabolite abundances can show that perhaps the
metabolism of certain metabolites are phylogenetically conserved, which can have
various implications. Throughout this thesis, we have attempted to decipher this relationship using multiple approaches. In chapter 2, we utilized a multi-omic data set
to identify strongly associated microbe-metabolite pairs. In chapter 3, we developed
a statistical method to leverage pre-defined taxa-function annotations (in the form of
sets) in standard epidemiological studies. In chapter 4, we evaluated an example of
such a source using trait databases aggregated from the literature.
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Section 5.1

Summary of findings
5.1.1. Mapping microbes to their function using multi-omics data
In chapter 2, we examined a paired metataxonomic-metabolomic data set to explore
the relationship between bacterial relative abundances and metabolite concentrations.
Even though multi-omics studies involving metabolomics are not new [174, 13, 143],
most studies have focused on defining differences between subject case/control status,
with limited exploration of the microbe-metabolite interface. Here, we characterized
associations between the microbiome (profiled using 16S rRNA gene sequencing) and
the metabolome (profiled using Nuclear Magnetic Resonance – NMR – techniques).
The analyzed metabolomic data set contained both untargeted taxonomic bins, as
well as concentrations of 36 specific metabolites. This data was generated from a
cohort of healthy infants from the New Hampshire Birth Cohort Study (NHBCS)
[103] with samples collected at 6-weeks and 12-months of age.
Using both Procrustes analysis and sparse canonical correlation analysis (sCCA)
[317], we found that overall metabolite concentrations are concordant with genuslevel taxonomic profiles. This relationship was weakly predictive, as we observed
poor performance across different machine learning models using predictive R2 as
the evaluation metric. However, model outputs performed better using Spearman
correlation ρ, but still lower compared to other studies using a similar performance
metric [187]. Using ρ = 0.3 as a threshold for defining “well-predicted” metabolites [187, 217], we found that short chain fatty acids (SCFAs) such as butyrate are
most predictive, consistent with our understanding of microbiome physiology [161].
Surprisingly, the degree of coupling is higher for infants at 6 weeks compared to 12
months, suggesting that in early life humans are more reliant on the microbiome for
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metabolic purposes.
In addition to overall patterns of associations, we also identified genera-metabolite
groups that are core to the overall multivariate correlation by looking at the nonzero loading coefficients of our sCCA model. Similar to our concordance analysis,
two SCFAs Butyrate and Proprionate were selected as the most important for the
overall microbiome-metabolome relationship, with a surprising negative correlation
with Bifidobacterium genera, a commonly identified producer of SCFAs [128]. We
hypothesized that this is an instance of strain-level variation where some strains of
Bifidobacterium compete with other butyrate-producing taxa [258]. Amino acids
were also well-represented among selected metabolites and were negatively correlated
with taxa abundances. We hypothesized that microbes are incorporating amino acids
in their environment directly instead of catabolizing them due to the fact that this
process is energetically inefficient [92, 228].
Our study showed that genus level microbial abundances are not sufficient to predict metabolite concentrations. However there is still a degree of overall coupling
that is supported by prior work [13, 143, 343]. Additional studies with higher taxonomic resolution using whole genome metagenomics can be used to find more granular
scales of association. We also provided further evidence to support the importance
of microbiome-mediated butyrate catabolism in early life, while also suggesting that
amino acids might play an important role. However, our study was limited by our
cross-sectional design. This is because metabolite abundances are always changing,
making measures of flux (or rate of change) more meaningful in finding associations
[118]. Some studies have attempted to bridge this gap using genome-scale metabolic
models [226], which can be fitted to observed data. However, additional studies with
dense longitudinal sampling are still needed.
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5.1.2. Developing novel methods to integrate taxa-function relationships
in statistical analyses
In chapter 3, we developed a statistical method to test for the enrichment of groups
of microbes. Gene set testing (or pathway analysis), is a commonly utilized in the
genomics literature to aggregate lists of genes obtained after a differential abundance
test [126, 105]. These methods have been shown to improve power, reproduciblity,
and interpretability [139]. As such, set-based analysis can be a useful method to not
only address some of the challenges of analyzing sequencing-based taxonomic data
tables (such as sparsity) [165], but also to provide a formal statistical approach to
incorporate taxa and function via sets. Here, we provided a method for set-based
enrichment analysis called competitive balances for taxonomic enrichment analysis
(CBEA) that is tailored to microbiome relative abundance data. CBEA generates
sample-level scores in an unsupervised manner by integrating the Q1 competitive null
hypothesis [283] and compositional balances [272, 80]. Inference is performed at the
sample-level through estimating an empirical null distribution that can be adjusted
for variance inflation due to inter-taxa correlation.
We evaluated our model using both real and simulated data sets. First, CBEA can
be used to test for enrichment at the sample level. Results indicated that our approach
was able to control for type I error at the appropriate α level, however, the trade off
was limited power to detect small effect sizes, especially at higher degrees of intertaxa correlation. In addition, CBEA can also perform population-level analyses to
detect sets that are differentially abundant between case/control status by combining
generated scores with a difference in means test (such as Welch’s t-test). Under this
task, CBEA was able to control well for type I error but without having to concede
as much power. Notably, CBEA produced fewer false positives compared to using a
sum-based approach to aggregate taxa to sets and performing a standard differential
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abundance test such as corncob [191]. Finally, even though CBEA generated scores
were informative for discriminating between healthy controls and patients with IBD,
performance scores were not significantly higher than other comparison methods.
Our study illustrates an example of a statistical method that can assist in generating taxa-function hypotheses through the use of set annotations. Using CBEA, users
can not only perform inference, but also use CBEA sample scores for downstream
analyses such as predictive modeling, sample ordination, or network analysis. However, additional follow-up approaches are required to improve the inference procedure,
as well address data sparsity beyond pseudocounts.

5.1.3. Leveraging existing microbiology knowledge to define microbial ecosystem roles
In chapter 4, we explored using an aggregated database of microbial traits defined
based on laboratory experiments to curate function-based taxon sets. Traits represents microbial phenotypic characteristics and are oriented towards describing ecosystem functions given their long history in ecological research [149]. We drew on two
sources: Madin et al. [184] which is a comprehensive compilation of traits across multiple different static repositories, and Weissman et al. [308], which provides a human
microbiome centric annotations based on a manual curation of Bergey’s manual. We
constructed our sets based on categorical traits assembled, focusing on “pathways”
and “substrates” as they represent traits that relate to microbes’ participation in host
biochemical processes.
First, we computed the coverage of traits across body sites and trait categories
using the HMP data set. We found that trait coverage is low when considering
the proportion of taxa covered, but much higher when accounting for their relative
abundances. This suggested that traits are well annotated for the abundant taxa
within each community, but less so for rare microbes. We did not identify significant
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differences in average coverage across body sites, but some body sites have much
lower coverage in some traits compared to others. It was difficult to annotate traits
for 16S rRNA gene sequencing data sets since traits are defined at the species level.
This is because the databases are not well sampled enough across the tree of life to
enable comprehensive profiling of all genera. Furthermore, of strain and species level
variability [175] complicates the process of aggregating traits.
We then utilized CBEA (as described in chapter 3), to generate enrichment scores
for trait-sets and utilized them as inputs to predictive models. We found that trait
scores are as good as pathway abundances in discriminating between case and control
patients, suggesting that they can be informative features. Surprisngly, performance
held for the 16S rRNA gene sequencing data sets when compared against PICRUSt2
predicted pathway abundances, despite lower coverage. We also looked at the top 10
most informative features for our models and found that some traits correspond with
known disease-associated biochemical pathways.
Our results demonstrated that set-based analysis can help integrate taxa and
function under one unified framework for hypothesis testing. Set annotations based
on traits provide an interesting avenue, given that they are sourced from laboratory
experiments with descriptions that are less granular but more interpretable than
MetaCyc pathways. Even though trait coverage for rare species is limited, traitbased sets are still informative in distinguishing healthy patients from those with
colorectal cancer and inflammatory bowel disease, suggesting that traits represent
meaningful biological processes. As such, additional studies are needed to further
refine the ontology of describing traits and to provide annotations to a larger selection
of microbes.
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Section 5.2

Perspectives and future research
Our work has shown promising applications of leveraging a taxa-function framework in
epidemiological studies. By contextualizing shifts in taxonomic abundances in terms
of their function, researchers can more easily interpret lists of differentially abundant
taxa and make informed choices on what to follow-up and validate in laboratory
experiments. However, there are still major hurdles to overcome before an integrative
framework can be confidently applied to future studies.

5.2.1. Defining microbial function
One of the most difficult aspects of investigating microbial function is the ability to
identify meaningfully relevant definitions [116, 340, 144]. Specifically, the question of
how to translate between definitions of genes and pathways (from KEGG or MetaCyc)
to ecosystem functions that the gut microbiome delivers. A relevant example is the
role of HMO metabolism [291], which is a host-relevant function that contextualizes
multiple gene families, all of which would be difficult to interpret individually.
Chapter 4 of this thesis attempted to examine function under the lens of microbial traits. Traits are usually conceptualized as defined, measurable properties
of organisms that link performance and contribution to core ecosystem needs [149].
While traits provide a more holistic conception of function, issues with unstandardized databases [184] and limited coverage for rare species makes it challenging to use
in scenarios where they might be conferring important services.
As such, comprehensive efforts are needed to centralize and standardize the ontology of microbial function with respect to ecosystem needs. Efforts such as the
ontology of microbial phenotypes (OMP) [51] have started to generate a repository
of terminology to standardize description of microbial phenotypes. Researchers can
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further expand the types of annotations of OMP to be specific to body sites (using the uber-anatomy ontology - UBERON) or study conditions (using experimental factor ontology - EFO). KEGG terms or MetaCyc pathways can be assigned to
OMP annotations, which can then be translated to specific strains using reference
genomes/pangenomes or measured metatranscriptomic data. By defining a standardized vocabulary, researchers can begin to conceptualize a host-centric view of
microbial function that is both standardized and context driven.
5.2.2. Leveraging multiple meta‘omic technologies
While there have been a large number of microbiome multi-omic studies (see section
1.2.2), they have mostly been focused on analyzing each data-layer independently
with some studies performing limited taxa-function analyses. However, as shown in
Chapter 2, paired profiling of microbiome structure and molecular functions can reveal
novel aspects of host-microbe interactions. As such, multi-omic data sets, especially
those including multiple layers of functional profiling, can be invaluable.
Additionally, these data sets can be further leveraged in conjunction with the
functional framework defined in section 5.2.1 in two ways:
• First, researchers can use these data sets directly to test for the enrichment of
ecosystem-specific functional roles similar to that of Vatanen et al. [291] and
HMO metabolism.
• Second, researchers can leverage the collection of these data sets to validate
encoded taxa-function relationships, specifically accounting for situations where
gene carriage does not directly correlate with expression [92]
• Third, they can be used to generate new core taxa-function relationships that
can be disease-associated that can serve as biomarkers or as potential candidates
for intervention.
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5.2.3. Novel representations of taxa-function relationships
To jointly test for association between taxa-function groups and relevant exposures
or disease outcomes, there is a need to identify appropriate representations that can
be translated into a statistical framework. Set-based approaches, used in Chapter
3, are simple but powerful methods. Sets naturally capture categorical information
such as the assignment of strains to functions. However, the definition of sets are
rigid, and does not account for nuances such as uncertainties or the degree of strain
presence/absence in the overall population. As such, novel numerical representations
of taxa-function relationships can help account for this gap and allow for a more
flexible way to encode these relationships.
One candidate would be to use weights within sets or across different sets depending on the experimental context. For example, Frost [94] curates a set of tissue-specific
weights for MSigDB gene sets. Here, body-site specific weights can be computed for
each functional term, or the contribution of each taxa can be weighted by its overall
prevalence estimated from a large cohort such as HMP.
Network-based methods offer another approach. Bipartite networks can be used
to model connections between taxonomic and functional nodes [282]. Networks also
have topological features such as degree centrality that can provide extra dimensions
such as being able to identify taxa that contribute to a large number of functions or
vice versa. Standard network structures that allow for connections within taxonomic
and functional nodes are also useful as they can account for inter-taxa correlation or
dependencies between metabolites or genes.
There are also machine-learning based approaches that can provide unique encoding opportunities. Word embeddings, such as Word2Vec [201], create dense numerical vectors that can represent high-dimensional co-occurrence relationships. This
application has been explored in the context of the microbiome-metabolome relation-
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ship [211]. Researchers can extend this approach to model different functional outputs, or to provide pre-trained embeddings based on a meta-analysis of microbiomemetabolome data sets.
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List of abbreviations
NHBCS: New Hampshire Birth Cohort Study
PCoA: Principal Coordinates Analysis
NMR: Nuclear Magnetic Resonance
ASV: Amplicon Sequence Variants
OTU: Operational Taxonomic Unit
gUniFrac: Generalized Unique Fraction
sCCA/CCA: Sparse Canonical Correlation Analysis
FDR: False Discovery Rate
RF: Random Forest
ASV: Amplicon Sequence Variants
SCFA: Short chain fatty acids
EN: Elastic Net
SVM-RBF: Support Vector Machines with Radial Basis Kernel Function
SPLS: Sparse Partial Least Squares
CLR: Centered Log Ratio Transformation
KEGG: Kyoto Encyclopedia of Genes and Genomes
GOLD: Genomes OnLine Database
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List of abbreviations
CBEA: Competitive Balances for taxonomic Enrichment Analysis
HMDB: Human Metabolite DataBase
HMP: Human Microbiome Project
GSVA: Gene Set Variation Analysis
GSEA: Gene Set Enrichment Analysis
ssGSEA: Single Sample Gene Set Variation Analysis
GO: Gene Ontology
CRC: Colorectal Cancer
IBD: Inflammatory Bowel Disease
MSigDB: Molecular Signatures Database
VAM: Variance-adjusted Mahalanobis
CoDA: Compositional Data Analysis
iNKT: Invariant natural killer T cells
TLR-5: Toll-like receptor 5
GI: Gastrointestinal tract
DNA: Deoxyribonucleic acid
RNA: Ribonucleic acid
SCC: Spearman correlation coefficient
PICRUSt: Phylogenetic Investigation of Communities by Reconstruction of Unobserved States
ILR: Isometric log ratio transformation
LASSO: Least absolute shrinkage and selection operator
FID: Free induction decay
PMA: Penalized Multivariate Analysis
PCR: Polymerase Chain Reaction
QC: Quality Control
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List of abbreviations
PRESS: Predicted residual error sum of squares
QC: Quality Control
DADA: Divisive Amplicon Denoising Algorithm
AUROC: Area under the receiver operating characteristic curve
QIIME: Quantitative Insights Into Microbial Ecology
MetaPhlAn: Metagenomic Phylogenetic Analysis
PhILR: Phylogenetic isometric log ratio transformation
SMOTE: Synthetic Minority Oversampling Technique
CDF: Cumulative distribution function
MSEA: Microbe-set enrichment analysis
NCBI: National Center of Biotechnology Information
LC: Liquid Chromatography
MS: Mass Spectrometry
UBERON: Uber-anatomy ontology
EFO: Experimental factor ontology
OMP: Ontology of microbial phenotypes
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Supporting material for
“Associations between the gut
microbiome and metabolime in
early life”
Section B.1

Supplemental Notes
B.1.1. Supplementary Note 1
Microbe-metabolite participation in significant pairwise Spearman correlation. Univariate pairwise Spearman correlations were performed to identify significant microbe-metabolite pairs. Significance was determined by the Spearman false
discovery rate (FDR) threshold of 0.05 following a Benjamini-Hochberg multiple hypothesis testing procedure. At both time points a majority of genera and metabolites
were significantly correlated, where at 6 weeks, 28 genera (65% of total genera) and
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36 metabolites (100% of metabolites) were part of 516 significant correlations (16.6%
of total pairwise comparisons) while at 12 months, 59 genera (81.9% of total genera)
and 29 metabolites (80% of metabolites) were involved in 214 significant correlations
(8.01% of total pairwise comparisons). This result also supported the observation that
at 6 weeks the microbiome was marginally more associated with the metabolome compared to 12 months. Similar to sCCA results, untargeted data set showed a similar
signal at both time points. Specifically, at 6 weeks, 37 genera (86% of genera) and
198 metabolite bins (95.1% of bins) were part of 1480 significant associations (16.5%
of pairwise comparisons). Similarly, at 12 months, 67 genera (93% of genera) and
207 metabolite bins (99.5% of bins) were part of 1392 significant associations (9.2%
of total pairwise comparisons).

B.1.2. Supplementary Note 2
Sparse canonical correlation analysis selects microbes and metabolites important to the inter-omic correlation. Only a small subset of metabolites and
microbes were selected (27% of taxa for both time points; 16.9% of metabolites at 6
weeks and 19.4% of metabolites at 12 months). At both time points, selected taxa
belong to the Firmicutes, Actinobacteria and Proteobacteria phyla with Firmicutes
being the most represented (58.3% of selected taxa at 6 weeks; 70% of selected taxa
at 12 months). Actinobacteria was the second most selected phylum (25% of selected
taxa) at 6 weeks while at 12 months it was Proteobacteria (30% of selected taxa).
For metabolites, amino acids were the most represented metabolite class (Supplementary Note 4) (60% of selected metabolites at 6 weeks, 85% of selected metabolites at
12 months). 6-week samples demonstrated a larger diversity of metabolite classes,
with additional representatives from carboxylic acids group, nucleotides and short
chain fatty acids (SCFA) while at 12 months, the only non-amino-acid metabolite
is uracil (of the nucleotide class). Across both time points, 3 genera (Flavonifrac120
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tor, Haemophilus and Acinetobacter genera) and 5 metabolites (lysine, isoleucine,
leucine, uracil, phenylalanine) were consistently selected. Surprisingly, in the untargeted analysis, nearly half of taxa and metabolites were selected at 6 weeks while the
number remained more similar to the targeted analysis at 12 months (6 weeks: 46% of
taxa and 42% of metabolite bins; 12 months: 13.8% of taxa and 17.3% of metabolite
bins). However, the taxonomic distribution of those selected taxa remained similar, with Firmicutes being the most dominating phyla (60% of selected taxa at both
time points). Additionally, for both time points, the sign of the sCCA loadings for
selected variables were also concordant with patterns of negative and positive correlation via univariate Spearman correlations (Figure 3, right panels). Notably, all
selected metabolites contain negative loadings for both time points, with the majority
of selected pairwise correlation to be negative (6 weeks: 76.6% of selected pairwise
comparisons, 12 months: 60.7% of selected pairwise comparisons). This pattern is
replicated in the untargeted data set as well (6 weeks: 61.3% of selected pairwise
comparisons, 12 months: 70% of selected pairwise comparisons).

B.1.3. Supplementary Note 3
Prediction results. Under R2 , at 6 weeks only 8 (22.2%) metabolites (Butyrate,
Glycerol, Isobutyrate, Isoleucine, Leucine, Methionine, Phenylalanine and Tyrosine)
were predictable, with a mean of 4.85% and a maximum of 11.8% (Butyrate using
EN). At 12 months, only 14 (38.9%) of metabolites (Butyrate, Formate, Inosine,
Isobutyerate, Isoleucine, Lactate, Leucine, Methionine, Phenylalanine, Propionate,
Propylene glycol, Tyrosine, Uracil, Valine) were predictable, with a mean of 4.81%
and a maximum of 8.7% (Propylene Glycol using RF). When looking at the average
R2 across all metabolites, performance was not good (-5.6% at 6 weeks; -3.07% at
12 months). This negative R2 value implies that the predicted model performs worse
than the naı̈ve, intercept only model. Conversely, correlative performance was much
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better. At 6 weeks 26 metabolites (83%) were predictable, with a mean correlation
of 0.344 and a maximum of 0.669 (Butyrate using EN). Similarly, at 12 months all
36 targeted metabolites were predictable, with a mean of 0.265 and a maximum of
0.549 (Succinate using EN). Using the SCC cutoff of 0.3 as criteria for well predicted
metabolites, many metabolites at 6 weeks were still retained (25 metabolites - 69.4%).
Conversely, at 12 months, only 13 metabolites remained to be well predicted (38.9%).
On average, performance based on SCC was good with a mean SCC value of 0.339
at 6 weeks and 0.249 at 12 months. In the untargeted analysis looking at the entire
metabolome, performance was much better for both metrics. Under R2, 116 (56.7%)
of metabolite bins were predictable at a maximum of 42.7% (Bin 33 using SPLS) and
a mean of 16.7% at 6 weeks while at 12 months, 94 (45.1%) of metabolite bins were
ell predicted at a maximum of 22.7% (Bin 16 using SVM) and a mean of 8.19%. The
overall average across all metabolites is 3.91% (6 weeks) and -0.59% (12 months).
This trend was similarly observed using SCC, as all all 208 metabolites bins were
predictable for both time points (using SCC = 0 as the threshold). Specifically, of
the predictable metabolites at 6 weeks the maximum value was 0.687 (Bin 32 using
EN) with a mean of 0.352 while at 12 months, the maximum value was 0.53 (Bin 16
using SVM) and a mean of 0.253. Using the SCC cutoff of 0.3 as above, at 6 weeks
120 metabolite bins (57% of bins) were well predicted while at 12 months only 60
(28.8% of bins) were well predicted.
B.1.4. Supplementary Note 4
Short chain fatty acids (SFCA)
• Metabolites: Acetate, Butyrate, Isobutyrate, Proprionate
• HMDB Ids: HMDB00042, HMDB00039, HMDB01873, HMDB00237
• Examples of associated microbes: Faecalibacterium, Eubacterium, Rose122
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buria, Clostridia clusters IV and XIVa [224]
• Potential biological functions: Fermented in the colon from dietary complex
carbohydrates, assist in regulating host immune functionality, act as substrate
for cellular activities, limit growth of pathogenic species, promote integrity of
the mucosal lining.

Amino acids and derivatives
• Metabolites: Alanine, Asparagine, Aspartate, Glutamate, Glycine, Histidine,
Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Proline, Threonine,
Tryptophan, Tyrosine, Valine, π-Methylhistidine
• HMDB Ids: HMDB00161, HMDB00168, HMDB00191, HMDB00148, HMDB00123,
HMDB00177, HMDB00172, HMDB00687, HMDB00182, HMDB00696, HMDB00159,
HMDB00162, HMDB00167, HMDB00929, HMDB00158, HMDB00883 HMDB00479
• Examples of associated microbes: Proteobacteria phylum; Bacili class;
Clostridium and Bifidobacterium genera [243], Lactobacilli, Enterococci, and
Streptococci families [246]; Faecalibacterium prausnitzii species [168].
• Potential biological functions: Catabolized to form other end products such
as SCFAs, branched chain fatty acids (BCFAs) and other compounds [228]. For
example, the catabolism of methionine results in methanethiol and hydrogen
sulfide [243]; catabolism of histidine can produce histamine, which can inhibit
the production of pro-inflammatory cytokines as well as act as a neurotransmitter [280]; catabolism of lysine can produce cadaverine [246], which is associated
with ulcerative colitis [159]; catabolism of tryptophan and tyrosine can produce
tryptamine, which is a neurotransmitter involved in intestinal motility and immune function [97].
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Carbohydrates
• Metabolites: Fucose, Glucose, Glycerol, Maltose
• HMDB Ids: HMDB00174, HMDB00122, HMDB00131, HMDB00163
• Examples of associated microbes: Bacteroides thetaiotaomicron (possesses
260 glycoside hydrolases in its genome [329]), B. Fragilis, Ruminococcaceae spp.
• Potential biological functions: Humans rely mostly on gut commensals for
breaking down complex carbohydrates [228]. Bacteria also take in complex
carbohydrates for additional purposes. For example, fucose participate in the
fucosylation of bacterial glycans, increasing fitness for both pathogenic and commensal microbes through host mimicry; facilitate promotion of useful bacterial
species and metabolites, suppress virulence genes [241]. Similarly, gut microbe
can metabolize glycerol into reuterin, which is an antimicrobial multicomponent
system [339].
Carboxylic and dicarboxylic acids
• Metabolites: Formate, Fumarate, Malonate, Succinate Lactate
• HMDB Ids: HMDB00142, HMDB00134, HMDB00691, HMDB00254, HMDB00190
• Examples of associated microbes: Bloom of Enterobacteriaceae phylum.
Others include Verrucomicrobia phylum. Producers from pyruvate catabolism
includes Bacteroides and Clostridia genera [120]. Specifically for lactate, Lactobacilli, Lactococci, Streptococci, Leuconostoc and Pediococci genera [240].
• Potential biological functions: Often used as terminal electron acceptors
for bacterial anaerobic respiration [150] and is produced by the microbiota itself
[82] and a highly competitive resource especially if induced by antibiotics [254].
124

B.1 Supplemental Notes
The presence and activation of enzymes associated with oxidizing these acids
are markers of inflammation such as in the case of formate [120]. Notably,
lactate is an important component in designing lactic acid bacteria probiotics
which can modulate intestinal immunity and provide a protective effect against
infection [99].

Vitamins
• Metabolites: Nicotinate (Vitamin B3)
• HMDB Ids: HMDB01488
• Examples of associated microbes: Lactic-acid commensal bacteria such as
Bifidobacterium bifidum, B. longum, B. breve, and B. adolescentis [162].
• Potential biological functions: Microbiome has been shown to both metabolize dietary B vitamins as well as produce them through folate metabolism
[162]. It is well known that vitamin Bs are essential micronutrients that are
precursors to important enzymes in humans.

Nucleosides
• Metabolites: Inosine, Uridine, Uracil
• HMDB Ids: HMDB00195, HMDB00296, HMDB00300
• Examples of associated microbes: Anaerococcus, Peptoniphilus, Fusobacterium, Lactobacillus genera [72].
• Potential biological functions: Can play an important role in immune response at the neonatal stage [297], supplementing the process of enterocyte
proliferation, maturation and apoptosis of intestinal cells [260].
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Alcohols
• Metabolites: Propylene Glycol
• HMDB Ids: HMDB01881
• Examples of associated microbes: Firmicutes and Lachnospiraceae phyla,
Dorea, Robinsonella and Roseburia genera [252].
• Potential biological functions: A solvent involved in propanoate metabolism
resulting in propanal (through KEGG [134]), which have been shown to be
associated with inflammatory bowel disease.

Bile acids
• Metabolites: Cholate
• HMDB Ids: HMDB00619
• Examples of associated microbes: Inhibits Bacterioidetes and Actinobacteria phyla, expansion of Firmicutes phylum, Blautia, Clostridium and Ruminococcus spp. [256, 127].
• Potential biological functions: Bile acid are involved in absorption of fats
and lipid-soluble vitamins [224], bile acid byproducts of microbial origins can
bind and activate host nuclear receptors and act as endocrine signaling molecules
[137, 122], which is found to be associated with cancer [334].

B.1.5. Supplementary Notes 5
Illumina MiSeq v4v5 primers used for bacteria 16S rRNA gene sequencing
• Forward Primer (518F): CCAGCAGCYGCGGTAAN
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• Reverse Primers (926R): CCGTCAATTCNTTTRAGT CCGTCAATTTCTTTGAGT
CCGTCTATTCCTTTGANT

Section B.2

Supplemental figures

Figure B.1: Inter-omics Procrustes biplots comparing PCoA ordinations of untargeted metabolite profiles and taxonomic relative abundances for 6 weeks (left panels)
(n = 158) and 12 months (right panels) (n = 262). Top panels present analyses based
on ordinations from Euclidean distances of genus level abundances after centered
log ratio transformation and Euclidean distances of arcsine square root transformed
metabolite relative abundances. Bottom panel presents analyses based on generalized
Unifrac distance of amplicon sequence variant (ASV) relative abundances and Euclidean distances of arcsine square root transformed metabolite relative abundances.
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Figure B.2: Pairwise Spearman correlation of metabolite bins and genus-level taxonomic abundances for 6-weeks (panel A, N = 158) and 12-months (panel B, N =
282) infants. Left panel displays the overall correlation pattern, where non-significant
correlations are not colored (false discovery rate (FDR) controlled q-value < 0.05).
Right panel displays the same heatmap restricted to taxa and metabolites selected
by the sparse CCA procedure. Additionally, correlation coefficient of the first sCCA
variate pair, bootstrapped 95% confidence interval and permutation p-value are also
reported.
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Figure B.3: Comparative analysis predictive model performance across all metabolites in the untargeted dataset for both 6-weeks (n = 158) and 12-months (n = 282)
timepoints. Top panel shows superimposed boxplots and violin plots of the distribution of predictive posterior mean for each evaluation metric across all 208 spectral
bins. Bottom panels show aggregated model rankings for all metabolites using Rsquared (left) and spearman correlation (right) using Borda scores (Methods).
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Figure B.4: Results for positive (Panel A) and negative simulations (Panel B). Positive simulations were conducted based on bootstrapped resamples of the original data
(12-month time point) and a normally distributed outcome vector which represented
a log-transformed metabolite profile. Different levels of model saturation (horizontal,
model sparsity (spar) at 0.05, 0.1, 0.5, 0.95) and effect sizes (vertical, signal-to-noise
ratio (snr) at 0.5, 0.7, 3, 5) were assessed, with 100 data sets generated for each
setting combination. Negative simulations were conducted based on permutations of
the original data (12-month time point), with a total of 1000 permutations. Highly
negative outliers were removed for the purposes of visualization.
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Figure B.5: Inter-omics Procrustes biplots comparing PCoA ordinations of targeted
metabolite profiles and taxonomic relative abundances in the sensitivity analyses for
6 weeks (left panels) (N = 65) and 12 months (right panels) (N = 65). Top panels present analyses based on ordinations from Euclidean distances of genus level
abundances after centered log ratio transformation and Euclidean distances of arcsine
square root transformed metabolite relative abundances. Bottom panel presents analyses based on generalized Unifrac distance of amplicon sequence variant (ASV) relative abundances and Euclidean distances of arcsine square root transformed metabolite relative abundances.
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Figure B.6: Inter-omics Procrustes biplots comparing PCoA ordinations of untargeted metabolite bin relative concentrations and taxonomic relative abundances in
the sensitivity analyses for 6 weeks (left panels) (N = 65) and 12 months (right
panels) (N = 65). Top panels present analyses based on ordinations from Euclidean
distances of genus level abundances after centered log ratio transformation and Euclidean distances of arcsine square root transformed metabolite relative abundances.
Bottom panel presents analyses based on generalized Unifrac distance of amplicon sequence variant (ASV) relative abundances and Euclidean distances of arcsine square
root transformed metabolite relative abundances.
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Figure B.7: Pairwise spearman correlation of concentration-fitted targeted metabolite concentrations and genus-level taxonomic abundances for 6-weeks (panel A,
N = 65) and 12-months (panel B, N = 65) infants in sensitivity analyses. Left
panel displays the overall correlation pattern, where non-significant correlations are
not colored (FDR controlled q-value < 0.05). Right panel displays the same heatmap
restricted to taxa and metabolites selected by the sCCA procedure. Additionally,
correlation coefficient of the first sCCA variate pair, bootstrapped 95% confidence
interval (nboot = 5000) and permutation p-value (nperm = 1000) are also reported.
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Figure B.8: Pairwise spearman correlation of untargeted metabolite bin relative
concentrations and genus-level taxonomic abundances for 6-weeks (panel A, N =
65) and 12-months (panel B, N = 65) infants in sensitivity analyses. Left panel
displays the overall correlation pattern, where non-significant correlations are not
colored (FDR controlled q-value < 0.05). Right panel displays the same heatmap
restricted to taxa and metabolites selected by the sCCA procedure. Additionally,
correlation coefficient of the first sCCA variate pair, bootstrapped 95% confidence
interval (nboot = 5000) and permutation p-value (nperm = 1000) are also reported.
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Figure B.9: Spearman correlation coefficients and 95% confidence intervals of significant correlations (q-value > 0.05) between metabolite concentrations in the targeted
data set and the abundances of pathways that produce them. Pathway abundances
were obtained via PICRUSt2 predictions, with pathway-metabolite relationship retrieved from MetaCyc database. Both 6-week (N = 158) and 12-month (N = 282)
samples are represented.
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Figure B.10: Top five contributors at the Genus level for each significantly correlated pathway-metabolite pair obtained using observed metabolite concentrations
and predicted pathway abundances (Spearman correlation with q-value ¡ 0.05). Panel
A represents 6-week samples while panel B represents samples at 12-months. Relative contributions are calculated as the total number of copies of genes mapped to a
pathway across all samples per Genus over the total number of gene copies assigned
to that pathway.
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Figure B.11: Heatmap representing overall spearman correlations between predicted
pathway abundances (obtained via PICRUSt2) and metabolite concentrations in the
targeted data set regardless of pathway-metabolite annotations. Both 6-week (N =
158) (Panel A) and 12-month (N = 282) (Panel B) samples are presented. Nonsignificant correlations (q-value > 0.05) are not colored.
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Supporting material for “CBEA:
Competitive balances for
taxonomic enrichment analysis”
Section C.1

Supplementary Note 1
In order to perform inference with CBEA, we estimated the null distribution empirically. This can be done either non-parametrically by constructing a null distribution
through computing scores on multiple permutations of the data, or parametrically via
estimating parameters of a distribution using the same permuted scores. This means
that our null distribution for a given set is equivalent to scores computed for sets
of similar sizes but containing randomly chosen taxa. We chose two distributional
forms for the null: the normal distribution and a two-component mixture normal distribution. For the normal distribution, we estimated parameters using the maximum
likelihood using the fitdistrplus package [66]. For the mixture normal distribution, we
utilized the expectation-maximization procedure from the package mixtools [22].
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An advantage of estimating the null using a parametric approach is the ability to
correct for variance inflation due to inter-taxa correlation within the set compared
to overall background correlation [324]. CBEA addresses this issue by combining the
location (or mean) estimate from the column permuted raw score matrix with the
spread (or variance) estimate from the original un-permuted scores. This still allows
us to leverage the null generated via column permutation while using the proper
variance estimate taken from scores where the correlation structure has not been
disrupted. As such, this procedure assumes that the variance of the test statistic
under the alternate hypothesis is the same as that of the null.
For the normal distribution, it is straightforward to combine mean and variance
estimates from the respective raw score matrices. For the mixture normal distribution,
however, due to the fact that the distribution is made of component-wise means,
variances and mixing coefficients, we decided to take an optimization based approach
to identifying the component wise variances σ1 and σ2 such the overall mean and
variance estimates come from the respective raw cILR score matrices as detailed
above. We can write the optimization problem as follows:

min

σ1 ,σ2

r
2
p
(σ1 + µ′1 − M ′ )λ′1 + (σ2 + µ′2 − M ′ )λ′2 − SD

s.t. σ1 ≥ 10−5 , σ2 ≥ 10−5

(C.1)

where M ′ , SD, µ′1 , µ′2 , λ′1 , λ′2 are constants
λ′1 , λ′2 , µ′1 , µ′2 , and M ′ are component-wise mixing coefficients, component-wise
means, and overall mean of the mixture distribution estimated from column-permuted
scores while SD is the overall standard deviation of the mixture distribution estimated from unpermuted scores. We solve for this optimization problem using a quasi
Newton method with box constraints (L-BFGS-B) with the default finite-difference
approximation of the gradient, as implemented in the optim function in R.
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There are also different variations to this approach. We can choose to vary both
σ1 and σ2 or to keep either σ1 or σ2 constant and varying the remaining component. We can assume that null distribution is a two-component mixture distribution
where there is one major component with smaller mean (representing the bulk of the
distribution centered at the permuted mean) and one minor component with higher
mean (representing the inflated right tail). Under this assumption, we can modify the
optimization problem to only estimate the variance parameter of the smaller component (i.e. without loss of generalizability keeping σ1 constant where λ′1 > λ′2 ). This
allows for the optimization procedure to more properly capture the right tail distribution rather than increasing weight on the left tail of the distribution which impacts
the computation of p-values for a one-sided test. Empirical experiments (data not
shown) done on simulated data and random set analyses suggest that this adjustment
improves performance of the adjusted CBEA under mixture-normal assumption. In
the R implementation of CBEA, users can control this behaviour by specifying the
fix comp parameter as part of the control argument.

Section C.2

Supplementary Note 2
C.2.1. Design
Even though real data evaluations provide good estimates for performance of CBEA
under typical analysis tasks, it does not allow for understanding of the behavior of the
model under different effect sizes, correlations, and sparsity. As such, we also perform
parametric numerical simulations by generating microbiome count data under the
assumption that it follows a zero-inflated negative binomial distribution, which is a
good fit for real microbiome relative abundance data [39]. Suppose Xij are observed
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counts for a sample i and taxon j, then we have the following probability model

Xij =




0

with probability pj

(C.2)



NB(µj , ϕj ) with probability 1 − pj
where µj and ϕj are mean and dispersion parameters, respectively. To incorporate
a flexible correlation structure into our simulation model, we utilized the NorTA
(Normal to Anything) method [43]. Given an n by p matrix of values U sampled
from multivariate normal distribution with correlation matrix ρ, we can generate
target microbiome count vector X.j for taxa j following the marginal distribution
NB characterized by the negative binomial cumulative distribution function FNB :
X.j = FNB −1 (ΦUi )

(C.3)

In this instance, for each taxon j, we set elements in U.j to be zero with probability pj
and applied NB−1 (µj , ϕj ) on non-zero elements to generate our final count matrix X.
To ensure that our simulations match closely to real data, we fitted negative binomial
distribution using a maximum likelihood approach (with the fitdistrplus package in R
[66]) to non-zero counts for each taxon from 16S rRNA profiling of stool samples from
the Human Microbiome Project (HMP). We take the median values of the estimated
mean (µj ) and dispersion parameters (ϕj ) as the baseline of our simulations. For
simplicity, we assumed that inter-taxa correlation follows an exchangeable structure
with correlation equals to ρ.

C.2.2. Scenarios
Simulation scenarios for enrichment analysis at the sample level. To
assess type I error rate and power for enrichment significance testing at the sample
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level, we simulated data based on the schema above, and assessed enrichment for one
focal set. Type I error was obtained under the global null as the number of samples
where the null hypothesis was rejected at α = 0.05 over the total number of samples
(which represents the total number of hypotheses tested). Power was obtained using
the same formulation as type I error rate but under the global alternate. We treated
type I error and power as estimates of binomial proportions and utilized the AgrestiCouli [3] formulation to calculate 95% confidence intervals. Across both analyses,
we varied sparsity levels (p = 0.2, 0.4, 0.6) and inter-taxa correlation within the set
(ρ = 0, 0.2, 0.5). For type I error analysis, we also varied the size of the set (50, 100,
150). For power analyses, set size was kept constant at 100 but different effect sizes
(fold change of 1.5, 2, and 3). All sample sizes were set at 10,000.
For classifiability, we evaluated the scores against the true labels per sample (indicating the sample has a set with inflated counts) using the area under the receiving
operator curve (AUROC). This is a strategy used in Frost [95] which evaluates the
informativeness of scores by assessing the relative ranking of samples (i.e. whether
samples with inflated counts are highly ranked using estimated scores). DeLong 95%
confidence intervals for AUROC [67] were obtained for each estimate. Simulation
settings for classification performance were identical to power analyses as detailed in
the previous paragraph.

Simulation scenarios for enrichment analysis at the population level. To
assess type I error rate and power for inferece at the population level, we simulated
data based on the schema above, and assessed the enrichment of 50 sets (with 100
taxa per set) across 10 replicates per simulation condition. Type I error is calculated
as the number of enriched sets over the total number of sets for each simulation under
the global null. Power is defined similarly, but instead under the global alternate hypothesis. Estimates and confidence intervals for type I error and power are calculated
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as cross-replicate mean and standard error. Across both analyses, we varied sparsity
levels (p = 0.2, 0.4, 0.6), and inter-taxa correlation within the set (ρ = 0, 0.2, 0.5). For
power analyse, we defined an enriched set as a set where all taxa within a set have
inflated means of the same effect size. Half of the sets are defined as enriched across
case/control status with varying effect sizes (fold change of 1.5, 2, and 3). Due to the
compositional nature of microbiome taxonomic data, simple inflation of raw counts
would cause an artificial decrease in the abundance of the remaining un-inflated sets.
As such, we applied a compensation procedure as described in Hawinkel et al. [113]
to ensure the validity of simulation results. All sample sizes were set at 500.

Simulation scenarios for downstream prediction. To assess predictive performance, we generated predictors based on the simulation schema presented above
and evaluated prediction for both binary and continuous outcomes using a standard
random forest model [33]. For binary outcomes, we use AUROC similar to the classification analyses above. For continuous outcomes, we used root mean squared error
(RMSE). All predictive model fitting was performed using tidymodels [152] suite of
packages. Across both learning tasks, we varied sparsity (p = 0.2, 0.4, 0.6), and intertaxa correlation (ρ = 0, 0.2, 0.5). Continuous outcomes Ycont were generated as linear
combinations of taxa counts.
Ycont = f (X) + ϵ

(C.4)

where ϵ ∼ N (0, σϵ2 ) and f (X) = β0 + Xβ. For each simulation, we set β0 to be

√6
10

similar to [327]. The degree of model saturation (the number of non zero β values)
were varied between 0.1 and 0.5, and signal to noise ratio (SNR =

σ(f (X))
)
σϵ

was varied

between 1.5, 2, and 3.
For binary outcomes, we generate Ybinary as Bernoulli draws with probability
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pbinary , where
pbinary =

1
1 + exp(f (X) + ϵ)

(C.5)

To ensure a balance of classes, we applied the strategy described in Dong et al.
[71] where the associated β values are evenly split between positive and negative
associations. All data sets generated from prediction tasks have 2,000 samples with
5,000 taxa over 50 sets with a size of 100 taxa per set.

C.2.3. Results
Statistical Inference. Fig C.1 demonstrate type I error evaluations for samplelevel inference with CBEA compared to the Wilcoxon rank sum test, which uses a
rank-based statistic to compare the mean count difference between taxa in the set
its complement. All methods demonstrate good type I error control at α = 0.05
under zero correlation across all simulation conditions. However, under both medium
(ρ = 0.2) and high (ρ = 0.5) correlation settings, both the Wilcoxon test and unadjusted CBEA variants show high levels of inflated type I error, where Wilcoxon test
performed the worst. On the other hand, adjusted CBEA methods (under both distributions) control for type I error at the appropriate α level even at high correlations.
This is opposite from our real data evaluations, where adjusted CBEA demonstrated
inflated type I error under random set evaluations.
We also assessed the ability to perform inference at the population level using
CBEA similar to GSVA [111]. Here, we test for enrichment of sets across case/control
status by generating CBEA scores and performing Welch’s t-test as a difference in
means test. We compared the performance of this approach with CBEA and two
commonly used methods for differential abundance testing in the microbiome literature: DESeq2 [177] and corncob [191]. Fig. C.2 present results for simulation studies
for both type I error evaluations. All methods were able to control for type I error
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Figure C.1: Simulation results for type I error evaluation for CBEA sample-level
inference. Type I error rate (y axis) was estimated for each approach across data
sparsity levels (x axis) across different set sizes (horizontal) and inter-taxa correlation
within the set (vertical). We compared variatns of CBEA against a Wilcoxon rank
sum test at α of 0.05. For each scenario, a data set of 10,000 samples (equivalent
to 10,000 hypotheses) was utilized. Confidence bounds were obtained using AgrestiCouli approach.
across both sparsity and correlation levels, where medium level sparsity (p = 0.4) and
correlation (ρ = 0.2) showed the strongest performance. In these scenarios, the CDF
values of CBEA generated under the adjusted mixture normal distribution performed
the best. This is different than our real data evaluations, where corncob and DESeq2
showed increased type I error.
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Figure C.2: Simulation results for type I error evaluation for CBEA populationlevel inference. Type I error (y-axis) was estimated as the average proportion of sets
with significant enrichment at 0.05 across 10 replications per simulation condition
under the global null. Error bars were estimated using standard errors computed
across 10 replicated data sets. Performance was evaluated across different sparsity
(x -axis) and inter-taxa correlation levels. For CBEA methods, enrichment analysis
was performed using a Welch’s t-test across case/control status with single sample
scores representing set-based features generated by CBEA (across different output
types and distributional assumptions). For corncob and DESeq2, set-based features
were constructed using element-wise summations.
Phenotype relevance. We assessed phenotype relevance similar to the main manuscript
by assessing statistical power and score rankings via AUROC. Results for this analysis
is shown in Fig C.3. For statistical power (panel A), under low-correlation settings,
all CBEA approaches demonstrate similar power, with the unadjusted methods being
slightly more performant at low effect sizes. Notably, all CBEA variants outperformed
the Wilcoxon rank sum test. However, as correlation increases, the adjusted CBEA
variants showed much lower power, congruent with the perspective that the adjustment process is conservative and trades off power for type I error control. Even at the
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highest effect size (fold change of 3 in means) adjusted CBEA does not approach 0.8.
For score rankings (panel B), all methods are close together in performance, with the
Wilcoxon W statistic being the worst performer. These results are similar to that of
our real data evaluations. Notably, performance values were not affected by sparsity
and increases to near perfect prediction at higher effect sizes.
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Figure C.3: Simulation results for phenotype relevance evaluation for CBEA samplelevel inference. (A) demonstrate statistical power (y-axis) across different data sparsity levels (x -axis) and power (B) for differential abundance test across different
parametric simulation scenarios. For CBEA methods, differential abundance analysis was performed using a difference in means test (either Wilcoxon rank-sum test
or Welch’s t-test) across case/control status using single sample scores generated by
CBEA (across different output types and distributional assumptions). CBEA associated methods demonstrated similar type I error to conventional differential abundance
analysis methods but with more power to detect differences even at small effect sizes.
For population-level analyses, we assessed phenotype relevance as statistical power
to detect sets that were simulated to be significantly enriched. Fig C.4 showed these
results. As expected, power decreases with increasing sparsity, where the effect was
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attenuated at lower effect sizes. Correlation did impact power, however the difference
was not notable. Interestingly, at lower effect sizes both DESeq2 and corncob has
comparable power with CBEA, however as effect size increases, the difference in performance values became more stark. This is different than our real data evaluations,
where power was more comparable (with slight advantage to corncob and DESeq2).
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Figure C.4: Simulation results for phenotype relevance evaluation for CBEA
population-level inference. Power (y-axis) was estimated as the average proportion of
sets correctly identified as significantly enriched (at 0.05) across 10 replications per
simulation condition under the global null. Error bars were estimated using standard
errors computed across 10 replicated data sets. Performance was evaluated across
different sparsity (x -axis) and inter-taxa correlation levels. For CBEA methods, enrichment analysis was performed using a Welch’s t-test across case/control status
with single sample scores representing set-based features generated by CBEA (across
different output types and distributional assumptions). For corncob and DESeq2,
set-based features were constructed using element-wise summations.

Predictive analysis. Fig C.5 shows results for simulation studies as detailed in
the Methods section. Panel A presents results for a regression learning task with a
continuous outcome. We observed no difference in performance values across different
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evaluation models. Overall, prediction error did not change across sparsity levels, and
decreases with increasing signal-to-noise ratio (SNR). However, at higher correlation
levels, the pattern was more erratic. For example, when ρ is set at 0.5, higher SNR
decreases performance only at low sparsity p = 0.2, but had the expected pattern
medium sparsity p = 0.4, where higher SNR correlates with improved performance.
This effect seems to be specific to low effect saturation scenarios (only a limited
number of taxa sets are associated with the outcome). Interestingly, higher sparsity
levels produces better performance.
Panel B represent results for a classification task with a binary outcome with
AUROC as the evaluation criteria. Here we observed similar results as that of our
real data evaluations, where using CLR transfromed data produces more predictive
models across all scenarios. Conversely, GSVA and ssGSEA were consistently under
performing when compared to CBEA and CLR. Interestingly, the degree of difference
varies across sparsity and inter-taxa correlations. We noticed that increasing sparsity
and correlation decreases the gap in performance between CBEA and CLR, while
increasing the gap in performance between CBEA/CLR and GSVA/ssGSEA. As such,
we can hypothesize that both GSVA and ssGSEA are more sensitive to the degree
of inter-taxa correlation and sparsity. Finally, effect saturation did not change model
rankings, but did decrease overall performance.
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A. Regression
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Figure C.5: Simulation results for predictive pefromance evaluation for CBEA.
Predictive performance of a random forest model (with no hyperparameter tuning)
trained on set-based features as inputs. Methods to generate these features include
CBEA, ssGSEA, GSVA, and the CLR transformation applied on sum-aggregated
sets. Simulation data was generated across different levels of data sparsity, inter-taxa
correlation, effect saturation, and signal-to-noise ratio. Panel (A) presents performance on a regression task using RMSE (root mean squared error) as the evaluation
measure. Panel (B) presents performance on a classification task with AUROC as
the evaluation measure.
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We implemented CBEA in the package CBEA on GitHub (https://www.github.
com/qpmnguyen/CBEA). We evaluated computational time using the bench package
in R. We applied CBEA to a standard data set generated using our simulation model
consisting of 40 sets (of size 20 each) and 500 samples. Benchmark was performed
on a single core using a node on the computing cluster (Specifications: Intel Xeon
E5-2690 (2.6GHz) with 4GB of RAM).
Permutations: 50

Permutations: 100

1.32m
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Normal
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Distribution
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Figure C.6: Runtime performance. Overall runtime of CBEA under different parameters for a data set of 500 samples, 800 taxa (40 sets of size 20 each). This data
set was generated via simulations.
In general, using the normal distribution is the fastest approach regardless of the
total number of permutations performed (2 minutes). However, using the mixture
normal distribution increased the runtime many folds, especially for the adjusted
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approach (highest was 5.53 hours). This time scales with the number of sets evaluated,
as well as the number of samples. We believe this is due to the procedure used to
estimate parameters of the mixture normal distrubiton as implemented in the mixtools
package. The default parameters used in CBEA also increased the runtime in order
to reduce convergence issues.
In order to reduce runtime, users can attempt the following: Since CBEA fits
parametric distributions over permuted values of all samples within a data set (i.e.
for N = 100 and 10 permutations, the fitting procedure will attempt to estimate
parameters from a vector of size 1000 for each set), if the sample size is high users can
reduce the number of permutations. Additionally, CBEA also implements a procedure
to parallelize computation across sets, which might be applicable to situations where
there are a lot of sets to evaluate. Finally, a lot of CBEA approaches work well without
parametric fit, so users can use the non-parametric approaches like the permutation
test or using raw CBEA scores.
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Figure C.7: Distribution of type I error values across all replications in real data
random set evaluations for CBEA inference at the sample-level. Density (y-axis) for
type I error values (x -axis) of each evaluated approach for sample-level inference using
real data across 500 replications. Here, type I error was estimated as the proportion
of samples where a randomly sampled set of different sizes where identified to be
statistically significant at p-value threshold of 0.05.
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Figure D.1: Trait coverage statistics for samples profiled with 16S rRNA gene metabarcoding. Panel (A) illustrates the
proportion of present taxa per sample annotated to at least one trait. Panel (B) illustrates the proportion of reads assigned
to taxa annotated to at least one trait which accounts for taxa relative abundances. Each plot facet represents different
trait categories that were evaluated. Error bar represents the standard error of the evaluation statistic of interest across the
the total number of samples evaluated per body site.
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[105] Jelle J. Goeman and Peter Bühlmann, Analyzing gene expression data in terms
of gene sets: Methodological issues, Bioinformatics 23 (2007), no. 8, 980–987.
[106] Antonio Gonzalez, Jose A. Navas-Molina, Tomasz Kosciolek, Daniel McDonald, Yoshiki Vázquez-Baeza, Gail Ackermann, Jeff DeReus, Stefan Janssen,
Austin D. Swafford, Stephanie B. Orchanian, Jon G. Sanders, Joshua Shorenstein, Hannes Holste, Semar Petrus, Adam Robbins-Pianka, Colin J. Brislawn,
Mingxun Wang, Jai Ram Rideout, Evan Bolyen, Matthew Dillon, J. Gregory
Caporaso, Pieter C. Dorrestein, and Rob Knight, Qiita: Rapid, web-enabled
microbiome meta-analysis, Nature Methods 15 (2018), no. 10, 796–798.
[107] John Guittar, Ashley Shade, and Elena Litchman, Trait-based community assembly and succession of the infant gut microbiome, Nat Commun 10 (2019),
no. 1, 512.
[108] Ankit Gupta, Darshan B. Dhakan, Abhijit Maji, Rituja Saxena, Vishnu Prasoodanan P K, Shruti Mahajan, Joby Pulikkan, Jacob Kurian, Andres M.
176

BIBLIOGRAPHY
Gomez, Joy Scaria, Katherine R. Amato, Ashok K. Sharma, and Vineet K.
Sharma, Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India, mSystems 4 (2019), no. 6, e00438–19.
[109] Andrew Brantley Hall, Moran Yassour, Jenny Sauk, Ashley Garner, Xiaofang
Jiang, Timothy Arthur, Georgia K. Lagoudas, Tommi Vatanen, Nadine Fornelos, Robin Wilson, Madeline Bertha, Melissa Cohen, John Garber, Hamed
Khalili, Dirk Gevers, Ashwin N. Ananthakrishnan, Subra Kugathasan, Eric S.
Lander, Paul Blainey, Hera Vlamakis, Ramnik J. Xavier, and Curtis Huttenhower, A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients, Genome Med 9 (2017), no. 1, 103.
[110] Geoffrey D. Hannigan, Melissa B. Duhaime, Mack T. Ruffin, Charlie C.
Koumpouras, and Patrick D. Schloss, Diagnostic Potential and Interactive Dynamics of the Colorectal Cancer Virome, mBio 9 (2018), no. 6, e02248–18.
[111] Sonja Hänzelmann, Robert Castelo, and Justin Guinney, GSVA: Gene set variation analysis for microarray and RNA-Seq data, BMC Bioinformatics 14 (2013),
no. 1, 7.
[112] Trevor Hastie, Robert Tibshirani, and J. H. Friedman, The elements of statistical learning: Data mining, inference, and prediction, 2nd ed ed., Springer
Series in Statistics, Springer, New York, NY, 2009.
[113] Stijn Hawinkel, Federico Mattiello, Luc Bijnens, and Olivier Thas, A broken
promise: Microbiome differential abundance methods do not control the false
discovery rate, Brief Bioinform 20 (2019), no. 1, 210–221.

177

BIBLIOGRAPHY
[114] Almut Heinken and Ines Thiele, Systems biology of host–microbe metabolomics,
Wiley Interdiscip Rev Syst Biol Med 7 (2015), no. 4, 195–219.
[115] Anna Heintz-Buschart, Patrick May, Cédric C. Laczny, Laura A. Lebrun,
Camille Bellora, Abhimanyu Krishna, Linda Wampach, Jochen G. Schneider,
Angela Hogan, Carine de Beaufort, and Paul Wilmes, Integrated multi-omics
of the human gut microbiome in a case study of familial type 1 diabetes, Nat
Microbiol 2 (2017), no. 1, 16180.
[116] Anna Heintz-Buschart and Paul Wilmes, Human Gut Microbiome: Function
Matters, Trends in Microbiology 26 (2018), no. 7, 563–574.
[117] Cian J. Hill, Denise B. Lynch, Kiera Murphy, Marynka Ulaszewska, Ian B.
Jeffery, Carol Anne O’Shea, Claire Watkins, Eugene Dempsey, Fulvio Mattivi,
Kieran Tuohy, R. Paul Ross, C. Anthony Ryan, Paul W. O’ Toole, and Catherine Stanton, Evolution of gut microbiota composition from birth to 24 weeks in
the INFANTMET Cohort, Microbiome 5 (2017), no. 1, 4.
[118] Katherine Hollywood, Daniel R. Brison, and Royston Goodacre, Metabolomics:
Current technologies and future trends, Proteomics 6 (2006), no. 17, 4716–4723.
[119] Ruizhu Huang, Charlotte Soneson, Felix G.M. Ernst, Kevin C. Rue-Albrecht,
Guangchuang Yu, Stephanie C. Hicks, and Mark D. Robinson, TreeSummarizedExperiment: A S4 class for data with hierarchical structure, F1000Research 9
(2021), 1246.
[120] Elizabeth R. Hughes, Maria G. Winter, Breck A. Duerkop, Luisella Spiga,
Tatiane Furtado de Carvalho, Wenhan Zhu, Caroline C. Gillis, Lisa Büttner,
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[185] Morgane Mailhe, Davide Ricaboni, Véronique Vitton, Jean-Michel Gonzalez, Dipankar Bachar, Grégory Dubourg, Frédéric Cadoret, Catherine Robert,
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Kämpfer, Fred A Rainey, and William B Whitman (eds.), Bergey’s Manual
of Systematics of Archaea and Bacteria, first ed., Wiley, April 2015.
[286] Duy Tin Truong, Eric A. Franzosa, Timothy L. Tickle, Matthias Scholz, George
Weingart, Edoardo Pasolli, Adrian Tett, Curtis Huttenhower, and Nicola
Segata, MetaPhlAn2 for enhanced metagenomic taxonomic profiling, Nature
Methods 12 (2015), no. 10, 902–903.
[287] Peter J. Turnbaugh and Jeffrey I. Gordon, An invitation to the marriage of
metagenomics and metabolomics, Cell 134 (2008), no. 5, 708–713.
[288] Peter J. Turnbaugh, Micah Hamady, Tanya Yatsunenko, Brandi L. Cantarel,
Alexis Duncan, Ruth E. Ley, Mitchell L. Sogin, William J. Jones, Bruce A. Roe,
Jason P. Affourtit, Michael Egholm, Bernard Henrissat, Andrew C. Heath, Rob
Knight, and Jeffrey I. Gordon, A core gut microbiome in obese and lean twins,
Nature 457 (2009), no. 7228, 480–484.
[289] Luke K Ursell, Jessica L Metcalf, Laura Wegener Parfrey, and Rob Knight,
Defining the human microbiome, Nutrition Reviews 70 (2012), S38–S44.
[290] K. Gerald van den Boogaart, Raimon Tolosana-Delgado, and Matevz Bren,
Compositions: Compositional data analysis, 2019.
[291] Tommi Vatanen, Eric A. Franzosa, Randall Schwager, Surya Tripathi, Timothy D. Arthur, Kendra Vehik, Åke Lernmark, William A. Hagopian, Marian J.
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